 SHARE EXCHANGE AGREEMENT BY AND AMONG
UNION ACQUISITION CORP.       

  

Exhibit 2.1

 

Execution Version

  

 

 

 

 

 

SHARE EXCHANGE AGREEMENT

 

BY AND AMONG

 

UNION ACQUISITION CORP.

 

THE PRE-CLOSING UNION REPRESENTATIVE

 

AND

 

BIOCERES, INC.

 

DATED AS OF NOVEMBER 8, 2018

  

 

 

   

TABLE OF CONTENTS

       |   |   |   |   | Page 
---|---|---|---|---|--- 
   ARTICLE 1 CERTAIN DEFINITIONS  |   | 3 
     | Section 1.1.   |   | Certain Definitions  |   | 3 
     | 
   ARTICLE 2 SHARE EXCHANGE AND RELATED MATTERS  |   | 15 
     | Section 2.1.   |   | The Exchange  |   | 15 
     | Section 2.2.   |   | The Closing  |   | 16 
     | Section 2.3.   |   | Deliveries at the Closing  |   | 17 
     | Section 2.4.   |   | Escrow  |   | 17 
     | Section 2.5.   |   | Working Capital Closing Adjustment  |   |
18 
     | Section 2.6.  |   | Post-Closing Working Capital Adjustment  |  
| 18 
     | Section 2.7.   |   | Sale Restriction  |   | 20 
     | Section 2.8.   |   | Bioceres Semillas Tag Along  |   | 20 
     | 
   ARTICLE 3 REPRESENTATIONS AND WARRANTIES REGARDING THE GROUP  |   | 
   COMPANIES  |   |   |   | 21 
     | Section 3.1.   |   | Organization and Qualification;
Subsidiaries  |   | 21 
     | Section 3.2.   |   | Capitalization of the Group Companies  |  
| 21 
     | Section 3.3.   |   | No Violation; Consents and Approval  |   |
23 
     | Section 3.4.   |   | Financial Statements; Undisclosed
Liabilities; Book and Records  |   | 23 
     | Section 3.5.   |   | [RESERVED]  |   | 24 
     | Section 3.6.   |   | Material Contracts  |   | 24 
     | Section 3.7.   |   | Absence of Changes  |   | 26 
     | Section 3.8.   |   | Litigation  |   | 26 
     | Section 3.9.   |   | Compliance with Applicable Law  |   | 26 
     | Section 3.10.  |   | Employee Benefit Plans  |   | 27 
     | Section 3.11.  |   | Environmental Matters  |   | 29 
     | Section 3.12.  |   | Intellectual Property  |   | 30 
     | Section 3.13.  |   | Labor Matters  |   | 35 
     | Section 3.14.  |   | Insurance  |   | 36 
     | Section 3.15.  |   | Tax Matters  |   | 36 
     | Section 3.16.  |   | Brokers  |   | 38 
     | Section 3.17.  |   | Real and Personal Property  |   | 38 
     | Section 3.18.  |   | Transactions with Related Parties  |   | 39 
     | Section 3.19.  |   | Certain Business Practices  |   | 39 
     | Section 3.20.  |   | Customers and Suppliers  |   | 41 
     | Section 3.21.  |   | Company Information  |   | 41 
     | Section 3.22.  |   | State Takeover Statutes  |   | 41 
     | Section 3.23.  |   | Product Warranty; Product Liability  |   |
41 
     | Section 3.24.  |   | Pre-Closing Reorganization Contracts  |   |
42 
   
      ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF BIOCERES AND  |  
| 
---|---|--- 
   PARENT  |   | 43 
     | Section 4.1.  |   | Authority  |   | 43 
     | Section 4.2.  |   | No Violations; Consents and Approval  |   |
43 
     | Section 4.3.  |   | Title to the Company Shares and Bioceres
Semillas Shares;  |   | 
     |   |   | Ownership of the Company and Bioceres Semillas  |   | 44 
     | Section 4.4.  |   | Litigation  |   | 44 
     | Section 4.5.  |   | Brokers  |   | 44 
     | 
   ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF UNION  |   | 45 
     | Section 5.1.  |   | Incorporation  |   | 45 
     | Section 5.2.  |   | Authority  |   | 45 
     | Section 5.3.  |   | No Violations; Consents and Approvals  |   |
46 
     | Section 5.4.  |   | Absence of Changes  |   | 46 
     | Section 5.5.  |   | Brokers  |   | 46 
     | Section 5.6.  |   | Union Information  |   | 46 
     | Section 5.7.  |   | Trust Account  |   | 46 
     | Section 5.8.  |   | Listing  |   | 47 
     | Section 5.9.  |   | Union Board Approval  |   | 47 
     | Section 5.10.  |   | Union SEC Documents and Financial
Statements  |   | 47 
     | Section 5.11.  |   | Litigation  |   | 48 
     | Section 5.12.  |   | Absence of Certain Payments  |   | 48 
     | Section 5.13.  |   | Union Ordinary Shares  |   | 48 
     | Section 5.14.  |   | Tax Matters  |   | 48 
     | 
    ARTICLE 6 COVENANTS  |   | 50 
     | Section 6.1.  |   | Conduct of Business of Union and the Group
Companies  |   | 50 
     | Section 6.2.  |   | Certain Tax Matters  |   | 53 
     | Section 6.3.  |   | Access to Information  |   | 54 
     | Section 6.4.  |   | Efforts to Consummate; Regulatory Matters  |
  | 54 
     | Section 6.5.  |   | Preparation of Proxy Statement/Registration
Statement  |   | 55 
     | Section 6.6.  |   | Transaction Proposals and the Union
Shareholder Approval  |   | 57 
     | Section 6.7.  |   | Third Party Consents  |   | 57 
     | Section 6.8.  |   | Notice  |   | 58 
     | Section 6.9.  |   | Public Announcements  |   | 58 
     | Section 6.10.  |   | Exclusive Dealing  |   | 58 
     | Section 6.11.  |   | Documents and Information  |   | 59 
     | Section 6.12.  |   | Contact with Customers, Suppliers and Other
Business Relations  |   | 59 
     | Section 6.13.  |   | [RESERVED]  |   | 59 
     | Section 6.14.  |   | No Ordinary Shares Transactions; Listing  |
  | 59 
     | Section 6.15.  |   | No Claim Against Trust Account  |   | 60 
     | Section 6.16.  |   | Union Borrowings  |   | 60 
     | Section 6.17.  |   | Post-Closing Integration and Transition  |
  | 60 
     | Section 6.18.  |   | Amending Governing Documents  |   | 60 
     | Section 6.19.  |   | Post-Closing Union Board  |   | 60 
     | Section 6.20.  |   | [RESERVED]  |   | 61 
     | Section 6.21.  |   | DandO Insurance and Indemnification  |   | 61 
     | Section 6.22.  |   | Pre-Closing Reorganization  |   | 61 
     | Section 6.23.  |   | Parent Joinder  |   | 62 
     
       | Section 6.24.  |   | Rizobacter Call Option  |   | 62 
---|---|---|---|---|--- 
     | Section 6.25.  |   | Intellectual Property  |   | 62 
     | Section 6.26.  |   | Pre-Closing Matters  |   | 63 
     | Section 6.27.  |   | Intellectual Property and Technology Rights 
|   | 63 
     | 
   ARTICLE 7 CONDITIONS TO CONSUMMATION OF THE TRANSACTIONS  |   | 
   CONTEMPLATED BY THIS AGREEMENT  |   | 64 
     | Section 7.1.  |   | Conditions to the Obligations of
Union and Bioceres  |   | 64 
     | Section 7.2.  |   | Other Conditions to the Obligations of Union 
|   | 64 
     | Section 7.3.  |   | Other Conditions to the Obligations of
Bioceres  |   | 66 
     | Section 7.4.  |   | Frustration of Closing Conditions  |   | 66 
     | 
   ARTICLE 8 TERMINATION; AMENDMENT; WAIVER; EXPENSES  |   | 67 
     | Section 8.1.  |   | Termination  |   | 67 
     | Section 8.2.  |   | Notice of Termination  |   | 68 
     | Section 8.3.  |   | Effect of Termination  |   | 68 
     | Section 8.4.  |   | Amendment  |   | 68 
     | Section 8.5.  |   | Extension; Waiver  |   | 68 
     | Section 8.6.  |   | Fees and Expenses  |   | 68 
     | 
   ARTICLE 9 INDEMNIFICATION  |   | 69 
     | Section 9.1.  |   | Survival of Representations, Warranties and
Covenants  |   | 69 
     | Section 9.2.  |   | Indemnification  |   | 69 
     | Section 9.3.  |   | Indemnification Claim Procedures  |   | 70 
     | Section 9.4.  |   | Basket  |   | 70 
     | Section 9.5.  |   | Other Limitations on Indemnification  |   |
71 
     | Section 9.6.  |   | Adjustment to Consideration  |   | 72 
     | Section 9.7.  |   | Exclusive Remedy  |   | 72 
     | 
   ARTICLE 10 MISCELLANEOUS  |   | 73 
     | Section 10.1.  |   | Entire Agreement; Assignment  |   | 73 
     | Section 10.2.  |   | Notices  |   | 73 
     | Section 10.3.  |   | Governing Law  |   | 75 
     | Section 10.4.  |   | Construction; Interpretation  |   | 75 
     | Section 10.5.  |   | Exhibits and Schedules  |   | 75 
     | Section 10.6.  |   | Parties in Interest  |   | 76 
     | Section 10.7.  |   | No Recourse Against Non-Party Affiliates  |
  | 76 
     | Section 10.8.  |   | Severability  |   | 77 
     | Section 10.9.  |   | Counterparts  |   | 77 
     | Section 10.10.  |   | WAIVER OF JURY TRIAL  |   | 77 
     | Section 10.11.  |   | Jurisdiction and Venue  |   | 78 
     | Section 10.12.  |   | Liability of Pre-Closing Union
Representative  |   | 78 
     | Section 10.13.  |   | Specific Performance  |   | 78 
     | Section 10.14.  |   | Conflicts; Privilege  |   | 79 
     

 _Exhibits_

 

Exhibit A - Escrow Agreement 
Exhibit B - Parent ROFR 
Exhibit C - Form of Warrant 
Exhibit D - Lock-Up Agreement 
Exhibit E - Parent Joinder 
Exhibit F - Rizobacter Call Option

 

 _Schedules_

 

Schedule 2.5 - Closing Working Capital 
Schedule 5.5 - Brokers 
Schedule 6.1(b) - Conduct of Business of the Group Companies 
Schedule 6.22(a) - Pre-Closing Reorganization Steps 
Schedule 6.25(b)(i) - Internet Domain Name 
Schedule 6.25(b)(ii) - Trademark Assignments 
Schedule 6.26(a) - Remedial Actions 
Schedule 6.26(b) - Notices and Acknowledgements   

SHARE EXCHANGE AGREEMENT

 

THIS SHARE EXCHANGE AGREEMENT, dated as of November 8, 2018, is made by and
among UNION ACQUISITION CORP., an exempted company incorporated under the laws
of the Cayman Islands (" _Union_ "), Joseph J. Schena (the " _Pre-Closing
Union Representative_ "), solely in his capacity as representative of the
holders of Union Ordinary Shares immediately prior to the Closing and their
successors, and Bioceres, Inc., a Delaware corporation (" _Bioceres_ "), and
its successor. Union and Bioceres are, from time to time, referred to
individually herein as a " _Party_ ", and collectively as the " _Parties_ ".
Capitalized terms used but not otherwise defined herein have the meanings
ascribed to such terms in _ARTICLE 1_.

 

WHEREAS, Union is a blank check company incorporated to acquire one or more
operating businesses through a Business Combination (as defined herein);

 

WHEREAS, as of the date hereof, the public shareholders of Union and the
Founders (as defined herein) own beneficially and of record one hundred
percent (100%) of the issued and outstanding Union Ordinary Shares (as defined
herein);

 

WHEREAS, after the consummation of the Pre-Closing Reorganization (as defined
herein), Bioceres will own beneficially and of record (a) one hundred percent
(100%) of the issued and outstanding equity securities (the " _Company Shares_
") of New Bioceres Inc., a Delaware corporation to be formed and to accede to
this Agreement prior to the Closing Date (the " _Company_ ") and (b) 87.2739%
of the issued and outstanding equity securities (the " _Bioceres Semillas
Shares_ ") of Bioceres Semillas S.A. (" _Bioceres Semillas_ ");

 

WHEREAS, Union desires to acquire the Company Shares and Bioceres Semillas
Shares from Bioceres in exchange (the " _Exchange_ ") for (a) newly issued
Union Ordinary Shares and (b) warrants to purchase Union Ordinary Shares,
subject to the terms and conditions set forth herein;

 

WHEREAS, in furtherance of the acquisition of the Company and of Bioceres
Semillas by Union and in accordance with the terms hereof, Union shall provide
holders of Public Shares (as defined herein) with the opportunity to elect to
effect a Share Redemption (as defined herein); and

 

WHEREAS, the board of directors of Union (the " _Union Board_ ") has, the
board of directors of Bioceres has, and the sole member of Bioceres is
anticipated to have, as of the Closing, approved and declared advisable this
Agreement and the transactions contemplated hereby.

 

NOW, THEREFORE, in consideration of the premises and the mutual promises
contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties, intending to be
legally bound, hereby agree as follows:

    

ARTICLE 1 
CERTAIN DEFINITIONS

 

Section 1.1. _Certain Definitions_.

 

As used in this Agreement, the following terms have the respective meanings
set forth below.

 

" _Additional Union SEC Documents_ " has the meaning set forth in _Section
5.10_.

 

" _Affiliate_ " means, with respect to any Person, any other Person who
directly or indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, such Person. The term
"control" means the possession, directly or indirectly, of the power to direct
or cause the direction of the management and policies of a Person, whether
through the ownership of voting securities, by contract or otherwise, and the
terms "controlled" and "controlling" have meanings correlative thereto.

 

" _Agreement_ " means this Agreement together with all Schedules, Exhibits and
Annexes hereto, as the same may from time to time be amended, modified,
supplemented or restated in accordance with the terms hereof.

 

" _Ancillary Documents_ " means the Escrow Agreement, the Lock-Up Agreement,
the Parent ROFR, the Parent Joinder and each other agreement, document,
instrument and/or certificate contemplated by this Agreement to be executed in
connection with the transactions contemplated hereby.

 

" _Audited Combined Financial Statements_ " has the meaning set forth in
_Section 6.5(e)_.

 

" _Audited Financial Statements_ " has the meaning set forth in _Section
3.4(a)_.

 

" _Basket_ " has the meaning set forth in _Section 9.4_.

 

" _Bioceres_ " has the meaning set forth in the introductory paragraph to this
Agreement.

 

" _Bioceres Designated Contact_ " means Gloria Montaron and such other Persons
as Bioceres may designate in writing from time to time.

 

" _Bioceres Fundamental Representation_ " means those representations and
warranties set forth in _Section 3.1_ , _Section 3.2_ , _Section 3.3_ ,
_Section 3.12_ , _Section 3.15_ , _Section 3.16_ , _Section 4.1_ , _Section
4.2_ , _Section 4.3_ and _Section 4.5_.

 

" _Bioceres Group_ " has the meaning set forth in _Section 10.14(a)(ii)_.

 

" _Bioceres Group Law Firms_ " has the meaning set forth in _Section
10.14(a)(ii)_.

     

" _Bioceres Material Adverse Effect_ " means any event, circumstance, change,
development or effect that, individually or in the aggregate with all other
events, circumstances, changes, developments or effects, has had, or would
reasonably be expected to have, a material adverse effect on (i) the assets,
liabilities, financial condition, business or results of operations of the
Group Companies, taken as a whole, or (ii) the ability of Bioceres to timely
consummate the transactions contemplated hereunder in accordance with the
terms and subject to the conditions set forth herein; _provided_ , _however_ ,
that any adverse event, circumstance, change, development or effect arising
from or related to (a) any national or international political or social
conditions, including, engagement in hostilities, whether or not pursuant to
the declaration of a national emergency or war, the occurrence of any military
or terrorist attack or otherwise, (b) financial, banking or securities markets
(including any disruption thereof and any decline in the price of any security
or any market index), (c) changes in U.S. GAAP or IFRS (or in the
interpretation thereof), (d) changes in (or in the interpretation of) any
laws, rules, regulations, orders, or other binding directives issued by any
Governmental Entity or any action required to be taken under any Law or
existing contract by which any Group Company (or any of their respective
assets or properties) is bound, (e) any change that is generally applicable to
the industries or markets in which the Group Companies operate, (f) the loss
or departure of officers or other employees of the Group Companies (other than
the loss or departure of Federico Trucco and Enrique Lopez Lecube) in
connection with the announcement of this Agreement or the pendency or
consummation of the transactions contemplated hereby or (g) the taking of any
action contemplated by this Agreement or any Ancillary Document (including the
completion of the transactions contemplated hereby or thereby) or with Union's
consent (but excluding effects resulting from the Closing), shall not be
considered a Bioceres Material Adverse Effect; _provided_ , _however_ , that
with respect to each of clauses (a) through (f), any event, circumstance,
change, development or effect referred to above shall be taken into account in
determining whether a Bioceres Material Adverse Effect has occurred or would
reasonably be expected to occur to the extent that such event, circumstance,
development, occurrence, fact, condition, or change has a materially
disproportionate effect on the Group Companies taken as a whole compared to
other participants in the industries in which such Group Companies primarily
conduct their businesses.

 

" _Bioceres Options_ " has the meaning set forth in _Section 2.1(d)_.

 

" _Bioceres Privileged Communications_ " has the meaning set forth in _Section
10.14(b)_.

 

" _Bioceres Semillas_ " has the meaning set forth in the recitals to this
Agreement.

 

" _Bioceres Semillas Shares_ " has the meaning set forth in the recitals to
this Agreement.

 

" _Business Combination_ " means a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination.

 

" _Business Day_ " means a day, other than a Saturday or Sunday, on which
commercial banks in New York City and Buenos Aires, Argentina are open for the
general transaction of business.

 

" _Closing_ " has the meaning set forth in _Section 2.2_.

 

" _Closing Adjustment_ " has the meaning set forth in _Section 2.5(b)_.

 

" _Closing Date_ " has the meaning set forth in _Section 2.2_.

    

" _Closing Exchange Shares_ " means the number of Exchange Shares less the
number of Escrow Shares delivered to Bioceres at the Closing.

 

" _Closing Working Capital_ " means (a) the Current Assets of the Group
Companies, less (b) the Current Liabilities of the Group Companies, determined
as of the open of business on the Closing Date.

 

" _Closing Working Capital Statement_ " has the meaning set forth in _Section
2.6(a)_.

 

" _COBRA_ " means Part 6 of Subtitle B of Title I of ERISA, Section 4980B of
the Code and any similar state law.

 

" _Code_ " means the Internal Revenue Code of 1986, as amended.

 

" _Company_ " has the meaning set forth in the recitals to this Agreement.

 

" _Company Patents_ " has the meaning set forth in _Section 3.12(h)_.

 

" _Company Shares_ " has the meaning set forth in the recitals to this
Agreement.

 

" _Confidentiality Agreement_ " means the Non-Disclosure and Confidentiality
Agreement, dated as of May 9, 2018, by and between Parent and Union.

 

" _Consents_ " has the meaning set forth in _Section 6.7_ (a).

 

" _Contract_ " has the meaning set forth in _Section 3.6(a)_.

 

" _Copyrights_ " means all Registered and unregistered works of authorship,
Software (in source code and object code), databases, specifications and
related items, mask work rights, and all registrations and applications for
registration of any of the foregoing.

 

" _Current Assets_ " means total current assets as presented in the Audited
Financial Statements as of the Closing Date minus the following accounts: (a)
cash and cash equivalents; and (b) other financial assets.

 

" _Current Employee_ " means any individual who is employed or engaged by any
Group Company as an employee or leased employee as of the date hereof.

 

" _Current Liabilities_ " means total current liabilities as presented in the
Audited Financial Statements as of the Closing Date minus Indebtedness.

 

" _Disclosure Schedule_ " has the meaning set forth in the first paragraph of
_ARTICLE 3_.

 

" _Disputed Amounts_ " has the meaning set forth in _Section 2.6(e)_.

 

" _Employee Benefit Plan_ " means each employee benefit plan (as defined in
Section 3(3) of ERISA whether or not subject to ERISA) and all other
retirement, bonus or incentive compensation, employment, share or stock
option, restricted share or stock, share or stock appreciation right, phantom
equity, change in control, severance, vacation, paid time off, fringe benefit
or other employee benefit agreement, plan, policy and program in effect and
covering one or more current or former employees, consultants, directors or
shareholders of any Group Company or the beneficiaries or dependents of any
such Persons, and is maintained, sponsored contributed to or required to be
contributed to by any Group Company or under which any Group Company has or
may have any Liability, but other than any Foreign Benefit Plan or
Multiemployer Plan or any governmental or statutory program.

    

" _Environmental Laws_ " means all applicable federal, state, local and
foreign statutes, regulations, and ordinances concerning pollution or
protection of the environment, as such of the foregoing are enacted and in
effect on or prior to the Closing Date.

 

" _Environmental Permit_ " means any authorization from a Governmental Entity,
including a foreign government, required under or issued, granted, given,
authorized by or made pursuant to Environmental Law.

 

" _ERISA_ " means the Employee Retirement Income Security Act of 1974, as
amended.

 

" _Escrow Account_ " has the meaning set forth in _Section 2.4(a)_.

 

" _Escrow Agent_ " means Continental Stock Transfer and Trust Company.

 

" _Escrow Agreement_ " means the Escrow Agreement among Bioceres, Union, the
Pre-Closing Union Representative and the Escrow Agent in the form of _Exhibit
A_ attached hereto.

 

" _Escrow Property_ " means, at any given time, the securities and other
property held by the Escrow Agent in the Escrow Account in accordance with the
terms and conditions of this Agreement and the Escrow Agreement, including the
Escrow Shares and any dividends or distributions paid or payable on the Escrow
Shares, giving effect to any disbursements or payments from the Escrow
Account.

 

" _Escrow Release Date_ " has the meaning set forth in _Section 2.4(b)_.

 

" _Escrow Shares_ " has the meaning set forth in _Section 2.4(a)_.

 

" _Estimated Closing Working Capital_ " has the meaning set forth in _Section
2.5(a)_.

 

" _Estimated Closing Working Capital Statement_ " has the meaning set forth in
_Section 2.5(a)_.

 

" _Exchange_ " has the meaning set forth in the recitals to this Agreement.

 

" _Exchange Act_ " means the Securities Exchange Act of 1934, as amended.

 

" _Exchange Shares_ " has the meaning set forth in _Section 2.1(b)(i)_.

 

" _Excluded Subsidiaries_ " means all subsidiaries of the Parent other than
the Group Companies to be acquired by Union in connection with the
transactions contemplated by this Agreement.

   

" _Exclusivity Agreement_ " means that certain Offer No. 01/2018, dated August
7, 2018, made by Union and accepted by Bioceres as amended and supplemented
from time to time.

 

" _Export and Sanctions Regulations_ " has the meaning set forth in _Section
3.19(b)_.

 

" _Extraordinary General Meetin_ g" has the meaning set forth in _Section
6.6_.

 

" _FCPA_ " has the meaning set forth in _Section 3.19(a)_.

 

" _Financial Statements_ " has the meaning set forth in _Section 3.4(a)_.

 

" _Foreign Benefit Plan_ " means each employee benefit plan maintained by any
of the Group Companies for its employees located outside of the United States,
other than any such plan to which contributions are mandated by a Governmental
Entity.

 

" _Founders_ " means the Persons who, prior to the initial public offering of
Union, were record owners of Union Ordinary Shares and/or other equity
securities of Union.

 

" _General Liability Cap_ " has the meaning set forth in _Section 9.5(b)_.

 

" _Governing Documents_ " means, with respect to any entity, the charter,
memorandum and articles of association, certificate of incorporation or
formation, articles of incorporation, bylaws, partnership agreement, limited
liability company agreement, operating agreement, declaration of trust, or
other similar governing documents of such entity, including any documents
designating or certifying the terms of any securities of such entity and the
shareholders agreements entered into in respect of any entity.

 

" _Government Official_ " has the meaning set forth in _Section 3.19(a)_.

 

" _Governmental Entity_ " means any U.S. or non-U.S. (a) federal, state,
local, municipal, or other government or political subdivisions, (b)
governmental or quasi-governmental entity of any nature (including any
governmental agency, branch, department, commission, board, bureau, official,
or entity and any court or other tribunal), including without limitation the
SEC, the Argentine _Comisi on Nacional de Valores_, and the Argentine
_Registro P ublico de Comercio _or (c) body exercising, or entitled to
exercise any administrative, executive, judicial, legislative, police,
regulatory, or taxing authority or power of any nature, including any arbitral
tribunal.

 

" _Group Companies_ " means, collectively, Bioceres Semillas, the Company and
each of the Company's direct and indirect Subsidiaries (whether existing as of
the date of this Agreement or thereafter), including but not limited to (a)
its direct subsidiaries (i) Verdeca LLC, (ii) RASA Holding LLC and (iii)
Trigall Genetics S.A.; and (b) its indirect subsidiaries, (i) Rizobacter S.A.
and (ii) Synertech Industrias S.A.

 

" _Group Company Intellectual Property_ " has the meaning set forth in
_Section 3.12(c)_.

 

" _Group Company Intellectual Property Licenses_ " has the meaning set forth
in _Section 3.12(i)_.

    

" _Group Company Products_ " means all products, ingredients, treatments,
traits or technologies tested, developed, commercialized, manufactured,
produced, propagated, modified, customized, processed, distributed or sold by
any Group Company.

 

" _Group Company Tax_ " means any Tax, if and to the extent that any Group
Company is or may be potentially liable under applicable Law, under contract
or on any other grounds (including, but not limited to, as a transferee or
successor, under Code Section 6901 or Treasury Regulation Section 1.1502-6, as
a result of any Tax sharing or other agreement, or by operation of law) for
any such Tax.

 

" _Group Company Tax Return_ " means any Tax Return relating to or inclusive
of any Group Company or any Group Company Tax.

 

" _Hazardous Substances_ " means any substance or material or waste that (a)
is regulated under any Environmental Law as a "pollutant," "contaminant,"
"toxic substance," "hazardous substance," "hazardous waste" or words of
similar meaning and regulatory effect or (b) contains asbestos, petroleum or
polychlorinated biphenyls.

 

" _IFRS_ " means International Financing Reporting Standards as adopted by the
International Accounting Standards Board.

 

" _Inbound Licenses_ " has the meaning set forth in _Section 3.12(h)_.

 

" _Indebtedness_ " means, without duplication and with respect to any Group
Company, (x) all (a) indebtedness for borrowed money, excluding discounted
checks; (b) obligations for the deferred purchase price of property or
services (other than Current Liabilities); (c) long or short-term obligations
evidenced by notes, bonds, debentures or other similar instruments; (d)
obligations under any interest rate, currency swap or other hedging agreement
or arrangement; (e) capital lease obligations that are required to be
capitalized in accordance with IFRS; (f) reimbursement obligations under any
letter of credit, banker\'s acceptance or similar credit transactions
excluding duplication arising from any guarantee related to obligations
included under (a) through (e); (g) guarantees made by any Group Company on
behalf of any Third Party in respect of obligations of the kind referred to in
the foregoing clauses (a) through (f); and (h) any unpaid interest that would
arise or become due as a result of the prepayment of any of the obligations
referred to in the foregoing clauses (a) through (g); provided that this
clause (x) excludes Transaction Expenses; minus (y) (i) cash and cash
equivalents and (ii) other financial assets.

 

" _Indemnification Claim_ " has the meaning set forth in _Section 9.3_.

 

" _Indemnified Party_ " has the meaning set forth in _Section 9.3._

 

" _Indemnitor_ " means the party that is required to provide indemnification
pursuant to _ARTICLE 9_.

 

" _Independent Accountant_ " has the meaning set forth in _Section 2.6(e)_.

 

" _Information Systems_ " has the meaning set forth in _Section 3.12(r)_.

    

" _Initial Holders_ " means the holders of Union Ordinary Shares immediately
prior to the date of this Agreement, or their successors.

 

" _Intellectual Property_ " means all Patents, Copyrights, Marks, Know-How,
confidential information, and any other such intellectual property rights, in
each case whether Registered or unregistered and including all applications
for and the right to apply for, and renewals or extensions (for their full
term) of, any such rights, and any similar or analogous rights anywhere
worldwide.

 

" _Interim Financial Statements_ " has the meaning set forth in _Section
6.5(e)_.

 

" _Know-How_ " means all clinical data, technical information, know-how, data
and materials, including inventions (whether patentable or not), discoveries,
Trade Secrets, specifications, instructions, processes, formulae, materials,
cell banks and other cellular materials, expertise and other technology
applicable to compounds, molecules, cell lines, formulations, compositions,
products or to their manufacture, development, registration, use or
commercialization or methods of assaying or testing them or processes for
their manufacture, formulations containing them, compositions incorporating or
comprising them and including all biological, chemical, pharmacological,
biochemical, toxicological, pharmaceutical, physical and analytical, safety,
quality control, manufacturing, preclinical and clinical data, and regulatory
data rights, and instructions, processes, formulae, expertise and information,
regulatory filings and copies thereof, relevant to the development,
manufacture, use or commercialization of and/or which may be useful in
studying, testing, development, production or formulation of products, or
intermediates for the synthesis thereof.

 

" _Knowledge of Bioceres_ " means the actual knowledge of Federico Trucco,
Enrique Lopez Lecube, Gloria Montaron, Jorge Wagner, Ricardo Yapur, Carlos
Camargo de Colon and Geronimo Watson after reasonable inquiry of the
management level employees who have administrative or operational
responsibility for the particular subject matter in question.

 

" _Latest Balance Sheet_ " has the meaning set forth in _Section 3.4(a)_.

 

" _Law(s)_ " means any law, treaty, writ, injunction, statute, code, order,
ordinance, decree, rule, regulation or guideline of any Governmental Entity,
including any final writ, judgment, verdict, decree, injunction, award or
similar final order of any Governmental Entity.

 

" _Leased Real Property_ " has the meaning set forth in _Section 3.17(a)_.

 

" _Liability_ " means any debt, loss, damage, adverse claim, fines, penalties,
liability or obligation (whether direct or indirect, known or unknown,
asserted or unasserted, absolute or contingent, accrued or unaccrued, matured
or unmatured, determined or determinable, disputed or undisputed, liquidated
or unliquidated, or due or to become due, and whether in contract, tort,
strict liability or otherwise), and including, for the avoidance of doubt, all
costs and expenses relating thereto (including all fees, disbursements and
expenses of legal counsel, experts, engineers and consultants and costs of
investigation).

     

" _Lien_ " means any mortgage, pledge, security interest, encumbrance, lien,
claim, option, easement, deed of trust, right-of-way, encroachment,
restriction on transfer (such as a right of first refusal or other similar
rights), defect of title or charge of any kind, whether voluntary or
involuntary, including any conditional sale or other title retention
agreement, any lease in the nature thereof and the filing of, or agreement to
give, any financing statement under the Uniform Commercial Code of any
jurisdiction. For the avoidance of doubt, the term "Lien" shall not be deemed
to include any license of any Group Company Intellectual Property.

 

" _Lock-Up Agreement_ " has the meaning set forth in _Section 2.7_.

 

" _Losses_ " has the meaning set forth in _Section 9.2_.

 

" _Marks_ " means all trademarks, service marks, trade names, service names,
brand names, trade dress rights, logos, Internet domain names and corporate
names and general intangibles of a like nature, together with the goodwill
associated with any of the foregoing, and all applications, registrations and
renewals thereof.

 

" _Material Contracts_ " has the meaning set forth in _Section 3.6(a)_.

 

" _Material Lease_ " has the meaning set forth in _Section 3.17(a)_.

 

" _Multiemployer Plan_ " has the meaning set forth in Section 3(37) of ERISA.

 

" _Non-Party Affiliates_ " has the meaning set forth in _Section 10.7_.

 

" _Non-Recourse Party_ " means, with respect to a party, any of such party\'s
former, current and future equityholders, controlling Persons, directors,
officers, employees, agents, representatives, Affiliates, members, managers,
general or limited partners, or assignees (or any former, current or future
equity holder, controlling Person, director, officer, employee, agent,
representative, Affiliate, member, manager, general or limited partner, or
assignee of any of the foregoing).

 

" _NYSE_ " means The New York Stock Exchange.

 

" _Ordinary Course Customer Licenses_ " has the meaning set forth in _Section
3.12(i)_.

 

" _Outbound Licenses_ " has the meaning set forth in _Section 3.12(i)_.

 

" _Outside Date_ " has the meaning set forth in _Section 8.1(c)_.

 

" _Owned Real Property_ " has the meaning set forth in _Section 3.17(a)_.

 

" _Owned Intellectual Property_ " is any and all Group Company Intellectual
Property owned or purported to be owned by a Group Company.

 

" _Parent_ " means Bioceres S.A.

 

" _Parent ROFR_ " means a right of first refusal substantially in the form of
_Exhibit B_.

 

" _Parent Joinder_ " has the meaning set forth in _Section 6.23_.

    

" _Parties_ ", and the correlative term " _Party_ ", have the respective
meanings set forth in the introductory paragraph to this Agreement.

 

" _Patents_ " means all patents and applications therefor, including all
substitutions, provisional applications, continuations, divisionals,
continuations-in-part, reexaminations, reissues, renewals, registrations,
utility models, design patents and extensions (including supplemental
protection certificates), and all counterparts and similar rights arising
under the Laws of any jurisdiction.

 

" _Pending Claims_ " has the meaning set forth in _Section 2.4(b)_.

 

" _Permits_ " has the meaning set forth in _Section 3.9(a)_.

 

" _Permitted Liens_ " means (a) mechanic's, materialmen's, carriers',
repairers' and other Liens arising or incurred in the ordinary course of
business for amounts that are not yet delinquent or are being contested in
good faith, (b) Liens for Taxes not yet due and payable as of the Closing Date
or which are being contested in good faith, (c) encumbrances and restrictions
on real property (including easements, covenants, conditions, rights of way
and similar restrictions) that do not, or would not reasonably be expected to,
materially interfere with any Group Company's present uses or occupancy of
such real property, and (d) Liens securing the obligations of the Group
Companies under any credit facility, except where such Liens result in the
violation of any agreement entered into with any Third Party (e.g. any
shareholders' agreement).

 

" _Person_ " means an individual, partnership, exempted company, corporation,
limited liability company, joint stock company, unincorporated organization or
association, trust, joint venture, association or other similar entity,
whether or not a legal entity.

 

" _Post-Closing Adjustment_ " has the meaning set forth in _Section 2.6(b)_.

 

" _Pre-Closing Period_ " has the meaning set forth in _Section 6.1(a)_.

 

" _Pre-Closing Reorganization_ " has the meaning set forth in _Section
6.22(a)_.

 

" _Pre-Closing Reorganization Consents_ " has the meaning set forth in
_Section 6.22(b)_.

 

" _Pre-Closing Union Group Law Firms_ " has the meaning set forth in _Section
10.14_.

 

" _Pre-Closing Union Representative_ " has the meaning set forth in the
introductory paragraph to this Agreement.

 

" _Proceeding_ " means any claim, action, suit, audit, arbitration, dispute,
hearing, injunction, investigation, judgment, litigation, order, subpoena,
suit, summons, testimony, or other proceeding involving or conducted by or on
behalf of any Person, including without limitation any Governmental Entity.

 

" _Proxy Statement_ " has the meaning set forth in _Section 6.5(a)_.

    

" _Public Shares_ " means Union Ordinary Shares sold in connection with
Union's initial public offering, excluding Union Ordinary Shares held by the
Founders.

 

" _Record Date_ " has the meaning set forth in _Section 6.5(b)_.

 

" _Registered_ " with respect to any item of Intellectual Property, means such
Intellectual Property to the extent issued by, filed with or recorded by any
Governmental Entity; "registrable" has a correlative meaning.

 

" _Registered Company Intellectual Property_ " means Owned Intellectual
Property that has been Registered.

 

" _Registration Statement_ " means the Registration Statement on Form S-4, or
other appropriate form, including any pre-effective or post-effective
amendments or supplements thereto, to be filed with the SEC by Union under the
Securities Act with respect to the Exchange Shares and Union Warrants to be
issued to Bioceres.

 

" _Representatives_ " of a Person means the directors, officers, employees,
advisors, agents, consultants, attorneys, accountants, investment bankers or
other representatives of such Person.

 

" _Resolution Period_ " has the meaning set forth in _Section 2.6(d)_.

 

" _Review Period_ " has the meaning set forth in _Section 2.6(c)_.

 

" _Reviewable Document_ " means any press release or other public
announcements or other statement with respect to the transactions contemplated
by this Agreement.

 

" _Rizobacter_ " has the meaning set forth in _Section 6.24_.

 

" _Rizobacter Call Option_ " has the meaning set forth in _Section 6.24_.

 

" _Rizobacter Injunction_ " means, without duplication, any and all (a)
Proceedings including any amendments to such Proceedings, (b) claims, (c)
cross claims or (d) other claims, whether currently existing or asserted in
the future, associated with, arising out of, or resulting from the shares of
Rizobacter's capital stock that are subject to an injunction (including but
not limited to the dividends that, since October 19, 2016 have been and are
being directed to a judicially created escrow account) as more fully described
in Parent's Registration Statement on Form F-1 filed with the SEC on January
8, 2018.

 

" _Rizobacter Injunction Cap_ " has the meaning set forth in _Section 9.5(b)_.

 

" _Schedule_ " means any schedule attached to this Agreement, including the
Disclosure Schedule.

 

" _SEC_ " means the United States Securities and Exchange Commission, and any
successor Governmental Entity.

 

" _Securities Act_ " means the Securities Act of 1933, as amended.

    

" _Share Redemption_ " means the election by a holder of Public Shares to
redeem all or a portion of Public Shares held by such holder at a price equal
to such holder's pro rata share of the aggregate amount then on deposit in the
Trust Account (net of Taxes payable), subject to the terms, conditions and
limitations set forth in this Agreement and Union's Governing Documents.

 

" _Software_ " means any and all (a) computer programs, including any and all
software implementations of algorithms, models and methodologies, whether in
source code or object code, (b) databases and compilations, including any and
all data and collections of data, whether machine readable or otherwise, (c)
descriptions, flow-charts and other work product used to design, plan,
organize and develop any of the foregoing, screens, user interfaces, report
formats, firmware, development tools, templates, menus, buttons and icons, and
(d) all documentation including user manuals and other training documentation
related to any of the foregoing.

 

" _Statement of Objections_ " has the meaning set forth in _Section 2.6(d)_.

 

" _Subsidiary_ " means, (a) with respect to any Person, any other Person of
which (i) a majority of the outstanding share capital, voting securities or
other equity interests are owned, directly or indirectly, by such Person or
(ii) such Person is entitled, directly or indirectly, to appoint a majority of
the board of directors or managers or comparable supervisory body or (b) with
respect to Bioceres, any Group Company. The term " _Subsidiaries_ " has the
meaning correlative to the foregoing.

 

" _Survival Period_ " means the period beginning on the Closing Date and
ending on the Escrow Release Date; _provided_ , _however_ , that the Survival
Period for a breach of (a) a Bioceres Fundamental Representation (except for
the representations and warranties in _Section 3.15_ (Tax Matters) which shall
be governed by clause (b) hereof) shall mean the period beginning on the
Closing Date and ending on the date that is four (4) years after the Closing
Date and (b) the representations and warranties in _Section 3.15_ (Tax
Matters) shall mean the period beginning on the Closing Date and ending on the
date that is ninety (90) days after expiration of the applicable statute of
limitations (as it may be extended or waived).

 

" _Target Working Capital_ " means seventy million U.S. Dollars
(US$70,000,000).

 

" _Tax_ " means any U.S. federal, state and local, and all non-U.S. taxes,
including, without limitation, income, gross receipts, franchise, estimated,
alternative minimum, add-on minimum, sales, use, transfer, real property
gains, registration, value added, excise, natural resources, severance, stamp,
occupation, windfall profits, environmental, customs, duties, real property,
personal property, capital stock, social security (or similar), unemployment,
disability, payroll, license, employee, or withholding tax, including any
interest, penalties or additions to tax in respect of the foregoing (whether
disputed or not).

 

" _Tax Return_ " means any return, form, declaration, report, claim for
refund, information return, statement and similar items with respect to Taxes,
including any schedule or attachment therefor or any amendment thereof.

 

" _Term Sheet_ " means that certain Offer No. 02/2018, dated August 7, 2018,
made by Union and accepted by Bioceres, Inc.

    

" _Third Party_ " means any Person other than a party to this Agreement or an
Affiliate of a party to this Agreement.

 

" _Third Party Claim_ " means any claim for indemnification under _Article IX_
arising from a claim of a Third Party (including any Governmental Entity).

 

" _Trade Secrets_ " means information, including discoveries, concepts, ideas,
research and development, know-how, formulae, inventions, compositions,
manufacturing and production processes and techniques, technical data,
procedures, designs, drawings, specifications, databases, and other
proprietary or confidential information, including customer lists, supplier
lists, pricing and cost information, and business and marketing plans and
proposals, in each case to the extent such information is protectable as a
trade secret under applicable Law.

 

" _Transaction Expenses_ " means all fees and expenses of any of Union,
Bioceres or any of the Group Companies incurred or payable as of the Closing
and not paid prior to the Closing (a) in connection with the negotiation or
consummation of the transactions contemplated hereby, including any amounts
payable to professionals (including investment bankers, brokers, finders,
attorneys, accountants and other consultants and advisors) retained by or on
behalf of Union, Bioceres or any of the Group Companies, (b) any change in
control bonus, transaction bonus, retention bonus, termination or severance
payment or payment relating to terminated options, warrants or other equity
appreciation, phantom equity, profit participation or similar rights, in any
case, to be made to any current or former employee, independent contractor,
director or officer of Union, Bioceres, or any Group Company at or after the
Closing pursuant to any agreement to which any of the foregoing is a party
prior to the Closing which become payable (including if subject to continued
employment) as a result of the execution of this Agreement or the consummation
of the transactions contemplated hereby and (c) any Taxes imposed in
connection with the transfer of the Exchange Shares that are imposed on Union,
Bioceres, the Company or Bioceres Semillas.

 

" _Transaction Proposals_ " has the meaning set forth in _Section 6.6._

 

" _Transfer Taxes_ " has the meaning set forth in _Section 6.2._

 

" _Treasury Regulations_ " means the regulations promulgated under the Code by
the United States Department of the Treasury.

 

" _Trust Account_ " means that certain trust account at JPMorgan Chase Bank,
N.A. (with Continental Stock Transfer and Trust Company (" _Trustee_ ") acting
as trustee) established by Union into which substantially all of the proceeds
received by Union as a result of its initial public offering plus additional
funds have been deposited for the benefit of Union's public shareholders.

 

" _Trust Agreement_ " means that certain Investment Management Trust
Agreement, dated as of February 27, 2018, between Union and the Trustee,
governing the funds held in the Trust Account, as amended from time to time in
accordance with its terms.

 

" _Trustee_ " has the meaning set forth in the definition of Trust Account.

 

" _Unaudited Combined Financial Statements_ " has the meaning set forth in
_Section 3.4(a)_.

    

" _Unaudited Financial Statements_ " has the meaning set forth in _Section
3.4(a)_.

 

" _Undisputed Amounts_ " has the meaning set forth in _Section 2.6(e)_.

 

" _Union_ " has the meaning set forth in the introductory paragraph to this
Agreement.

 

" _Union Articles_ " means the Amended and Restated Memorandum and Articles of
Association of Union, dated February 27, 2018.

 

" _Union Board_ " has the meaning set forth in the recitals to this Agreement.

 

" _Union Designated Contact_ " means Kyle Bransfield and such other Persons as
Union may designate in writing from time to time.

 

" _Union Group_ " has the meaning set forth in _Section 10.14_.

 

" _Union Indemnified Parties_ " has the meaning set forth in _Section 9.2_.

 

" _Union Material Adverse Effect_ " means any event, circumstance, change,
development or effect, individually or in the aggregate with all with all
other events, circumstances, changes, developments or effects, has had a
material adverse effect on the ability of Union to perform its obligations
under this Agreement or to consummate the transactions contemplated hereby.

 

" _Union Ordinary Share_ " means an ordinary share par value US$0.0001 in the
share capital of Union.

 

" _Union Privileged Communications_ " has the meaning set forth in _Section
10.14(b)_.

 

" _Union SEC Documents_ " has the meaning set forth in _Section 5.10_.

 

" _Union Shareholder Approval_ " has the meaning set forth in _Section 6.6_.

 

" _Union Tax Return_ " means any Tax Return relating to Union.

 

" _Union Warrants_ " has the meaning set forth in _Section 2.1(b)(ii)_.

 

" _U.S. GAAP_ " means the United States generally accepted accounting
principles.

 

ARTICLE 2 
SHARE EXCHANGE AND RELATED MATTERS

 

Section 2.1. _The Exchange_.

 

(a) On the terms and subject to the conditions set forth in this Agreement, on
the Closing Date, Bioceres shall assign, transfer and deliver, free and clear
of all Liens, all of the Company Shares and Bioceres Semillas Shares to Union,
with the objective of such Exchange being the acquisition by Union of 100% of
the issued and outstanding shares of capital stock of the Company and 87.2739%
of the issued and outstanding shares of capital stock of Bioceres Semillas.

    

(b) In consideration of the transfer of the Company Shares and the Bioceres
Semillas Shares to Union, Union shall issue to Bioceres:

 

(i) twenty-seven million, one hundred sixteen thousand, one hundred seventy-
four (27,116,174) newly issued Union Ordinary Shares (the " _Exchange Shares_
").

 

(ii) (A) two million, five hundred thousand (2,500,000) warrants to purchase
Union Ordinary Shares, having a strike price of US$11.50, that will vest if
and when the price of Union Ordinary Shares trades above US$15.00 for any
twenty (20) trading days within any thirty (30) trading-day period; (B) two
million, five hundred thousand (2,500,000) Union Warrants, having a strike
price of US$15.00, which will vest upon issuance; and (C) two million, five
hundred thousand (2,500,000) Union Warrants, having a strike price of
US$18.00, which will vest upon issuance (the warrants described in clause (A)
together with the warrants described in clauses (B) and (C), collectively, the
" _Union Warrants_ ", each of which is in the form of _Exhibit C_ attached
hereto).

 

(c) On the Closing Date, on surrender to Union of Bioceres' certificate or
certificates (if any) representing the Company Shares and the Bioceres
Semillas Shares, Bioceres shall be entitled to receive (i) the Exchange
Shares, subject to those Exchange Shares placed in escrow in accordance with
the terms of _Section 2.4_ and the Escrow Agreement and (ii) the Union
Warrants. On the Closing Date, the Escrow Shares (as defined herein) shall be
delivered in book entry form by Union to the Escrow Agent to be held pending
the terms of this Agreement and the Escrow Agreement and the Closing Exchange
Shares and the Union Warrants shall be delivered in book entry form directly
to Bioceres.

 

(d) Bioceres and Union agree that any and all options of Bioceres outstanding
as of the date hereof (the " _Bioceres Options_ ") shall, upon Closing, each
convert, to the extent permitted by the relevant terms of issuance, into the
right to receive one Union Ordinary Share; _provided_ , however, except for
the Exchange Shares, no Union Ordinary Shares will be issued in connection
with the transactions contemplated hereby for which such Bioceres Options may
be converted into. For the avoidance of doubt, this provision is solely
intended to reflect the allocation of the Exchange Shares among the equity
holders and option holders of Bioceres.

 

Section 2.2. _The Closing_.

 

Upon the terms and subject to the conditions set forth in this Agreement, the
closing of the transactions contemplated by this Agreement (the " _Closing_ ")
shall take place at the offices of Arnold and Porter Kaye Scholer LLP at 250
West 55th Street, New York, NY 10019, at 10:00 a.m. (local time) or by
exchange of the required documents by facsimile or email on the date that is
two (2) Business Days following the satisfaction or waiver of all conditions
to Closing set forth in _ARTICLE 7_ hereof (other than those conditions that
by their nature can only be satisfied at Closing), or at such other time and
place as the Parties may agree (the " _Closing Date_ "). For purposes of this
Agreement and the transactions contemplated hereby, the Closing shall be
deemed to occur as of the open of business on the Closing Date.

   

Section 2.3. _Deliveries at the Closing_.

 

At the Closing, each Party shall deliver (or cause to be delivered) all of the
certificates, instruments and other documents required to be delivered by such
Party pursuant to _ARTICLE 7_.

 

Section 2.4. _Escrow_.

 

(a) At or prior to the Closing, Bioceres, Parent, Union, the Pre-Closing Union
Representative and the Escrow Agent shall enter into the Escrow Agreement
pursuant to which Union shall cause to be delivered to the Escrow Agent at the
Closing five percent (5%) of the Exchange Shares (including any equity
securities paid as dividends or distributions with respect to such shares or
into which such shares are exchanged or converted, the " _Escrow Shares_ ").
The Escrow Shares, along with any dividends, distributions and other earnings
thereon, shall be held by the Escrow Agent in a segregated escrow account (the
" _Escrow Account_ ", and as reduced by any disbursements of such Escrow
Shares from the Escrow Account by the Escrow Agent in accordance with the
terms of this Agreement and the Escrow Agreement, the " _Escrow Property_ ")
and disbursed therefrom in accordance with the terms and conditions of this
Agreement and the Escrow Agreement. The Escrow Shares shall serve as a source
of security after the Closing for Bioceres and Parent's indemnification
obligations under _ARTICLE 9_.

 

(b) The Escrow Property shall no longer be subject to any Indemnification
Claim after the date that is the later of (i) October 31, 2019 and (ii) thirty
(30) days after the date on which Bioceres delivers to Union the Group
Companies' financial statements for its 2019 fiscal year audited in accordance
with IFRS (the " _Escrow Release Date_ "); _provided_ , _however_ , with
respect to any Indemnification Claim made in accordance with _ARTICLE 9_
hereof on or prior to the Escrow Release Date that remain unresolved as of the
end of the Escrow Release Date (" _Pending Claims_ "), all or a portion of the
Escrow Property reasonably necessary to satisfy such Pending Claims shall
remain in the Escrow Account until such time as such Pending Claim shall have
been finally resolved. After the Escrow Release Date, any Escrow Property
remaining in the Escrow Account that is not subject to Pending Claims, if any,
and not subject to resolved but unpaid claims in favor of an Indemnified
Party, shall be disbursed by the Escrow Agent to Bioceres. Promptly after the
final resolution of all Pending Claims and the payment of all indemnification
obligations in connection therewith, the Escrow Agent shall disburse any
Escrow Property remaining in the Escrow Account to Bioceres.

 

(c) Notwithstanding the provisions of this _Section 2.4_ and consistent with
the General Liability Cap set forth in _Section 9.5(b)_ , the aggregate
Liability of Bioceres and Parent to the Union Indemnified Parties for Losses
pursuant to _Section 9.2(i)_ shall not exceed twenty million U.S. Dollars
(US$20,000,000) in aggregate value irrespective of the value of the Escrow
Shares at the time in which they are valued for purposes of satisfying
Indemnification Claims. For the avoidance of doubt, the foregoing cap shall
not apply to Losses of the Union Indemnified Parties arising directly or
indirectly from or in connection with (i) any breach or inaccuracy of any
Bioceres Fundamental Representation, (ii) any breach or non-fulfillment of any
covenant, (ii) _Section 9.2(iii)_ , _(iv)_ and _(v)_ , or (iii) fraud;
_provided_ , that, as also set forth in _Section 9.5(b)_ , the aggregate
Liability of Bioceres and Parent to the Union Indemnified Parties for Losses
in respect of clauses (i) and (ii) of this _Section 2.4(c)_ , shall not exceed
the value of the Exchange Shares at Closing.

   

(d) For the avoidance of doubt, other than the Escrow Shares, which shall be
set aside to cover Indemnification Claims under this Agreement, Union shall
not be entitled to demand payment from Bioceres or Parent in the form of Union
Ordinary Shares for any Losses under this Agreement. Furthermore, the
cancellation of any Escrow Shares in accordance with _Section 9.5(a)_ as a
result of a payment resulting from an Indemnification Claim shall not reduce
Bioceres' post-Closing ownership of Union to amount that is below fifty-one
percent (51%) of the then outstanding Union Ordinary Shares (taking into
account all outstanding Union Warrants to the extent provided in Treasury
Regulations Section 1.7874-2(h)). In the event that a payment resulting from
an Indemnification Claim would reduce Bioceres' post-Closing ownership of
Union to an amount that is below fifty-one percent (51%) of the then
outstanding Union Ordinary Shares (taking into account all outstanding Union
Warrants to the extent provided in Treasury Regulations Section 1.7874-2(h)),
Bioceres shall make up any shortfall in cash (subject to the caps on liability
set forth herein).

 

Section 2.5. _Working Capital Closing Adjustment_.

 

(a) At least five (5) Business Days before the Closing, Bioceres shall prepare
and deliver to Union a statement (the " _Estimated Closing Working Capital
Statement_ ") setting forth its good faith estimate of Closing Working Capital
(the " _Estimated Closing Working Capital_ "), which statement shall contain
(i) line items for estimated Current Assets of the Group the Group Companies,
estimated Current Liabilities of the Group Companies and estimated
Indebtedness of the Group Companies and (ii) a certificate of an authorized
officer of Bioceres that the Estimated Closing Working Capital Statement was
prepared in accordance with IFRS applied as of the date of such Estimated
Closing Working Capital Statement. _Schedule 2.5_ sets forth an illustrative
statement prepared in good faith by Bioceres in cooperation with Union, and
their respective accountants, setting forth the various line items used (or to
be used) in, and illustrating for sample purposes only as of the date hereof,
the calculation of Closing Working Capital, prepared in accordance with this
Agreement.

 

(b) The " _Closing Adjustment_ " shall be an amount equal to the Estimated
Closing Working Capital _minus_ the Target Working Capital _plus_ the
difference, if positive, of (x) US$101,000,000 _minus_ (y) the Group
Companies' Indebtedness at the time of the Estimated Closing Working Capital
Statement. If the Closing Adjustment is a negative number, then either (A)
Bioceres shall pay Union at the Closing an amount in cash by wire transfer of
immediately available funds equal to the absolute value of the Closing
Adjustment or (B) Parent shall assume one or more borrowings constituting
Indebtedness representing an amount equal to the absolute value of the Closing
Adjustment. For the avoidance of doubt, if the Closing Adjustment is a
positive number, Union shall have no obligation to pay Bioceres any amount in
cash or otherwise.

 

Section 2.6. _Post-Closing Working Capital Adjustment_.

 

(a) As soon as practicable, but not later than forty-five (45) days after the
Closing Date, Union shall prepare and deliver to the Pre-Closing Union
Representative a statement (the " _Closing Working Capital Statement_ ")
setting forth its calculation of Closing Working Capital, which statement
shall contain (i) line items for Current Assets of the Group Companies as of
the Closing Date, Current Liabilities of the Group Companies as of the Closing
Date and Indebtedness of the Group Companies as of the Closing Date and (ii) a
certificate of an authorized officer of Union that the Closing Working Capital
Statement was prepared in accordance with IFRS applied as of the date of such
Closing Working Capital Statement.

   

(b) The " _Post-Closing Adjustment_ " shall be an amount equal to the Closing
Working Capital _minus_ the Estimated Closing Working Capital _plus_ the
difference, if positive, of (x) US$101,000,000 _minus_ (y) the Group
Companies' Indebtedness at the time of the Closing Working Capital Statement.
If the Post-Closing Adjustment is a negative number, then either (A) Bioceres
shall pay Union an amount in cash by wire transfer of immediately available
funds equal to the absolute value of the Post-Closing Adjustment or (B) Parent
shall assume one or more borrowings constituting Indebtedness representing an
amount equal to the absolute value of the Post-Closing Adjustment. If the
Post-Closing Adjustment is a positive number, Union shall pay Bioceres an
amount in cash by wire transfer of immediately available funds equal to the
Post-Closing Adjustment, subject to a cap equal to the amount in cash Union
may have received in connection with _Section 2.5(b)_.

 

(c) After receipt of the Closing Working Capital Statement, the Pre-Closing
Union Representative shall have thirty (30) days (the " _Review Period_ ") to
review the Closing Working Capital Statement. During the Review Period, the
Pre-Closing Union Representative, its accountants and their respective
Representatives shall, upon advance notice, and, to the extent that they
relate to the Closing Working Capital Statement, have reasonable access to (i)
the books and records of the Group Companies, (ii) the personnel of Union and
(iii) work papers prepared by Union and/or Union's accountants as the Pre-
Closing Union Representative may reasonably request for the purpose of
reviewing the Closing Working Capital Statement and to prepare a Statement of
Objections, _provided_ , that such access shall be during normal business
hours and in a manner that does not interfere with the normal business
operations of Union or the Group Companies.

 

(d) On or prior to the last day of the Review Period, the Pre-Closing Union
Representative may object to the Closing Working Capital Statement by
delivering to Union a written statement setting forth the Pre-Closing Union
Representative's objections in reasonable detail, indicating each disputed
item or amount and the basis for the Pre-Closing Union Representative's
disagreement therewith (the " _Statement of Objections_ "). If the Pre-Closing
Union Representative fails to deliver the Statement of Objections before the
expiration of the Review Period, the Closing Working Capital Statement and the
Post-Closing Adjustment, as the case may be, reflected in the Closing Working
Capital Statement shall be deemed to have been accepted by the Pre-Closing
Union Representative. If the Pre-Closing Union Representative delivers the
Statement of Objections before the expiration of the Review Period, Union and
the Pre-Closing Union Representative shall negotiate in good faith to resolve
such objections within thirty (30) days after the delivery of the Statement of
Objections (the " _Resolution Period_ "), and, if the same are so resolved
within the Resolution Period, the Post-Closing Adjustment and the Closing
Working Capital Statement with such changes as may have been previously agreed
in writing by Union and the Pre-Closing Union Representative, shall be final
and binding.

 

(e) If the Pre-Closing Union Representative and Union fail to reach an
agreement with respect to all of the matters set forth in the Statement of
Objections before expiration of the Resolution Period, then any amounts
remaining in dispute (" _Disputed Amounts_ " and any amounts not so disputed,
the " _Undisputed Amounts_ ") shall be submitted for resolution to the office
of Ernst and Young LLP (the " _Independent Accountant_ ") and the Independent
Accountant who, acting as experts and not arbitrators, shall resolve the
Disputed Amounts only and make any adjustments to the Post-Closing Adjustment,
as the case may be, and the Closing Working Capital Statement. The Parties
hereto agree that all adjustments shall be made without regard to materiality.
The Independent Accountants shall only decide the specific items under dispute
by the parties to such dispute and their decision for each Disputed Amount
must be within the range of values assigned to each such item in the Closing
Working Capital Statement and the Statement of Objections, respectively.

   

(f) The Independent Accountant shall make a determination as soon as
practicable within thirty (30) days (or such other time as the parties in
dispute shall agree in writing) after their engagement, and their resolution
of the Disputed Amounts and their adjustments to the Closing Working Capital
Statement and/or the Post-Closing Adjustment shall be conclusive and binding
upon the parties hereto absent manifest error.

 

(g) Except as otherwise provided herein, any payment or satisfaction of the
Post-Closing Adjustment shall (A) be due (x) within ten (10) Business Days of
acceptance of or agreement on the applicable Closing Working Capital Statement
or (y) if there are Disputed Amounts, then within ten (10) Business Days of
the resolution described in clause (f) above; and (B) be paid or satisfied in
accordance with _Section 2.6(b)_.

 

(h) All fees and expenses of the Independent Accountant and of the Pre-Closing
Union Representative's accountants and Representatives shall be paid by Union
regardless of the Independent Accountant's determination in _Section 2.6(f)_.

 

Section 2.7. _Sale Restriction_.

 

Each of the Exchange Shares and Union Warrants issued to Bioceres in
connection with the Exchange shall be subject to certain restrictions on
transfer, in accordance with the terms of the Lock-Up Agreement (the " _Lock-
Up Agreement_ ") attached as _Exhibit D_ executed as of the date hereof and
effective as of the Closing Date. Certificates representing Exchange Shares
and Union Warrants issued as a result of the Exchange shall bear a prominent
legend to such effect.

 

Section 2.8. _Bioceres Semillas Tag Along_

 

Within five (5) days of the approval of the transactions contemplated herein
by the then-current holders of Union Ordinary Shares, Bioceres, directly or
through one of its Affiliates, shall give notice of the transaction
contemplated herein to the minority shareholders of Bioceres Semillas in
accordance with the tag along provisions set forth in the Shareholders
Agreement of Bioceres Semillas dated June 1, 2010. To the extent any minority
shareholders of Bioceres Semillas exercise their tag-along rights, they shall
receive consideration in exchange for their shares in the form of (a) Union
Ordinary Shares redeemed prior to or concurrently with the Closing, (b) cash,
or (c) any combination of items (a) and (b). The value of such consideration
shall equal an amount not to exceed two million U.S. Dollars (US$2,000,000).

   

ARTICLE 3 
REPRESENTATIONS AND WARRANTIES REGARDING THE GROUP COMPANIES

 

Except as set forth in the disclosure schedule delivered by Bioceres to Union
(the " _Disclosure Schedule_ "), Bioceres and Parent hereby jointly and
severally represent and warrant to Union as follows:

 

Section 3.1.  _Organization and Qualification; Subsidiaries_.

 

(a) Each Group Company is a limited liability company, _sociedad an onima_,
business company, corporation, partnership or other business association or
entity, as the case may be, duly organized, validly existing and, if
applicable in such jurisdiction, in good standing (or the equivalent thereof)
under the Laws of its respective jurisdiction of formation or organization (as
applicable). Each Group Company has the requisite corporate, limited liability
company, partnership, limited company or other applicable business entity
power and authority to own, lease and operate its properties and to carry on
its businesses as presently conducted.

 

(b) Each Group Company is duly qualified or licensed to transact business and,
is in good standing (or the equivalent thereof) in each jurisdiction in which
the property owned, leased or operated by it, or the nature of the business
conducted by it, makes such qualification or licensing necessary, except in
such jurisdictions where the failure to be so duly qualified or licensed and
in good standing has not had a Bioceres Material Adverse Effect.

 

(c) No Group Company is in default under or in violation of any material
provision of such Group Company's Governing Documents.

 

(d) Each Group Company is in compliance with all applicable requirements
regarding capitalization and is neither subject to any mandatory capital
increase or reduction nor is it subject to a mandatory dissolution.

 

Section 3.2. _Capitalization of the Group Companies_.

 

(a) The Company Shares comprise all of the Company's authorized capital stock
that are issued and outstanding and all of the Company Shares have been duly
authorized and validly issued and are fully paid and non-assessable, and were
issued free and clear of any preemptive rights (except to the extent provided
by applicable Law), restrictions on transfer (other than restrictions under
applicable federal, state and other securities laws), or other Liens and are
owned, beneficially and of record, by Bioceres free and clear of all Liens
(other than Permitted Liens or restrictions under applicable federal, state or
other securities laws). There are no outstanding (i) equity securities of the
Company other than the Company Shares, (ii) securities of the Company having
the right to vote on any matters on which the holders of equity securities of
the Company may vote or which are convertible into or exchangeable for, at any
time, equity securities of the Company, (iii) options or other rights to
acquire from the Company, and no obligations of the Company to issue, purchase
or redeem any equity securities or securities convertible into or exchangeable
for equity securities of the Company or (iv) proxies, voting agreements or
other agreements or arrangements to which any Group Company is a party or is
otherwise obligated relating to any equity securities of the Company.

 

(b) The Bioceres Semillas Shares comprise 87.2739% of Bioceres Semillas'
authorized capital stock that is issued and outstanding. All of the Bioceres
Semillas Shares have been duly authorized and validly issued and are fully
paid and non-assessable, and were issued free and clear of any preemptive
rights (except to the extent provided by applicable Law), restrictions on
transfer (other than restrictions under applicable federal, state and other
securities laws), or other Liens and are owned, beneficially and of record, by
Bioceres free and clear of all Liens (other than Permitted Liens or
restrictions under applicable federal, state or other securities laws). Except
as set forth in _Section 3.2(b)_ of the Disclosure Schedule, there are no
outstanding (i) equity securities of Bioceres Semillas other than the Bioceres
Semillas Shares and the remaining 12.7261% of Bioceres Semillas's common stock
not comprising Bioceres Semillas Shares, (ii) securities of Bioceres Semillas
having the right to vote on any matters on which the holders of equity
securities of the Bioceres Semillas may vote or which are convertible into or
exchangeable for, at any time, equity securities of Bioceres Semillas, (iii)
options or other rights to acquire from Bioceres Semillas, and no obligations
of Bioceres Semillas to issue, purchase or redeem any equity securities or
securities convertible into or exchangeable for equity securities of Bioceres
Semillas or (iv) proxies, voting agreements or other agreements or
arrangements to which any Group Company is a party or is otherwise obligated
relating to any equity securities of Bioceres Semillas.

   

(c) No Group Company directly or indirectly owns any equity or similar
interest in, or any interest convertible into or exchangeable or exercisable
for, at any time, any equity or similar interest in, any Person except as set
forth in _Section 3.2(c)_ of the Disclosure Schedule. _Section 3.2(c)_ of the
Disclosure Schedule sets forth the name, owner, jurisdiction of formation or
organization (as applicable) and percentages of outstanding equity securities
owned, directly or indirectly, by each Group Company with respect to each
Person of which such Group Company owns, directly or indirectly, any equity or
equity-related securities. Except as set forth in the applicable Governing
Documents, all outstanding equity securities of any Group Company, in each
case, (except to the extent such concepts are not applicable under the
applicable Law of such Group Company's jurisdiction of formation) have been
duly authorized and validly issued and are fully paid and non-assessable, and
were issued free and clear of any preemptive rights (except to the extent
provided by applicable Law and other such rights as may be held by any Group
Company), restrictions on transfer (other than restrictions under applicable
federal, state and other securities laws), or Liens other than Permitted Liens
and are majority owned, beneficially and of record, by another Group Company.
There are no outstanding (i) equity securities of any Subsidiary of the
Company, (ii) securities of any Subsidiary of the Company having the right to
vote on any matters on which the holders of equity securities of such
Subsidiary may vote or which are convertible into or exchangeable for, at any
time, equity securities of any Subsidiary of the Company, (iii) options or
other rights to acquire from any Subsidiary of the Company and no obligation
of any Subsidiary of the Company, to issue any equity securities or securities
convertible into or exchangeable for, at any time, equity securities of any
Subsidiary of the Company or (iv) proxies, voting agreements or other
agreements or arrangements to which any Group Company is a party or is
otherwise obligated relating to any equity securities of any of the Company's
Subsidiaries.

 

(d) There are no outstanding phantom securities or other equity-based
compensation arrangements, profit participation or other similar rights with
respect to any Group Company except for the Incentive Plans set forth in
_Section 3.2(d)_ of the Disclosure Schedule.

   

Section 3.3. _No Violation; Consents and Approval_.

 

Except as set forth in _Section 3.3(a)_ of the Disclosure Schedule, the
execution and delivery of this Agreement and any Ancillary Document, does not,
and the consummation of the transactions contemplated hereby and performance
by the parties hereto of their obligations hereunder and thereunder will not:
(a) result in any violation of any Group Company's Governing Documents; (b)
conflict with, or result in a breach of any of the terms or provisions of, or
constitute a default under, or result in the termination, cancellation,
acceleration or modification (whether after the giving of notice or the lapse
of time or both) of any right or obligation of any Group Company under any
Contract to which any Group Company is a party or by which it is bound or to
which its assets or properties are subject; (c) violate or result in a breach
of or constitute a default under any Law, judgment, order, injunction or
decree applicable to any Group Company or by which any Group Company or its
respective assets or properties is bound; (d) result in the creation or
imposition of any Lien upon the Company Shares or Bioceres Semillas Shares or
any assets or properties of any Group Company; or (e) trigger any change of
ownership or change of control provisions in any Contract entered into by any
Group Company. Except as set forth in _Section 3.3(b)_ of the Disclosure
Schedule, no Consent or Permit with respect to any Person or Governmental
Entity is required on the part of any Group Company in connection with: (a)
the execution and delivery of this Agreement and any of the Ancillary Document
by the parties thereto, the performance of such party's respective obligations
hereunder and thereunder, and the consummation of the transactions
contemplated hereby and thereby; or (b) the continuing validity and
effectiveness immediately following the Closing of any Contract or Permit of
any Group Company.

 

Section 3.4. _Financial Statements; Undisclosed Liabilities; Book and
Records_.

 

(a) _Section 3.4(a)_ of the Disclosure Schedule sets forth true and complete
copies of (i) Parent's draft consolidated balance sheet as of September 30,
2018 (including the notes related thereto) as prepared by its management (the
" _Latest Balance Sheet_ "); (ii) the audited consolidated financial
statements of Parent for the years ended June 30, 2018, the six (6) month
transition period ended June 30, 2017, and the year ended December 31, 2016
(including the notes related thereto) (such financial statements, the "
_Audited Financial Statements_ "); (iii) the unaudited financial statements of
Parent for the six (6) month transition period ended December 31, 2017
(including the notes related thereto) (the " _Unaudited Financial Statements_
"), and (iv) the unaudited combined balance sheets of the Group Companies as
of June 30, 2018, as of the six (6) months ended June 30, 2017 and as of the
year ended December 31, 2016 and the related unaudited combined statements of
operations, shareholders' equity and cash flows for such periods (including
the notes related thereto) (the " _Unaudited Combined Financial Statements_ "
together with the Latest Balance Sheet, Audited Financial Statements and the
Unaudited Financial Statements, the " _Financial Statements_ "). The Financial
Statements (x) have been prepared from the books and records of the Group
Companies in accordance with IFRS applied on a consistent basis throughout the
periods covered thereby, except as may be indicated in the notes thereto and
except for the absence of footnotes and subject to customary year-end
adjustments (including year-end reserve, accrual and tax accounting
adjustments), and (y) fairly present in all material respects, the
consolidated financial position and the combined financial position, as
applicable, of the Group Companies as of the dates thereof and their
consolidated or combined, as applicable, results of operations for the periods
then ended.

   

(b) Except for matters reflected or reserved against in the Financial
Statements, no Group Company has any liabilities of any nature that would be
required under IFRS, as in effect on the date of this Agreement, to be
reflected on a consolidated balance sheet of the Group Companies (including
the notes thereto), except liabilities that (i) were incurred since the date
of such balance sheet in the ordinary course of business (none of which
results from or arises out of any material breach of or material default under
any contract, material breach of warranty, tort, material infringement or
material violation of applicable Law) or (ii) are incurred in connection with
the transactions contemplated by this Agreement or the Ancillary Documents.

 

(c) The books and records of the Group Companies accurately and fairly, in all
material respects, reflect the operations and conduct of business by the Group
Companies. Each Group Company maintains a system of internal accounting
controls sufficient, in all material respects, to provide reasonable assurance
that (i) transactions are executed only in accordance with the respective
management's authorization, (ii) all income and expense items are promptly and
properly recorded for the relevant periods in accordance policies maintained
by such Group Company; (iii) access to assets is permitted only in accordance
with the respective management's authorization; (iv) recorded assets are
compared with existing assets at reasonable intervals, and appropriate action
is taken with respect to any differences; and (v) all Proceedings against any
of the Group Companies are adequately and sufficiently reserved for, including
without limitation court costs and attorney fees.

 

Section 3.5. _[RESERVED]_.

 

Section 3.6. _Material Contracts_.

 

(a) _Section 3.6(a)_ of the Disclosure Schedule sets forth a list of all of
the following oral or written agreements, contracts, arrangements,
understandings and commitments (each, a " _Contract_ ") (except for this
Agreement and any Material Lease) to which any Group Company is a party or by
which any Group Company is bound as of the date hereof and, in each case,
where there are still remaining obligations on the part of any party thereto
(collectively, the " _Material Contracts_ "):

 

(i) any Contract for the employment of any officer, individual employee or
other Person on a full-time, part-time, consulting or other basis providing
annual base salary or consulting fees in excess of fifty thousand U.S. Dollars
(US$50,000), that are not terminable at will by the applicable Group Company;

 

(ii) any severance Contracts or employee termination Contracts with respect to
any officer, individual employee or other Person on a full-time, part-time,
consulting or other basis that are not terminable at will by the applicable
Group Company and that are not covered by _Section 3.6(a)(i)_ ;

 

(iii) any Contract under which any Group Company has borrowed or loaned money,
or any note, bond, indenture, mortgage, installment obligation or other
evidence of indebtedness for borrowed or loaned money or any guarantee of such
indebtedness, in each case, relating to amounts in excess of one million U.S.
Dollars (US$1,000,000);

 

(iv) any Contract or lease under which any Group Company is lessee of or holds
or operates any tangible property (other than real property), owned by any
other Person, except for any Contract or lease under which the aggregate
annual rental payments do not exceed fifty thousand U.S. Dollars (US$50,000);

   

(v) any Contract or lease under which any Group Company is lessor of or
permits any Third Party to hold or operate any tangible property (other than
real property), owned or controlled by any Group Company, except for any
Contract or lease under which the aggregate annual rental payments do not
exceed fifty thousand U.S. Dollars (US$50,000);

 

(vi) all material partnership agreements, joint venture agreements, strategic
alliances and similar Contract relating to the Group Companies;

 

(vii) all Contracts that require any Group Company to purchase its total
requirements of any product or service from a Third Party or that contain
"take or pay" provisions;

 

(viii) any Contract (other than in the ordinary course of business) with any
customer or supplier;

 

(ix) any Contract containing any covenant materially limiting the ability of
the either of any Group Company from engaging in any material line of business
or to compete with any business or Person;

 

(x) any collective bargaining or other Contract with any labor union or
similar employee organization;

 

(xi) any Contract related to the development or ownership (other than the
sale, assignment, transfer or acquisition) of any Group Company Intellectual
Property or agreement pursuant to which any Group Company grants or receives a
license to use any Group Company Intellectual Property (other than non-
exclusive licenses granted or received in the ordinary course of business and
licenses acquired in connection with the acquisition of off-the-shelf or other
commercially available software);

 

(xii) any Contract that relates to the future disposition or acquisition of
material assets or properties by any Group Company, or any merger or business
combination with respect to any Group Company, except for this Agreement;

 

(xiii) any Contract requiring or providing for any capital expenditure in
excess of one hundred and fifty thousand U.S. Dollars (US$150,000);

 

(xiv) any material interest rate, currency, or other hedging Contract;

 

(xv) all Contracts with any Governmental Entity to which any Group Company is
a party;

 

(xvi) any Contract that may not be terminated by the relevant Group Company at
any time after Closing upon prior notice not exceeding four (4) months without
requiring a payment of any penalty or compensation; or

 

(xvii) any Contract containing any provision pursuant to which any Group
Company will be obligated to make a payment to any Person at the Closing as a
direct result of the consummation of the transactions contemplated by this
Agreement or any Ancillary Document.

   

(b) As of the date hereof, each Material Contract is valid and binding on the
applicable Group Company and enforceable in accordance with its terms against
such Group Company and, to the Knowledge of Bioceres, each other party thereto
(in each case, subject to applicable bankruptcy, insolvency, reorganization,
moratorium or other laws affecting generally the enforcement of creditors'
rights and subject to general principles of equity). The applicable Group
Company has performed all material obligations required to be performed by it
under such Material Contracts, and none of the Group Companies or, to the
Knowledge of Bioceres, the other parties thereto are in material breach or
material default thereunder and no event has occurred which would permit
termination, modification or acceleration of any Material Contract by any
party thereto. As of the date of this Agreement, no Group Company has received
written notice of any current default under any Material Contract. None of the
Group Companies has given a written notice of its intent to terminate, modify,
amend or otherwise materially alter the terms and conditions of any Material
Contract or has received any such written notice from any other party thereto.

 

Section 3.7. _Absence of Changes_.

 

During the period beginning on the date of the Latest Balance Sheet and ending
on the date of this Agreement, (a) to the Knowledge of Bioceres, there has not
been any Bioceres Material Adverse Effect, (b) each Group Company has
conducted its business in the ordinary course and (c) no Group Company has
taken any action or omitted to take any action which, if taken or omitted to
be taken after the date hereof, would require the consent of Union in
accordance with _Section 6.1(b)_.

 

Section 3.8. _Litigation_.

 

Except as set forth in _Section 3.8_ of the Disclosure Schedule, as of the
date of this Agreement, (a) there is no Proceeding pending or, to the
Knowledge of Bioceres, threatened against any Group Company or the
shareholders of any Group Company in connection with their shareholding in
such Group Company before any Governmental Entity, which and (b) no Group
Company nor the shareholders of any Group Company is subject to any
outstanding order, writ, injunction or decree that, in either case, would, if
finally determined pursuant to a final nonappealable judgment, have an adverse
effect which is material to the Group Companies, taken as a whole.

 

Section 3.9. _Compliance with Applicable Law_.

 

(a) Each Group Company has been granted and possesses in good standing all
permits, licenses, registrations, qualifications, consents, approvals,
certificates, concessions, notifications, franchises and any other
authorizations under any Law necessary for and material to the conduct of the
businesses of the Group Companies as presently conducted and as presently
intended to be conducted or the ownership of material properties and assets of
the Group Companies (collectively, " _Permits_ "). Each such Permit is valid
and is in full force and effect, and none of the Permits are impaired or in
any way affected by the consummation of transactions contemplated hereby.
There are no Proceedings pending, or, to the Knowledge of Bioceres, threatened
with respect to the suspension, revocation or modification of any such Permit.
_Section 3.9(a)_ of the Disclosure Schedule contains a complete and accurate
list of each Permit. The Group Companies are, and at all times since their
respective formations have been, in compliance in all material respects with
all terms and requirements of each Permit.

   

(b) The businesses of the Group Companies are operated in material compliance
with, and, to the Knowledge of Bioceres, each of the officers, directors and
key employees of such Persons are in compliance and, have complied, in all
material respects, with all applicable Laws. There is no suit, claim or action
pending or, to the Knowledge of Bioceres, threatened by any Governmental
Entity with respect to any alleged material violation by any Group Company or
officer, director or key employee of any of such Person, of any Law.

 

Section 3.10. _Employee Benefit Plans_.

 

(a) _Section 3.10(a)_ of the Disclosure Schedule lists all Employee Benefit
Plans and Foreign Benefit Plans.

 

(b) No Group Company has any Liability, contingent or otherwise, with respect
to (i) a plan that is subject to Title IV of ERISA, (ii) any plan that
provides post-retirement health or other welfare benefits coverage to former
employees of any Group Company other than as required by COBRA or through the
last day of the calendar month in which the date of retirement occurs, or
(iii) a Multiemployer Plan.

 

(c) Each Employee Benefit Plan has, to the extent applicable, been maintained
and administered in compliance in all material respects with the applicable
requirements of ERISA, the Code and any other applicable Laws including the
Health Insurance Portability and Accountability Act, and all material
contributions and premium payments required to have been paid with respect to
each Employee Benefit Plan have been made. Each Employee Benefit Plan that is
intended to be qualified under Section 401(a) of the Code has received a
favorable determination letter from the Internal Revenue Service or is
maintained pursuant to a volume submitter or prototype document for which it
may properly rely on a favorable opinion letter or advisory from the Internal
Revenue Service on the form of such Employee Benefit Plan and, to the
Knowledge of Bioceres, there are no facts or circumstances that would be
reasonably likely to materially and adversely affect the qualified status of
any such Employee Benefit Plan.

 

(d) Each Employee Benefit Plan that is subject to Section 409A of the Code has
been operated in compliance with such section and all applicable regulatory
guidance (including notices, rulings and proposed and final regulations).

 

(e) No Group Company has engaged in any transaction with respect to any
Employee Benefit Plan that would subject any Group Company to any material Tax
or penalty (civil or otherwise) imposed by ERISA or the Code.

 

(f) With respect to each Employee Benefit Plan, Bioceres has made available to
Union copies of (i) the current plan and trust documents and the most recent
summary plan description provided to participants, (ii) the three most recent
annual report (Form 5500 series), (iii) the most recent financial statements,
and (iv) the most recent Internal Revenue Service determination letter.

    

(g) Each Foreign Benefit Plan has been maintained and administered in
compliance in all material respects with its terms and the requirements of all
applicable Laws. Each Group Company has complied in all material respects with
its obligations under any such Foreign Benefit Plan and there are no
contributions due from any Foreign Benefit Plan which have not been paid.

 

(h) The execution and performance of this Agreement will not (i) constitute a
stated triggering event under any Employee Benefit Plan, Foreign Benefit Plan
or employment agreement that will result in any payment (whether of severance
pay or otherwise) becoming due to any employee of any Group Company; (ii)
accelerate the time of payment or vesting or increase the amount of
compensation due under any Employee Benefit Plan, Foreign Benefit Plan or
employment agreement, (iii) cause any individual to accrue or receive
additional benefits, service or accelerated rights to payment of benefits
under any Employee Benefit Plan, Foreign Benefit Plan or employment agreement,
or (iv) directly or indirectly cause any Group Company to transfer or set
aside any assets to fund or otherwise provide for benefits for any individual.
There are no contracts or arrangements providing for payments that could
subject any Person to Liability for tax under Section 4999 of the Code or
cause the loss of a deduction to the any Group Company under Section 280G of
the Code.

 

(i) There is currently no audit or investigation by any Governmental Entity or
any action, suits or claims (other than routine, non-contested claims for
benefits in the ordinary course) pending or threatened against or involving
any Employee Benefit Plan or Foreign Benefit Plan or any administrator or
fiduciary thereof.

 

(j) Since the date of the Latest Balance Sheet, other than in the ordinary
course of business, no Group Company has communicated to any of its employees
or formally adopted or authorized any additional Employee Benefit Plan or
Foreign Benefit Plan or any material change in or termination of any existing
Employee Benefit Plan or Foreign Benefit Plan.

 

(k) The Company has properly classified for all purposes (including for Tax
purposes and for purposes of determining eligibility to participate in any
Employee Benefit Plan or Foreign Benefit Plan) all persons who have performed
services for or on behalf of any Group Company.

 

(l) There have been no statements, either written or oral, or communications
made or materials provided to any individual regarding offers of employment or
terms and conditions of employment with Union following the Closing, other
than benefits under the Employee Benefit Plans or Foreign Benefit Plans.

 

(m) There are no Employee Benefit Plans that grant to any employee of any
Group Company equity in any Group Company and, for the avoidance of doubt, any
and all Employee Benefit Plans of any Group Company only grant equity in
entities that Union is not acquiring in connection with the transaction
contemplated hereby.

    

Section 3.11. _Environmental Matters_.

 

Except as set forth in _Section 3.11_ of the Disclosure Schedule

 

(a) Each Group Company is currently and has been in compliance with all
Environmental Laws in all material respects and has not received from any
Third Party any: (i) written notice or claiming alleging a violation of
Environmental Law; or (ii) written request for information pursuant to
Environmental Law, which, in each case, either remains pending or unresolved,
or is the source of ongoing obligations or requirements.

 

(b) Each Group Company has obtained and is in material compliance with all
Environmental Permits (each of which is disclosed in _Section 3.11(b)_ of the
Disclosure Schedule) necessary for the ownership, lease, operation or use of
the business or assets of the Group Companies and all such Environmental
Permits are in full force and effect and shall be maintained in full force and
effect through Closing in accordance with Environmental Law, and there is no
condition, omission, event or circumstance that might prevent or impede, after
the Closing, the renewal of or ongoing compliance with such Environmental
Permits, or the ownership, lease, operation or use of the business or assets
of the Group Companies as currently carried out.

 

(c) No real property currently or formerly owned, operated or leased by any
Group Company is listed on, or has been proposed for listing on, the National
Priorities List (or CERCLIS) under CERCLA, or any similar state list and to
the Knowledge of Bioceres no real property formerly owned, operated or leased
by any Group Company is listed on, or has been proposed for listing on, the
National Priorities List (or CERCLIS) under CERCLA, or any similar state list.

 

(d) There has been no release of Hazardous Substances in contravention of
Environmental Law with respect to the business or assets of any Group Company
or any real property currently or formerly owned, operated or leased by a
Group Company, and no Group Company has received written notice that any real
property currently or formerly owned, operated or leased in connection with
the business of a Group Company (including soils, groundwater, surface water,
buildings and other structure located on any such real property) has been
contaminated with any Hazardous Substance which could reasonably be expected
to result in Liability under Environmental Law.

 

(e) No off-site treatment, storage, or disposal facilities or locations used
by any Group Company and any predecessors as to which such Group Company may
retain Liability, has been placed or proposed for placement on the National
Priorities List (or CERCLIS) under CERCLA, or any similar state list, and no
Group Company has received any written notice regarding potential liabilities
with respect to such off-site treatment, storage, or disposal facilities or
locations used by such Group Company.

 

(f) No Group Company has retained or assumed, by contract or operation of Law,
any liabilities or obligations of third parties under Environmental Law.

    

(g) Bioceres has provided or otherwise made available to Union, and listed in
_Section 3.11(g)_ of the Disclosure Schedule: (i) any and all environmental
reports, studies, audits, records, sampling data, site assessments, risk
assessments, economic models and other similar and material documents with
respect to the business or assets of any Group Company or any currently or
formerly owned, operated or leased real property which are in the possession
or control of the Company, Bioceres, or any Group Company related to
compliance with Environmental Laws, alleged or potential Liability under
Environmental Law, the release of Hazardous Substances, or the physical
condition of any Group Company property; and (ii) any and all material
documents concerning planned or anticipated capital expenditures required to
reduce, offset, limit or otherwise control pollution and/or emissions, manage
waste or otherwise ensure compliance with current or future Environmental Laws
(including, without limitation, costs of remediation, pollution control
equipment and operational changes).

 

(h) No Person set forth in the definition of "Knowledge of Bioceres" is aware
of or reasonably anticipates, as of the Closing, any condition, event or
circumstance concerning the release or regulation of Hazardous Substances that
might, after the Closing, prevent, impede or materially increase the costs
associated with the ownership, lease, operation, performance or use of the
business or assets of any Group Company as currently carried out.

 

(i) No Hazardous Substance have been disposed of, or identified on, under or
at any Group Company property in violation of Environmental Laws. No Group
Company has received written notice from any Person alleging a violation of
Environmental Law.

 

Section 3.12. _Intellectual Property_.

 

(a) (i) The use, practice or other exploitation of the Group Company
Intellectual Property owned, used, practiced or otherwise commercially
exploited by any Group Company, (ii) the development, manufacturing,
licensing, sublicensing, marketing, importation, offer for sale, sale or use
of any Product as conducted and as proposed to be conducted and (iii) any of
the Group Company's business practices and methods and proposed business
practices and methods, in each case, (A) have not infringed upon,
misappropriated or otherwise constituted an unauthorized use of or otherwise
violated the Intellectual Property of Parent or any Third Party, (B) do not
infringe upon, misappropriate, constitute an unauthorized use of or otherwise
violate the Intellectual Property of any Third Party, and (C) if any products
of any Group Company in development were to be manufactured, licensed,
marketed, imported, offered for sale, sold or used as of the date hereof, to
the Knowledge of Bioceres, would not infringe upon, misappropriate, constitute
an unauthorized use of or otherwise violate the Intellectual Property of any
Third Party. As of the date hereof, no claim has been made to the Company or
Bioceres Semillas or, to the Knowledge of Bioceres, any other Group Company
nor has the Company or Bioceres Semillas or, to the Knowledge of Bioceres, any
other Group Company, received any other notice alleging, that the conduct of
the business of any Group Company as conducted and as proposed to be conducted
(including the development, manufacturing, licensing, sublicensing, marketing,
importation, sale, offer for sale or use, and future manufacturing,
sublicensing, licensing, marketing, importation, sale, offer for sale or use,
of any Group Company Products, including in development) infringes upon, may
infringe upon, misappropriates, constitutes an unauthorized use of or
otherwise violates the Intellectual Property of Parent or any Third Party. As
of the date hereof, no claim has been or could reasonably be made to any
Representative or founder of any Group Company, nor has any Representative or
founder of any Group Company received any other notice alleging, that such
Representative or founder of such Group Company has misappropriated or
otherwise engaged in an unauthorized use of Parent's or a Third Party's
Intellectual Property in the development of Group Company Intellectual
Property.

    

(b) The Group Company Intellectual Property includes all of the Intellectual
Property used by any Group Company to conduct its business in the manner in
which such business is being conducted and, to the Knowledge of Bioceres,
includes all of the Intellectual Property used by any Group Company to conduct
its business in the manner proposed to be conducted (including the research,
manufacturing, licensing, marketing, importation, sale, offer for sale or use
and future research, manufacturing, licensing, marketing, importation, sale,
offer for sale or use, of any Product or any products of any Group Company in
development).

 

(c) Except as set forth in _Section 3.12(c)(i)_ of the Disclosure Schedule,
the applicable Group Company (i) is the sole and exclusive owner of all right,
title and interest in and to or (ii) has valid, exclusive and continuing
rights to develop, manufacture, license, sublicense, market, import, sell,
offer or use as the case may be, the Group Company Intellectual Property, in
each case, free and clear of all Liens (other than Permitted Liens) or
obligations to Parent or to any Third Party. " _Group Company Intellectual
Property_ " shall mean all Intellectual Property, which is owned, used,
practiced or otherwise exploited by or licensed by or to, any Group Company in
the conduct of their respective businesses as conducted on the date hereof
(including the development, manufacturing, licensing, sublicensing, marketing,
importation, sale, offer for sale or use, and future development,
manufacturing, licensing, sublicensing, marketing, importation, sale, offer
for sale or use, of any Group Company Products, including in development).
_Section 3.12(c)(ii)_ of the Disclosure Schedule contains a true and complete
list of all Owned Intellectual Property that is Registered with or applied for
Registration with any Governmental Entity.

 

(d) Except for patent applications abandoned or allowed to expire in the
ordinary course of patent prosecution, as of the date hereof, all Registered
Company Intellectual Property is pending, issued or Registered, as applicable,
and, to the Knowledge of Bioceres, is valid, enforceable and in good standing
(including, without regard to the Knowledge of Bioceres, the payment of all
applicable maintenance fees and other fees, such that no such Registered
Company Intellectual Property has been allowed to lapse or become abandoned
due to failure to pay a maintenance fee or other fee). No Group Company has,
and, to the Knowledge of Bioceres, neither Parent nor any Third Party that has
granted to a Group Company rights to any Group Company Intellectual Property
has, received any written or verbal notice challenging the validity or
enforceability of any Group Company Intellectual Property.

 

(e) None of the Patents that constitute Group Company Intellectual Property is
involved in any interference, reissue, reexamination, derivation, supplemental
examination, inter partes review, post-grant review, conflict, opposition or
other post-issuance proceeding, and, to the Knowledge of Bioceres, there has
been no threat or other written indication that any such proceeding shall
hereafter be commenced.

 

(f) As of the date hereof, no claim has been made to the Company or Bioceres
Semillas or, to the Knowledge of Bioceres, any other Group Company, Parent or
any Third Party alleging that any Group Company Intellectual Property is being
licensed in conflict with the terms of any Third Party license or other
agreement.

    

(g) To the Knowledge of Bioceres, no Person is engaging in any activity that
infringes upon, violates, misuses or misappropriates any Group Company
Intellectual Property or Group Company Products, or, that, with respect to
products under development, would constitute an act of infringement if such
products were manufactured, marketed, imported, offered for sale, sold or used
as of the date hereof, and no such claims have been made against any Person by
any Group Company.

 

(h) _Section 3.12(h)_ of the Disclosure Schedule sets forth (i) all licenses,
sublicenses and other agreements to which any Group Company is a party and
pursuant to which any Group Company is granted any license or right in or to,
or is otherwise authorized to use, exercise or receive any benefit from, any
Intellectual Property of Parent or any Third Party (the " _Inbound Licenses_
") and (ii) a true and complete list of all Intellectual Property that is
Registered, or Registerable, and which any Group Company is granted any
license or right in or to, or is otherwise authorized to use, exercise or
receive any benefit from pursuant to the Inbound Licenses. Each Group Company
is in compliance in all material respects with the terms and conditions of the
Inbound Licenses. The patents and patent applications listed (or which are
required to be listed) in _Section 3.12(h)_ of the Disclosure Schedule are
referred to herein as the " _Company Patents_."

 

(i) _Section 3.12(i)_ of the Disclosure Schedule sets forth a complete and
accurate list of all Contracts to which any Group Company is a party (i)
granting any Intellectual Property licenses by any Group Company to any other
Person other than licenses granted to customers in the ordinary course of
business solely to use a Product (the " _Ordinary Course Customer Licenses_
"), (ii) containing exclusivity provisions or (iii) containing an agreement to
indemnify any other Person against any claim of infringement, violation,
misappropriation or unauthorized use of any Intellectual Property (the "
_Outbound Licenses_ " and collectively with the Inbound Licenses, the " _Group
Company Intellectual Property Licenses_ ").

 

(j) Except as set forth in _Section 3.12(j)_ of the Disclosure Schedule, no
Group Company is (and with the passage of time, the giving of notice or both,
will be) required, obligated, or under any Liability whatsoever, to make any
payments by way of royalties, fees or otherwise or provide any other
consideration of any kind, to any owner or licensor of, or other claimant to,
any Intellectual Property, or any other Person, with respect to the use
thereof or in connection with the conduct of the business of the Group
Companies as conducted or proposed to be conducted (including the development,
manufacturing, licensing, sublicensing, marketing, importation, sale, offer
for sale or use, and future manufacturing, licensing, sublicensing, marketing,
importation, sale, offer for sale or use, of any Group Company Products,
including in development).

 

(k) Each Group Company has taken all reasonable measures to protect and
maintain the proprietary nature of each item of Group Company Intellectual
Property. All employees, consultants and contractors of any Group Company
involved in the creation or development of any Group Company Intellectual
Property have assigned all of their right, title and interest in and to such
Group Company Intellectual Property to such Group Company and are bound by
confidentiality obligations through signed agreements containing intellectual
property assignments and confidentiality provisions in favor of such Group
Company.

    

(l) No Trade Secret of any Group Company used in its business as conducted or
as proposed to be conducted (including the development, manufacturing,
licensing, sublicensing, marketing, importation, sale, offer for sale or use,
and future manufacturing, licensing, sublicensing, marketing, importation,
sale, offer for sale or use, of any Group Company Products, including in
development) has been authorized to be disclosed or has been actually
disclosed by such Group Company to any employee, consultant or independent
contractor or any Third Party, in each case, other than pursuant to a written
non-disclosure agreement including restrictions on the disclosure and use of
the Intellectual Property that constitutes such Trade Secret consistent with
best practices in the industry in which such Group Company operates. Each
Group Company has taken all reasonable adequate security measures to protect
the secrecy, confidentiality and value of all the Trade Secrets of such Group
Company, including invention disclosures that are not the subject of any
issued patents owned by, or published patent applications owned by such Group
Company, which measures are consistent with best practices in the industry in
which such Group Company operates. Each employee, consultant and independent
contractor of each Group Companies, and each former employee, consultant and
independent contractor of each Group Companies, has entered into a written
non-disclosure and invention assignment agreement with the applicable Group
Company, and each such agreement includes restrictions on the disclosure and
use of Intellectual Property consistent with best practices in the industry in
which such Group Company operates. With respect to each Trade Secret of each
Group Company, the documentation relating to such Trade Secret is accurate and
sufficient in detail and content to identify and explain it and to allow its
full and proper use without reliance on the knowledge or memory of any
individual. Each Group Company has good title and an absolute right to use the
Trade Secrets used in its business as conducted or as proposed to be conducted
(including the development, manufacturing, licensing, sublicensing, marketing,
importation, sale, offer for sale or use, and the future manufacturing,
licensing, sublicensing, marketing, importation, sale, offer for sale or use,
of any Group Company Products, including in development). The Trade Secrets of
any Group Company are not part of the public knowledge or literature, and have
not been used, divulged, or appropriated either for the benefit of any Person
(other than such Group Company) or to the detriment of such Group Company. No
Trade Secret of any Group Company is subject to any adverse claim or has been
challenged or threatened in any way.

 

(m) Neither the execution, delivery or performance of this Agreement, nor the
consummation of any of the transactions contemplated by this Agreement, shall
result in, or give any other Person the right to cause, (i) a loss of, or Lien
or restriction on, any Group Company Intellectual Property; (ii) a material
breach of any Group Company Intellectual Property Licenses including without
limitation those resulting from a change of control; (iii) the grant,
assignment or transfer to any other Person of any license or other rights or
interest under any Group Company Intellectual Property; (iv) payment of any
additional fees, or trigger any payment escalation under, any Inbound License,
or (v) the loss or impairment, license revocation or Lien or restriction on,
Union's, any Group Company's or their respective Affiliates' right to own or
use any of the Group Company Intellectual Property.

    

(n) There are no orders, injunctions, judgments, doctrines, decrees,
arbitration awards, rulings, writs, assessments of any Governmental Entity to
which any Group Company is a party or by which any Group Company is bound
which restrict, in any material respect, the right to use any of the Group
Company Intellectual Property.

 

(o) To the Knowledge of Bioceres, no employee, consultant or independent
contractor of any Group Company is, as a result of or in the course of such
employee's, consultant's or independent contractor's engagement by such Group
Company, in default or breach of any material term of any employment
agreement, non-disclosure agreement, assignment of invention agreement or
similar agreement.

 

(p) _Section 3.12(p)_ of the Disclosure Schedule sets forth a complete and
accurate list of (i) all Software that is owned by any Group Company and (ii)
all Software that is used by any Group Company in the business of such Group
Company that is not owned by the applicable Group Company, excluding Software
available on reasonable terms through commercial distributors or in consumer
retail stores for a license fee of no more than five hundred U.S. Dollars
(US$500) per "seat" annually.

 

(q) _Section 3.12(q)_ of the Disclosure Schedule lists all open source
computer code contained or used in any product or service of any Group Company
and describes (i) the applicable Software name and version number, (ii) the
licensor, (iii) the license under which such code was obtained, (iv) the
manner in which such code is used, (v) whether (and if so, how) such code was
modified by or for the applicable Group Company, (vi) whether such code was
distributed by or for such Group Company, and (vii) how such code is
integrated with or interacts with any other Software. Except as disclosed on
_Section 3.12()_ of the Disclosure Schedule, no Product or any product or
service of any Group Company constitutes, contains, or is dependent on any
open source computer code, and neither any Product nor any product or service
of any Group Company is subject to any contractual obligation that would
require such Group Company to divulge to any Person any source code that is
part of a Product or any product or service of such Group Company.

 

(r) Each Group Company owns, leases or licenses all Software, hardware,
computer and telecommunications equipment and other information technology and
related services (collectively, " _Information Systems_ ") that are material
to the operation of its respective businesses as conducted, including the
capacity and ability to process peak volumes in a timely manner. In the last
twelve (12) months, there have been no material failures, breakdowns,
breaches, outages or unavailability of such Information Systems. Upon
Closing, the Information Systems will be in the possession, custody or
control of the relevant Group Companies, along with all tools, documentation,
and other materials, as existing immediately prior to the Closing. The
transactions contemplated by this Agreement and the Ancillary Documents will
not adversely affect (i) any Product or the Information Systems, or (ii) any
Group Company's legal right and ability to continue (x) using any Product and
the Information Systems and (y) operating the applicable Group Company's
business after the Closing Date, in each of (x) and (y), to the same extent
as any Product and the Information Systems, respectively, are used or the
applicable Group Company's business is operated prior to the Closing Date.

    

Section 3.13. _Labor Matters_.

 

(a) Except as set forth in _Section 3.13(a)_ of the Disclosure Schedule, since
January 1, 2015, there have not been any actions, grievances, investigations,
suits, claims, charges or administrative matters pending, or, to the Knowledge
of Bioceres, threatened against any Group Company by or before a Governmental
Entity relating to any employee or former employee, leased employee or
employment issue, (including but not limited to union, health care, social
security and safety matters) and, since January 1, 2015, no Group Company has
received any written notice regarding any breach of its legal obligations
concerning the employment of any employees or former employees of any Group
Company.

 

(b) Except as set forth in _Section 3.13(b)_ of the Disclosure Schedule, no
Group Company is party to or bound by any collective bargaining agreement.
There is no labor dispute, grievance or unfair labor practice charge, or, to
the Knowledge of Bioceres, union organizational activity pending with respect
to any Group Company, nor, to the Knowledge of Bioceres, is any material labor
dispute, work stoppage, lockout, grievance or unfair labor practice charge
threatened against any Group Company.

 

(c) The Group Companies have been and are in compliance in all material
respects with all applicable Laws relating to labor, labor relations,
employment, including, without limitation, provisions thereof relating
thereto, employment practices, terms, conditions and classifications of
employment, employee safety and health, wages and hours, equal employment
opportunity overtime regulation, and in each case with respect to employees,
leased employees and independent contractors (i) are not liable in for any
arrears of wages, severance pay or any Taxes or any penalty for failure to
comply with any of the foregoing (other than any arrearages in wages for the
current payment cycle for employees), and (ii) are not liable for any past due
payment to any trust or other fund governed by or maintained by or on behalf
of any Governmental Entity, with respect to unemployment compensation
benefits, social security or other benefits or obligations for Current
Employees (as defined herein) or former employees. No Group Company has any
unsatisfied Liability to any previously terminated employee or independent
contractor.

 

(d) No Current Employee or former employee will receive additional vested
employment rights or acquired rights (including the additional protection of
existing employment terms and conditions) by virtue of the Exchange or
transactions contemplated by this Agreement, and the employment of each
Current Employee is terminable at will, except where prohibited by Law, and
the employment of each such Current Employee can be terminated at any time for
any lawful reason without any amounts being owed to such individual other than
with respect to wages and benefits accrued before the termination.

 

(e) To the Knowledge of Bioceres, no key employee (i) has provided written
notice of an intention to terminate his or her employment with any Group
Company and (ii) is a party to or bound by any confidentiality agreement,
noncompetition agreement or similar Contract (with any other Person) that
would in any way adversely affect (A) such individual's performance of his or
her duties on behalf of any Group Company or (B) the ability of any Group
Company to conduct its business.

    

(f) To the Knowledge of Bioceres, no key employee is in violation of any
material term of any employment agreement, patent disclosure agreement, non-
competition agreement, or any restrictive covenant to a former employer
relating to the right of any such Current Employee to be employed by a Group
Company because of the nature of the business conducted by such Group Company
or proposed to be conducted by such Group Company or to the use of Trade
Secrets or proprietary information of others.

 

Section 3.14. _Insurance_.

 

 _Section 3.14_ of the Disclosure Schedule contains a list of all material
policies of insurance owned or held by any Group Company as of the date of
this Agreement. All such policies provide coverage sufficient for a business
of the size and type operated by any of the Group Companies as customary for
the industries in which they respectively operate. All such policies are, as
of the date of this Agreement, in full force and effect, all premiums with
respect thereto covering all periods up to the Closing on the Closing Date
will have been paid, and no notice of cancellation, termination, material
reduction in coverage or disallowance of any material claim has been received
by any Group Company with respect to any such policy.

 

Section 3.15. _Tax Matters_.

 

(a) Each Group Company has:

 

(i) duly and timely filed, or caused to be filed, in accordance with
applicable Law all Group Company Tax Returns, each of which is true, correct
and complete in all material respects, and

 

(ii) duly and timely paid in full, or caused to be paid in full, all Group
Company Taxes (whether or not shown on any Group Company Tax Return).

 

(b) No extension of time to file any Group Company Tax Return, which Group
Company Tax Return has not since been filed in accordance with applicable Law,
has been filed. There is no power of attorney in effect with respect or
relating to any Group Company, Group Company Tax or Group Company Tax Return.

 

(c) No Group Company has been a member of an affiliated group filing a
consolidated U.S. federal income Tax Return (other than such a group including
only other Group Companies) and has no Liability for the Taxes of any other
Person (other than other Group Companies) under Treasury Regulation Section
1.1502-6 (or any similar provision of U.S. state, U.S. local or non-U.S. law);
by reason of any agreements, contracts or arrangements (other than customary
provisions in commercial contracts the primary purpose of which is not Tax),
as a successor or transferee.

 

(d) Each Group Company has complied in all material respects with all
applicable Laws relating to the deposit, collection, withholding, payment or
remittance of any Group Company Tax (including, but not limited to, Section
3402 of the Code).

 

(e) There is no Lien for any Tax upon any asset or property of any Group
Company (except for Permitted Liens).

    

(f) There is no U.S. state, U.S. local or non-U.S. Proceeding related to Taxes
that is pending or currently being conducted or, to the Knowledge of Bioceres,
threatened or proposed in writing with regard to any Group Company, Group
Company Tax or Group Company Tax Return. No Group Company has received from
any U.S. federal, state or local, or non-U.S. taxing authority in the past
three (3) years any written (i) notice indicating an intent to open a
Proceeding related to Taxes, (ii) request for information related to Tax
matters, or (iii) notice of deficiency or proposed adjustment for any amount
of Tax proposed, asserted or assessed by any taxing authority against any of
the Group Companies.

 

(g) No statute of limitations for any ongoing Proceeding relating to any Group
Company Tax or any Group Company Tax Return has been modified, extended or
waived.

 

(h) No jurisdiction where no Group Company Tax Return has been filed or no
Group Company Tax has been paid has made a written claim for the payment of
any Group Company Tax or the filing of any Group Company Tax Return.

 

(i) No Group Company is or will be required to include any item of income in,
or exclude any item of deduction from, taxable income for any taxable period
(or portion thereof) ending after the Closing Date, as a result of any: (i)
change in or use of any improper method of accounting for a taxable period
ending on or prior to the Closing Date; (ii) agreement entered into with any
taxing authority (including a "closing agreement" as described in Section 7121
of the Code, or any corresponding or similar provision of U.S. state, U.S.
local or non-U.S. Tax law) on or prior to the Closing Date; (iii) deferred
intercompany transactions occurring at or prior to the Closing or any excess
loss account in existence at the Closing described in Treasury Regulations
under Section 1502 of the Code (or any corresponding or similar provision of
U.S. state, U.S. local or non-U.S. Tax law); (iv) installment sale or open
transaction or disposition made on or prior to the Closing Date; (v) prepaid
amount received or deferred revenue accrued on or prior to the Closing Date;
(vi) election (including a protective election) made under Section 108(i) of
the Code (or any corresponding or similar provision of U.S. state, U.S. local
or non-U.S. Tax law) on or prior to the Closing Date; (vii) current ownership
interest in a "controlled foreign corporation" (within the meaning of Section
957(a) of the Code) owning "United States property" (as defined in Section
956(c) of the Code) acquired prior to the Closing, (viii) current ownership
interest in a "controlled foreign corporation" (within the meaning of Section
957(a) of the Code) having "subpart F income" (within the meaning of Section
952(a) of the Code) or "global intangible low-taxed income" (within the
meaning of Section 951A of the Code) prior to the Closing, or (ix) application
of Section 965 of the Code (including an election under Section 965(h) of the
Code).

 

(j) No Group Company is or has ever been a beneficiary of or otherwise
participated in any "listed transaction" within the meaning of Treasury
Regulation Section 1.6011-4(b)(2).

 

(k) No Group Company has distributed stock of another Person nor has its stock
been distributed by another Person, in a transaction that was purported or
intended to be governed in whole or in part by Section 355 of the Code or
Section 361 of the Code.

    

(l) No Group Company is a party to a gain recognition agreement under Section
367 of the Code, and no Group Company has transferred an intangible the
transfer of which would be subject to the rules of Section 367(d) of the Code.

 

(m) No Group Company has any Liability for any unpaid Taxes which have not
been accrued for or reserved in the audited combined financial statements of
the Group Companies for the fiscal year ended June 30, 2018, whether asserted
or unasserted, contingent or otherwise, other than any Liability for unpaid
Taxes that may have accrued since the end of fiscal year ended June 30, 2018
in connection with the operation of the business of the Group Companies in the
ordinary course of business.

 

(n) No Group Company is a party to any Tax allocation, Tax indemnity or Tax
sharing agreement (other than (i) such an agreement involving only other Group
Companies or (ii) pursuant to commercial agreements entered into in the
ordinary course of business, the primary purpose of which is not Taxes).

 

(o) The Company is not, nor has it ever been, a "United States real property
holding corporation" within the meaning of Section 897(c)(2) of the Code at
any time during the applicable period referred to in Section 897(c)(1)(A)(ii)
of the Code.

 

(p) As of the date hereof, neither Parent nor Bioceres has any plan or
intention of selling, transferring or otherwise disposing of (or causing such
actions to occur) any Union Warrants or Union Ordinary Shares after the
Closing Date, except in connection with the transactions contemplated in
_Section 2.8_ and _Section 6.24_ ; _provided_ , however, that Bioceres plans
and intends to hold at least 51% of the Union Ordinary Shares (taking into
account all outstanding Union Warrants to the extent provided in Treasury
Regulations Section 1.7874-2(h)).

 

(q) Each Group Company has complied in all material respects with applicable
escheat and unclaimed property laws and no Group Company is subject to any
levy or assessment for unclaimed property under applicable escheat or
unclaimed property laws.

 

Section 3.16. _Brokers_.

 

No broker, finder, financial advisor or investment banker is entitled to any
broker's, finder's, financial advisor's or investment banker's fee or
commission in connection with the transactions contemplated by this Agreement
based upon arrangements made by and on behalf of Bioceres or Parent for which
any Group Company or Union would become liable after the Closing.

 

Section 3.17. _Real and Personal Property_.

 

(a) _Real Property_. _Section 3.17(a)_ of the Disclosure Schedule sets forth
(i) a list of all real property owned as of the date hereof by any Group
Company (such real property, the " _Owned Real Property_ ") and (ii) whether
as lessee or lessor, a list of all leases (each a " _Material Lease_ ") of
real property (such real property, the " _Leased Real Property_ ") to which
any Group Company is a party or by which any of them is bound, in each case,
as of the date of this Agreement. The Company or, applicable Group Company,
has good and marketable fee simple title to all of the Owned Real Property, in
each case free and clear of all Liens other than Permitted Liens. Each
Material Lease is valid and binding on the Group Company party thereto,
enforceable in accordance with its terms (subject to proper authorization and
execution of such Material Lease by the other party thereto and subject to
applicable bankruptcy, insolvency, reorganization, moratorium or other laws
affecting generally the enforcement of creditors' rights and subject to
general principles of equity). To the Knowledge of Bioceres, each of the Group
Companies and each other party thereto, as applicable, has performed in all
material respects all material obligations required to be performed by it
under each Material Lease. With respect to each Material Lease, the other
party to such lease is not an Affiliate of any Group Company. The Group
Companies have not subleased or otherwise granted any Person the right to use
or occupy any Owned Real Property or Leased Real Property. Except as set forth
in _Section 3.17(a)(ii)_ , the Group Companies have not collaterally assigned
or granted any other security interest in the Leased Real Property or any
interest therein. Except for Permitted Liens, there exist no Liens affecting
the Leased Real Property created by, through or under the Group Companies.

    

(b) _Personal Property_. As of the date of this Agreement, the Group Companies
collectively own or hold under valid leases all material machinery, equipment
and other tangible personal property necessary for the conduct of their
businesses as currently conducted, subject to no Lien except for Permitted
Liens. Such personal property is reasonably suitable for its intended use, is
in good operating condition and repair (subject to normal wear and tear) and
is free from material defects and has been reasonably maintained.

 

Section 3.18. _Transactions with Related Parties_.

 

 _Section 3.18_ of the Disclosure Schedule sets forth all Contracts between
any Group Company, on the one hand, and Affiliates of any Group Company, on
the other hand, that will not be terminated effective as of the Closing Date.
To the Knowledge of Bioceres, none of the Group Companies and their respective
Affiliates, directors, officers or employees possesses, directly or
indirectly, any financial interest in, or is a director, officer or employee
of, any Person (other than any Group Company) which is a material client,
supplier, customer, lessor, lessee, or competitor of any Group Company.
Ownership of securities of a company whose securities are registered under the
Exchange Act of five percent (5%) or less of any class of such securities
shall not be deemed to be a financial interest for purposes of this _Section
3.18_.

 

Section 3.19. _Certain Business Practices_

 

(a) The Company, the other Group Companies and, to the Knowledge of Bioceres,
their respective directors, officers, employees, consultants, sales
representatives, distributors and agents have complied at all times since
January 1, 2016, and are in compliance, with (i) the provisions of the U.S.
Foreign Corrupt Practices Act of 1977, as amended (15 U.S.C.  78dd1, et seq.)
(" _FCPA_ "), and (ii) the provisions of all anti-bribery, anti-corruption and
anti-money laundering Laws of each jurisdiction in which the Group Companies
operate or have operated and in which any agent thereof is conducting or has
conducted business involving any Group Company. None of the Group Companies
nor, to the Knowledge of Bioceres, any of their respective directors,
officers, employees and agents have paid, offered or promised to pay, or
authorized or ratified the payment, directly or indirectly, of any monies or
anything of value to any national, provincial, municipal or other Government
Official or any political party or candidate for political office for the
purpose of influencing any act or decision of such official or of any
Governmental Entity to obtain or retain business, or direct business to any
person or to secure any other improper benefit or advantage, in each case in
violation in any material respect of the FCPA and any Laws described in clause
(ii) of the immediately preceding sentence. As used in this Agreement, the
term " _Government Official_ " means any official, officer, employee, or
representative of, or any Person acting in an official capacity for or on
behalf of, any Governmental Entity, and includes any official or employee of
any entity directly or indirectly owned or controlled by any Governmental
Entity, and any officer or employee of a public international organization, as
well as any Person acting in an official capacity for or on behalf of any such
Governmental Entity, or for or on behalf of any such public international
organization. The Group Companies (x) have instituted policies and procedures
reasonably designed to ensure compliance with the FCPA and other anti-bribery,
anti-corruption and anti-money laundering Laws in each jurisdiction in which
the Group Companies operates and (y) have maintained such policies and
procedures in force.

     

(b) The Group Companies have at all times since January 1, 2016 been, and are,
in compliance with relevant sanctions and export control Laws and regulations
in jurisdictions in which such Group Companies do business or are otherwise
subject to jurisdiction, including the U.S. International Traffic in Arms
Regulations, the Export Administration Regulations, and U.S. sanctions Laws
and regulations administered by the U.S. Department of the Treasury's Office
of Foreign Assets Control (collectively, " _Export and Sanctions Regulations_
"). No Group Company manufactures or exports any technology, product,
technical data or any other material that is subject to U.S. Export and
Sanctions Regulations (other than, with respect to the Export Administration
Regulations, items designated as EAR99 on the Commodity Classification List).
The Group Companies (i) have instituted policies and procedures reasonably
designed to ensure compliance with the Export and Sanctions Regulations in
each jurisdiction in which the Group Companies operate or are otherwise
subject to jurisdiction and (ii) have maintained such policies and procedures
in force.

 

(c) Except as disclosed in _Section 3.19(c)_ of the Disclosure Schedule, no
Group Company (i) has received, directly or, to the Knowledge of Bioceres,
indirectly, material grants or similar funding from any Governmental Entity
since January 1, 2016, (ii) is, or since January 1, 2016, has been, a party to
any customer or supply Contract (whether classified or unclassified) with any
Governmental Entity as a prime contractor or as a subcontractor, (iii) has
received or placed, since January 1, 2015, any priority contracts or orders
under the Defense Priorities and Allocation System, (iv) stores or accesses
information that is classified for national security purposes under Executive
Order 13526 (or any similar Law) or (v) has been granted a facility security
clearance. To the Knowledge of Bioceres, no director or senior executive of
any Group Company holds a personnel security clearance in relation to such
director or senior executive's job at such Group Company.

     

Section 3.20. _Customers and Suppliers_.

 

 _Section 3.20_ of the Disclosure Schedule sets forth a list of the Group
Companies' fifteen (15) largest customers and the fifteen (15) largest
suppliers as measured by the dollar amount of purchases therefrom or thereby,
for the fiscal year ending June 30, 2018, showing the approximate total sales
by the Group Companies to each such customer and the approximate total
purchases by the Group Companies from each such supplier, during each such
period. No such customer or supplier listed in _Section 3.20_ of the
Disclosure Schedule has (a) terminated its relationship with any of the Group
Companies, (b) reduced its business with any of the Group Companies or
adversely modified its relationship with the Group Companies as a whole, (c)
notified any of the Group Companies in writing of its intention to take any of
the actions described in clauses (a) or (b), and (d) to the Knowledge of
Bioceres, become insolvent or subject to bankruptcy proceedings, in each case,
that would be material to the Group Companies taken as a whole.

 

Section 3.21. _Company Information_.

 

None of the information supplied or to be supplied by Bioceres relating to the
Group Companies and/or their respective shareholders, stockholders, members,
control Persons and Representatives expressly for inclusion or incorporation
by reference in (a) the filings with the SEC, (b) mailings to holders of Union
Ordinary Shares with respect to the Transaction Proposals, and/or the
redemption of Public Shares, and/or (c) any other document filed with any
Governmental Entity in connection herewith (including the Proxy Statement and
the Registration Statement) and any supplements thereto, will, at the date of
filing and/or mailing, as the case may be, contain any untrue statement of a
material fact or omit to state any material fact necessary in order to make
the statements therein, in light of the circumstances under which they are
made, not misleading (subject to the qualifications and limitations set forth
in the materials provided by Bioceres or that is included in such filings
and/or mailings).

 

Section 3.22. _State Takeover Statutes_.

 

To the Knowledge of Bioceres, no state takeover statute or similar statute
applies or purports to apply to any Group Company with respect to this
Agreement, the Ancillary Documents, or any of the transactions contemplated
hereby and thereby.

 

Section 3.23. _Product Warranty; Product Liability_.

 

(a) To the extent any warranties are implied or imposed by any Law, no Group
Company Product sold, distributed, delivered or licensed by any Group Company
or any of its licensees, partners, collaborators or joint venturers is subject
to any guaranty or warranty from or on behalf of any Group Company. _Section
3.23(a)_ of the Disclosure Schedule lists each claim exceeding the equivalent
of thirty-five thousand U.S. Dollars (US$35,000) made, or to the Knowledge of
Bioceres, threatened against any Group Company, during the three (3) years
preceding the date of this Agreement, by a customer or any other Person
alleging that (i) such Group Company Product (A) did not comply with any
express or implied warranty regarding such Group Company Product, (B)
contained an unintended Hazardous Substance, or (C) was otherwise
contaminated, adulterated, mislabeled, defective or improperly packaged or
transported, or (ii) a Group Company or any licensee, partner, collaborator,
joint venturer, supplier, warehouse, distributor or seller of any Group
Company Product breached any duty to warn, test, inspect or instruct of the
risks, limitations, precautions or dangers related to the use, application, or
transport of any such Group Company Product.

     

(b) No Group Company, nor, to the Knowledge of Bioceres, any of its licensees,
partners, collaborators or joint venturers has developed, manufactured,
commercialized, produced, formulated, propagated, modified, customized,
processed, distributed or sold any Group Company Product that did not comply
with any express or implied warranty regarding such Group Company Product or
that contained any unintended Hazardous Substance or that was otherwise
adulterated, contaminated, mislabeled, defective, off-specification or
improperly packaged or transported.

 

(c) Each Group Company and, to the Knowledge of Bioceres, each of its
licensees, partners, collaborators and joint venturers has in place policies
and procedures that are reasonably designed to ensure that there is no
presence of transformation events regulated by any relevant Governmental
Entity in any Group Company Product produced, transferred to Third Parties for
trialing or multiplication purposes, exported and/or commercialized by a Group
Company or any of its licensees, partners, collaborators or joint venturers
that is not in accordance with any Law. Each Group Company and, to the
Knowledge of Bioceres, each of its licensees, partners, collaborators and
joint venturers has obtained all Permits and have made all material
declarations and filings required by any Law for the handling and delivery to
Third Parties of Group Company Products and during the three (3) years
preceding the date of this Agreement, each Group Company and, to the Knowledge
of Bioceres, each of its licensees, partners, collaborators and joint
venturers has complied with, and has reasonably monitored the compliance of
their respective counterparties with, applicable industry standards and
including without limitation, herbicide resistance management practices and
insect resistance management practices.

 

(d) Except as set forth in _Section 3.23(d_ ) of the Disclosure Schedule there
have been no recalls, market withdrawals or replacements (voluntary or
involuntary) with respect to any Group Company Product or any similar actions,
investigations, notices or threatened recalls by any Governmental Entity with
respect to any Group Company Product and, to the Knowledge of Bioceres, no
facts or circumstances exist that are reasonably likely to (i) result in the
recall, market withdrawal or replacement of any Group Company Product sold or
intended to be sold, or (ii) cause, as a result of any regulatory action by
any Governmental Entity, (y) a material change in the labeling or packaging of
any Group Company Product or (z) a termination or suspension of the marketing,
distribution or sale of any Group Company Product.

 

(e) Except as set forth in _Section 3.23(e)_ of the Disclosure Schedule, no
Person has claimed or, to the Knowledge of Bioceres, alleged during the three
(3) years preceding the date of this Agreement that any Group Company has
committed any act, or failed to commit any act, which would result in, and
there has been no occurrence which would reasonably give rise to, or form the
basis of, whether or not covered by insurance, any (i) product Liability, (ii)
Liability for injuries or damage to individuals or property (including without
limitation any crops, animals or livestock) or (iii) Liability for economic
damages or losses including, without limitation, claims relating to alleged
crop failure or damage from insects or fungus, inadequate crop yield or
inadequate biotic or drought tolerance.

 

Section 3.24. _Pre-Closing Reorganization Contracts_

 

 _Section 3.24_ of the Disclosure Schedule sets forth a list of all Contracts
to which Bioceres is a party immediately prior to the Pre-Closing
Reorganization. Set forth next to the title of each such Contract is reference
to whether such Contract (i) is assignable without consent and therefore will
be assigned to the Company in connection with the Pre-Closing Reorganization
or (ii) requires the consent, approval or waiver (the " _Pre-Closing
Reorganization Consents_ "), whether of an Affiliate or Third Party, in order
for it to be assigned to the Company prior to Closing.

     

ARTICLE 4 
REPRESENTATIONS AND WARRANTIES OF BIOCERES AND PARENT

 

Except as set forth in the Schedules, Bioceres and Parent hereby jointly and
severally represent and warrant to Union as follows:

 

Section 4.1. _Authority_.

 

Bioceres and Parent have the requisite corporate and _sociedad an onima _power
and authority, as applicable, to execute and deliver this Agreement and the
Ancillary Documents to which Bioceres and Parent, as applicable, are a party
and Bioceres and Parent have, or prior to the Closing will have, the requisite
limited liability company and _sociedad an onima_, power and authority, as
applicable, to consummate the transactions contemplated hereby and thereby.
The execution and delivery of this Agreement and the Ancillary Documents by
Bioceres and Parent, as applicable, and the consummation of the transactions
contemplated hereby and thereby have been duly authorized by all necessary
corporate action, in the case of Bioceres (or limited liability company, in
the case of Bioceres if after the Pre-Closing Reorganization) and all
necessary _sociedad an onima _action, in the case of Parent. This Agreement
has been (and the execution and delivery of each of the Ancillary Documents to
which Bioceres and/or Parent will be a party will be, when delivered at the
Closing) duly executed and delivered by Bioceres (and Parent, upon execution
the Parent Joinder) and constitutes (and, with respect to each of the
Ancillary Documents to which Bioceres and/or Parent will be a party when
delivered at Closing, will constitute) a valid, legal and binding agreement of
Bioceres and Parent, as applicable (assuming that this Agreement has been, and
the Ancillary Documents to which Bioceres and/or Parent are/is a party will
be, duly and validly authorized, executed and delivered by the other Persons
party thereto), enforceable against Bioceres and Parent, as applicable, in
accordance with their respective terms, except (a) to the extent that
enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other laws affecting the enforcement of
creditors' rights generally and (b) that the availability of equitable
remedies, including specific performance, is subject to the discretion of the
court before which any proceeding thereof may be brought.

 

Section 4.2. _No Violations; Consents and Approval_.

 

The execution and delivery of this Agreement and any Ancillary Document by
Bioceres and/or Parent, does not, and the consummation of the transactions
contemplated hereby and performance by Bioceres and Parent, as applicable, of
their respective obligations hereunder and thereunder will not: (a) result in
any violation of Bioceres or Parent's Governing Documents; (b) conflict with,
or result in a breach of any of the terms or provisions of, or constitute a
default under, or result in the termination, cancellation, acceleration or
modification (whether after the giving of notice or the lapse of time or both)
of any right or obligation of Bioceres or Parent under any Contract to which
either is a party or by which either is bound or to which either's assets or
properties are subject; (c) violate or result in a breach of or constitute a
default under any Law, judgment, order, injunction or decree applicable to
Bioceres and/or Parent or by which either of their respective assets or
properties is bound; (d) result in the creation or imposition of any Lien upon
any assets or properties of Bioceres or Parent; or (e) trigger any change of
ownership or change of control provisions in any Contract entered into by
Bioceres or Parent. Except as set forth in _Section 4.2(b)_ of the Disclosure
Schedule, no Consent or Permit with respect to any Person or Governmental
Entity is required on the part of Bioceres or Parent in connection with: (a)
the execution and delivery of this Agreement and any of the Ancillary
Documents by Bioceres or Parent, or the performance of such party's respective
obligations hereunder and thereunder, and the consummation of the transactions
contemplated hereby and thereby; or (b) the continuing validity and
effectiveness immediately following the Closing of any Contract or Permit of
Bioceres or Parent.

     

Section 4.3. _Title to the Company Shares and Bioceres Semillas Shares;
Ownership of the Company and Bioceres Semillas_.

 

(a) As of the date hereof, Bioceres owns beneficially and of record the
Company Shares and has good and valid title to the Company Shares free and
clear of all Liens (other than restrictions under applicable federal, state
and other securities laws). As of immediately prior to the Closing, Bioceres
will be the record and beneficial owner of the Company Shares and it will have
good and valid title to the Company Shares, free and clear of all Liens (other
than restrictions under applicable federal, state and other securities laws).

 

(b) As of the date hereof, Bioceres owns beneficially and of record the
Bioceres Semillas Shares and has good and valid title to the Bioceres Semillas
Shares free and clear of all Liens (other than (i) restrictions under
applicable federal, state and other securities laws and (ii) Permitted Liens).
As of immediately prior to the Closing, Bioceres will be the record and
beneficial owner of the Bioceres Semillas Shares and it will have good and
valid title to the Bioceres Semillas Shares, free and clear of all Liens
(other than (i) restrictions under applicable federal, state and other
securities laws and (ii) Permitted Liens).

 

Section 4.4. _Litigation_.

 

As of the date hereof, (a) there is no material Proceeding pending or, to the
Knowledge of Bioceres, threatened against Bioceres or Parent before any
Governmental Entity which, and (b) neither Bioceres nor Parent is subject to
any material outstanding order, writ, injunction or decree that, if not
complied with, in either case, would have a material adverse effect on
Bioceres' ownership of the Company Shares and the Bioceres Semillas Shares, or
otherwise prevent or materially delay the Closing.

 

Section 4.5. _Brokers_.

 

Except as set forth in _Section 4.5_ of the Disclosure Schedule, no broker,
finder, financial advisor or investment banker is entitled to any broker's,
finder's, financial advisor's, investment banker's fee or commission or
similar payment in connection with the transactions contemplated by this
Agreement based upon arrangements made by or on behalf of Bioceres or Parent
for which any Group Company would become liable after the Closing.

    

ARTICLE 5 
REPRESENTATIONS AND WARRANTIES OF UNION

 

Union hereby represents and warrants to Bioceres as follows:

 

Section 5.1. _Incorporation_.

 

Union is an exempted company, duly incorporated, validly existing and in good
standing under the laws of the Cayman Islands and has all requisite power and
authority to carry on its businesses as now being conducted, except where the
failure to have such power or authority would not prevent or materially delay
the consummation of the transactions contemplated hereby or the consummation
of the transactions contemplated by the Ancillary Documents to which Union is
a party. Union has delivered to Bioceres true, correct and complete copies of
its Governing Documents in effect as of the date of this Agreement. Union is
not in default under or in violation of any material provision of such
Governing Documents.

 

Section 5.2. _Authority_.

 

Union has all necessary power and authority to execute and deliver this
Agreement and the Ancillary Documents to which Union is a party and, except as
contemplated by this Agreement and the Ancillary Documents, to consummate the
transactions contemplated hereby and thereby. Except as contemplated by this
Agreement and the Ancillary Documents, the execution and delivery of this
Agreement and the Ancillary Documents to which Union is a party and the
consummation of the transactions contemplated hereby and thereby have been
duly authorized by all necessary action on the part of Union and no other
proceeding (including by its equityholders) on the part of Union is necessary
to authorize this Agreement and the Ancillary Documents to which Union is a
party or to consummate the transactions contemplated hereby. This Agreement
has been (and the Ancillary Documents to which Union is a party will be when
executed and delivered by Union at the Closing) duly and validly executed and
delivered by Union and constitutes (and, with respect to each of the Ancillary
Documents to which Union will be a party, will constitute) a valid, legal and
binding agreement of Union (assuming this Agreement has been and the Ancillary
Documents to which Union is a party will be duly authorized, executed and
delivered by the other parties thereto), enforceable against Union in
accordance with their respective terms, except (a) to the extent that
enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other laws affecting the enforcement of
creditors' rights generally and (b) that the availability of equitable
remedies, including specific performance, is subject to the discretion of the
court before which any proceeding thereof may be brought.

     

Section 5.3. _No Violations; Consents and Approvals_.

 

The execution and delivery of this Agreement and the Ancillary Documents do
not, and the consummation of the Transaction by Union and performance by Union
of its obligations hereunder and thereunder will not: (a) result in any
violation of the Union Governing Documents; (b) conflict with, or result in a
breach of any of the terms or provisions of, or constitute a default under, or
result in the termination, cancellation, acceleration or modification (whether
after the giving of notice or the lapse of time or both) of any right or
obligation of Union under, any Contract to which Union is a party or by which
it is bound or to which its assets or properties are subject; (c) violate or
result in a breach of or constitute a default under any Law, judgment, order,
injunction or decree applicable to Union or by which Union or its assets or
properties are bound; and (d) require any Consent of any Governmental Entity
or any party to any material Contract to which Union is a party or by which
Union is bound or to which Union's assets or properties are subject. No
Consent or Permit with respect to any Person or Governmental Entity (except
the SEC in connection with the Proxy Statement and Registration Statement to
be filed with the SEC in connection with the transactions contemplated by this
Agreement) is required on the part of Union in connection with the execution
and delivery of this Agreement and the Ancillary Documents by Union, the
performance of their respective obligations hereunder, and the consummation of
the transactions contemplated hereby.

 

Section 5.4. _Absence of Changes_.

 

Between the date of Union's formation and the date of this Agreement, (a)
there has not been a Union Material Adverse Effect and (b) Union has conducted
its business only in the ordinary course of business.

 

Section 5.5. _Brokers_.

 

Except as set forth on _Schedule 5.5_ , no broker, finder, financial advisor
or investment banker is entitled to any brokerage, finder's, financial
advisor's or investment banker's fee or commission or similar payment in
connection with the transactions contemplated by this Agreement based upon
arrangements made by and on behalf of such Party or any of its Affiliates for
which Bioceres may become liable.

 

Section 5.6. _Union Information_.

 

None of the information supplied or to be supplied by Union or any of its
Affiliates expressly for inclusion or incorporation by reference, if
applicable, in (a) the filings with the SEC, including the Registration
Statement (which contains the Proxy Statement in connection with the
Transaction Proposals), (b) mailings to holders of Union Ordinary Shares with
respect to the Transaction Proposals, and/or the redemption of Public Shares,
and/or (c) any other document filed with any Governmental Entity in connection
herewith and any supplements thereto, will, at the date of filing and/or
mailing, as the case may be, contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the statements
therein, in light of the circumstances under which they are made, not
misleading (subject to the qualifications and limitations set forth in the
materials provided by Union or that are included in the Union SEC Documents).
No representation or warranty is made by Union with respect to statements made
or incorporated by reference therein based on information supplied by, or on
behalf of, Bioceres or any Group Company.

 

Section 5.7. _Trust Account_.

 

As of the date hereof, Union has approximately one hundred and seventeen
million seventy-six thousand seventy-four U.S. Dollars (US$117,076,074) in the
Trust Account and held in trust by the Trustee pursuant to the Trust
Agreement.

    

Section 5.8. _Listing_.

 

The Union Ordinary Shares are registered pursuant to Section 12(b) of the
Exchange Act and are listed on the NYSE. There is no Proceeding pending or, to
Union's knowledge, threatened in writing against Union by the SEC with respect
to the deregistration of the Union Ordinary Shares under the Exchange Act. As
of the date hereof, there is no Proceeding pending or, to Union's knowledge,
threatened in writing against Union by the NYSE with respect to the delisting
of the Union Ordinary Shares on the NYSE. Union has taken no action that is
designed to terminate the registration of the Union Ordinary Shares under the
Exchange Act.

 

Section 5.9. _Union Board Approval_.

 

The Union Board, at a meeting duly called and held and acting upon the
unanimous recommendation of the members of the Union Board, has, as of the
date of this Agreement, (a) approved and declared the advisability of this
Agreement, the Ancillary Documents and the transactions contemplated hereby
and thereby, including but not limited to the Proxy Statement and the
Registration Statement and the filing thereof with the SEC; (b) determined
that this Agreement and the Ancillary Documents and the transactions
contemplated hereby and thereby are in the best interests of Union and the
holders of Union Ordinary Shares, (c) determined that as of the date of this
Agreement, the Group Companies will have a fair market value equal to at least
80% of the assets held in the Trust Account (excluding Taxes payable on the
income earned on the Trust Account), and (d) approved the calling of the
Extraordinary General Meeting.

 

Section 5.10. _Union SEC Documents and Financial Statements_.

 

Union has filed all forms, reports, schedules, statements and other documents,
including any exhibits thereto, required to be filed or furnished by Union
with the SEC since Union's formation under the Exchange Act or the Securities
Act, together with any amendments, restatements or supplements thereto, and
will file all such forms, reports, schedules, statements and other documents
required to be filed subsequent to the date of this Agreement (the "
_Additional Union SEC Documents_ "). Union has made available to Bioceres
copies in the form filed with the SEC of all of the following, except to the
extent available in full without redaction on the SEC's website through EDGAR
for at least two (2) days prior to the date of this Agreement: (a) Union's
Quarterly Reports on Form 10-Q for each fiscal quarter of Union beginning with
the first quarter Union was required to file such a form, (b) its Current
Reports on Form 8-K filed since the effectiveness of its registration
statement on Form S-1, (c) all other forms, reports, registration statements
and other documents (other than preliminary materials if the corresponding
definitive materials have been provided to Bioceres pursuant to this _Section
5.10_ ) filed by Union with the SEC since Union's formation (the forms,
reports, registration statements and other documents referred to in clauses
(a), (b), and (c) above, whether or not available through EDGAR, are,
collectively, the " _Union SEC Documents_ "). The Union SEC Documents were,
and the Additional Union SEC Documents will be, prepared in all material
respects in accordance with the requirements of the Securities Act, the
Exchange Act, and the Sarbanes-Oxley Act of 2002, as amended, as the case may
be, and the rules and regulations under each. The Union SEC Documents did not,
and the Additional Union SEC Documents will not, at the time they were or are
filed, as the case may be, with the SEC (except to the extent that information
contained in any Union SEC Document or Additional Union SEC Document has been
or is revised or superseded by a later filed Union SEC Document or Additional
Union SEC Document, then on the date of such filing) contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements made therein, in
the light of the circumstances under which they were made, not misleading. As
used in this _Section 5.10_ , the term "file" shall be shall be broadly
construed to include any manner in which a document or information is
furnished, supplied or otherwise made available to the SEC.

     

Section 5.11. _Litigation_.

 

As of the date of this Agreement, (a) there is no Proceeding pending or, to
Union's knowledge, threatened against Union before any Governmental Entity,
which, and (b) Union is not subject to any outstanding order, writ, injunction
or decree that, in either case, would, if finally determined pursuant to a
final nonappealable judgment, have an adverse effect which is material to
Union, taken as a whole. Union has filed or intends to file any suit,
litigation, arbitration, claim or action against any other Person.

 

Section 5.12. _Absence of Certain Payments_.

 

As of the date of this Agreement, to Union's knowledge, neither Union, nor any
Representative acting on Union's behalf, has (a) used any corporate funds for
any unlawful contribution, gift, entertainment or other unlawful expense
relating to political activity; (b) made any direct or indirect unlawful
payment to any foreign or domestic government official or employee from
corporate funds; (c) violated or is in violation of any provision of the
Foreign Corrupt Practices Act of 1977; or (d) made any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment.

 

Section 5.13. _Union Ordinary Shares_.

 

Union has not granted any rights to convert any indebtedness into Union
Ordinary Shares.

 

Section 5.14. _Tax Matters._

 

(a) Union has:

 

(i) duly and timely filed, or caused to be filed, in accordance with
applicable Law all Union Tax Returns required to be filed by or with respect
to Union, each of which is true, correct and complete in all material
respects, and

 

(ii) duly and timely paid in full, or caused to be paid in full, all Taxes
required to be paid by or with respect to Union (whether or not shown on any
Union Tax Return).

 

(b) No extension of time to file any Union Tax Return, which Union Tax Return
has not since been filed in accordance with applicable Law, has been filed.
There is no power of attorney in effect with respect or relating to any Union
Tax Return.

    

(c) Union has never been a member of an affiliated group filing a consolidated
U.S. federal income Tax Return and has no Liability for the Taxes of any other
Person under Treasury Regulation Section 1.1502-6 (or any similar provision of
U.S. state, U.S. local or non-U.S. law); by reason of any agreements,
contracts or arrangements (other than customary provisions in commercial
contracts the primary purpose of which is not Tax), as a successor or
transferee.

 

(d) Union has complied in all material respects with all applicable Laws
relating to the deposit, collection, withholding, payment or remittance of any
Group Company Tax (including, but not limited to, Section 3402 of the Code).

 

(e) There is no Lien for any Tax upon any asset or property of Union (except
for Permitted Liens).

 

(f) There is no U.S. state, U.S. local or non-U.S. Proceeding related to Taxes
that is pending or currently being conducted, or to the knowledge of Union,
threatened or proposed in writing with regard to Union, any Union Tax or any
Union Tax Return. Union has never received from any U.S. federal, state or
local, or non-U.S. taxing authority any written (i) notice indicating an
intent to open a Proceeding related to Taxes, (ii) request for information
related to Tax matters, or (iii) notice of deficiency or proposed adjustment
for any amount of Tax proposed, asserted or assessed by any taxing authority
against Union.

 

(g) No statute of limitations for any ongoing Proceeding relating to Union Tax
or any Union Tax Return has been modified, extended or waived.

 

(h) Union is resident for Tax purposes solely in the Cayman Islands. No
jurisdiction where Union has not filed a Tax Return or paid Tax has made a
written claim for the payment of any Tax by Union or the filing of any Tax
Return by Union.

 

(i) Union is not and will not be required to include any item of income in, or
exclude any item of deduction from, taxable income for any taxable period (or
portion thereof) ending after the Closing Date, as a result of any: (i) change
in or use of any improper method of accounting for a taxable period ending on
or prior to the Closing Date; (ii) agreement entered into with any taxing
authority (including a "closing agreement" as described in Section 7121 of the
Code, or any corresponding or similar provision of U.S. state, U.S. local or
non-U.S. Tax law) on or prior to the Closing Date; (iii) deferred intercompany
transactions occurring at or prior to the Closing or any excess loss account
in existence at the Closing described in Treasury Regulations under Section
1502 of the Code (or any corresponding or similar provision of U.S. state,
U.S. local or non-U.S. Tax law); (iv) installment sale or open transaction or
disposition made on or prior to the Closing Date; (v) prepaid amount received
or deferred revenue accrued on or prior to the Closing Date; (vi) election
(including a protective election) made under Section 108(i) of the Code (or
any corresponding or similar provision of U.S. state, U.S. local or non-U.S.
Tax law) on or prior to the Closing Date; (vii) current ownership interest in
a "controlled foreign corporation" (within the meaning of Section 957(a) of
the Code) owning "United States property" (as defined in Section 956(c) of the
Code) acquired prior to the Closing, (viii) current ownership interest in a
"controlled foreign corporation" (within the meaning of Section 957(a) of the
Code) having "subpart F income" (within the meaning of Section 952(a) of the
Code) or "global intangible low-taxed income" (within the meaning of Section
951A of the Code) prior to the Closing, or (ix) application of Section 965 of
the Code (including an election under Section 965(h) of the Code).

    

(j) Union is not and has never been a beneficiary of or otherwise participated
in any "listed transaction" within the meaning of Treasury Regulation Section
1.6011-4(b)(2).

 

(k) Union has not distributed stock of another Person nor has its stock been
distributed by another Person, in a transaction that was purported or intended
to be governed in whole or in part by Section 355 of the Code or Section 361
of the Code.

 

(l) Union is not a party to a gain recognition agreement under Section 367 of
the Code, and Union has never transferred an intangible the transfer of which
would be subject to the rules of Section 367(d) of the Code.

 

(m) Union does not have Liability for any unpaid Taxes which have not been
accrued for or reserved on Union's balance sheets included in Union's audited
consolidated financial statements, whether asserted or unasserted, contingent
or otherwise, other than any Liability for unpaid Taxes that may have accrued
since the end of the most recent fiscal year in connection with the operation
of the business of Union in the ordinary course of business.

 

(n) Union is not a party to any Tax allocation, Tax indemnity or Tax sharing
agreement (other than pursuant to commercial agreements entered into in the
ordinary course of business, the primary purpose of which is not Taxes).

 

(o) Union is not, nor has it ever been, a "United States real property holding
corporation" within the meaning of Section 897(c)(2) of the Code at any time
during the applicable period referred to in Section 897(c)(1)(A)(ii) of the
Code.

 

ARTICLE 6 
COVENANTS

 

Section 6.1. _Conduct of Business of Union and the Group Companies_.

 

(a) Except as contemplated by this Agreement, from and after the date hereof
until the earlier of the Closing Date or the termination of this Agreement in
accordance with its terms (the " _Pre-Closing Period_ "), (i) Union shall,
(ii) Bioceres shall cause the Group Companies to and (iii) prior to the Pre-
Closing Reorganization, Parent shall cause Bioceres Semillas to, except as set
forth herein or as consented to in writing by Union and Bioceres or Union and
Parent, to the extent applicable, (in each case, which consent shall not be
unreasonably withheld, conditioned or delayed), (A) conduct its business in
the ordinary and regular course in substantially the same manner heretofore
conducted (including any conduct that is reasonably related, complementary or
incidental thereto) and (B) use commercially reasonable efforts to preserve
substantially intact its business organization and to preserve the present
commercial relationships with key Persons with whom it does business.

   

(b) Without limiting the generality of _Section 6.1(a)_ , except as otherwise
contemplated by this Agreement, as required by applicable Law or as set forth
in _Schedule 6.1(b)_ , Bioceres shall cause the Group Companies and, prior to
the Pre-Closing Reorganization, Parent shall cause Bioceres Semillas, not to
do or cause to be done any of the following without the prior consent of Union
(which consent shall not be unreasonably withheld, conditioned or delayed):

 

(i) issue (other than to any other Group Company) (A) any equity securities of
or any equity interest in any Group Company; or (B) any options, warrants,
rights of conversion or other rights, agreements, arrangements or commitments
obligating any Group Company to issue, deliver or sell any equity securities
of or any equity interest in any Group Company;

 

(ii) (A) obtain or incur any Indebtedness which, on a pro forma basis, would
cause the Indebtedness of the Group Companies to exceed one hundred and one
million U.S. Dollars (US$101,000,000) or (B) create any Lien on any assets or
properties (whether tangible or intangible) of any Group Company, other than
Permitted Liens;

 

(iii) sell, assign, transfer, lease, license or otherwise dispose of, or agree
to sell, assign, transfer, lease, license or otherwise dispose of, any of the
material fixed assets of any Group Company having a value in excess of four
hundred and fifty thousand U.S. Dollars (US$450,000);

 

(iv) acquire (by merger, consolidation or combination, or acquisition of
shares or stock or assets) any corporation, partnership or other business
organization or division thereof;

 

(v) except in the ordinary course of business and would not qualify as a
Material Contract or Material Lease under this Agreement, enter into, amend,
terminate or extend (other than as a result of automatic renewals and
extensions set forth therein) any Material Contract or Material Lease, or
waive, release, assign or fail to enforce any material rights or claims under
any such Material Contract or Material Lease;

 

(vi) (A) enter into or amend any employment, deferred compensation, severance
or similar agreement, except any employment agreement providing for annual
base salary of less than $250,000 per annum; (B) increase the compensation
payable, or to become payable, by any Group Company to directors or officers
of such Group Company; (C) pay or make provision for the payment of any bonus,
stock option, stock purchase, profit sharing, deferred compensation, pension,
retirement or other similar payment or arrangement to any employee of any
Group Company, or any director or officer of any Group Company other than in
the ordinary course of business; or (D) other than as required by applicable
Law, increase the coverage or benefits available under any Employee Benefit
Plan or Foreign Benefit Plan, payment or arrangement made to, for or with any
director, officer, employee of any Group Company, agent or representative,
other than, in the case of each of clauses (A) through (D), increases,
payments or provisions which are made in the ordinary course of business
consistent with past practice, or which are made pursuant to a contractual
obligation in existence as of the date of this Agreement;

 

(vii) make any capital expenditures in excess of $350,000 individually;

   

(viii) adopt, terminate or change any method of financial or Tax accounting or
financial or Tax accounting practice used by any Group Company, other than as
required by IFRS or applicable Law;

 

(ix) make any material election relating to Taxes; alter, modify, change,
terminate or revoke any election relating to Taxes; enter into any closing
agreement or other Tax-related agreement with a taxing authority; settle any
material Proceeding relating to Taxes; file any amended Tax Return relating to
a material amount of Taxes; or take any affirmative action to surrender any
right to claim a material Tax refund;

 

(x) allow any material insurance policy of the Group Companies to lapse
uncured;

 

(xi) effect or agree to any change, other than in the ordinary course of
business with regard to any material practices or terms, including payment
terms, with respect to Group Company customers or suppliers listed in _Section
3.20_ of the Disclosure Schedule;

 

(xii) waive, release, assign, settle or compromise any material rights, claims
or litigation (including relating to any confidentiality agreement) with a
value in excess of four hundred thousand U.S. Dollars (US$400,000);

 

(xiii) adopt or propose any amendment to the Governing Documents of any Group
Company, other than in connection with the Pre-Closing Reorganization;

 

(xiv) adopt or effect a plan of complete or partial liquidation, dissolution,
restructuring, recapitalization or other reorganization of any Group Company,
other than the Pre-Closing Reorganization; or

 

(xv) enter into any agreement to take, or cause to be taken, any of the
actions set forth in this _Section 6.1(b)_ or publicly recommend, publicly
propose or publicly announce an intention to do any of the foregoing.

 

(c) Without limiting the generality of _Section 6.1(a)_ , except as otherwise
contemplated by this Agreement or as required by applicable Law, Union shall
not do or cause to be done any of the following without the prior consent of
Bioceres (which consent shall not be unreasonably withheld, conditioned or
delayed):

 

(i) issue (A) any shares, capital stock or other equity or debt securities; or
(B) any options, warrants, rights of conversion or other rights, agreements,
arrangements or commitments obligating Union to issue, deliver or sell any
shares, capital stock or other equity or debt securities;

 

(ii) adopt or propose any amendment to the Governing Documents of Union;

 

(iii) acquire any capital stock, membership interest, partnership interest,
joint venture interest or other equity or other interest in any Person
(except, for the benefit of doubt, the Group Companies), or merge, consolidate
or adopt a plan or scheme of arrangement with, or purchase a substantial
portion of the assets of any Person or any division or business thereof;

   

(iv) create, issue, deliver, pledge or sell, or propose or authorize the
creation, issuance, delivery, pledge or sale of, or grant any options or other
awards with respect to any capital stock or other equity or debt securities,
or make any other agreements with respect to, any of its shares of capital
stock or any other equity or debt securities or adopt or implement any
shareholder, stockholder or member rights plan;

 

(v) as applicable, split, combine, divide, subdivide, reclassify or redeem,
purchase or otherwise acquire, or propose to redeem or purchase or otherwise
acquire, any Union Ordinary Shares or any other equity or debt securities of
Union;

 

(vi) increase in any manner the compensation or benefits payable or to become
payable to any Founder;

 

(vii) adopt or effect a plan of complete or partial liquidation, dissolution,
restructuring, recapitalization or other reorganization;

 

(viii) (A) obtain or incur any Indebtedness in excess of five hundred thousand
U.S. Dollars (US$500,000) (other than pursuant to the Union's credit
facilities existing as of the date hereof up to an amount not to exceed the
facility limit applicable to each such credit facility as of the date hereof)
or (B) create any Lien on any assets or properties (whether tangible or
intangible) of Union;

 

(ix) voluntarily incur any Liability or obligation (whether absolute, accrued,
contingent or otherwise) in excess of $100,000 individually or $250,000 in the
aggregate other than (A) pursuant to the terms of a material Contract in
existence as of the date hereof or entered into in the ordinary course of
business or (B) in connection with the engagement of legal counsel, tax or
financial advisors or other consultants in connection with the transactions
contemplated hereby; or

 

(x) enter into any agreement to take, or cause to be taken, any of the actions
set forth in this _Section 6.1(c)_ or publicly recommend, publicly propose or
publicly announce an intention to do any of the foregoing.

 

Section 6.2. _Certain Tax Matters_.

 

All sales, use, value added, transfer, stamp, registration, real property
transfer or similar Taxes (" _Transfer Taxes_ ") arising in connection with
the transfer of the Company Shares and the Bioceres Semillas Shares hereunder
shall be borne by Union. Union shall file such Tax Return required to be filed
to report Transfer Taxes imposed on or with respect to the transactions
contemplated by this Agreement. The Parties shall use commercially reasonable
efforts to avail themselves of any available exemptions from any such Taxes,
and to cooperate with the other Party in providing any information and
documentation that may be necessary to obtain such exemptions.

   

Section 6.3. _Access to Information_.

 

(a) During the Pre-Closing Period, upon reasonable notice, and subject to
applicable Law and restrictions contained in the confidentiality agreements to
which the Group Companies are subject, Bioceres shall cause the Group
Companies to provide to Union, and its authorized Representatives, during
normal business hours, reasonable access to all books and records of the Group
Companies reasonably requested by Union (in a manner so as to not interfere
with the normal business operations of any Group Company); provided that (i)
such access shall occur in such a manner as Bioceres reasonably determines to
be appropriate to protect the confidentiality of the transactions contemplated
by this Agreement and (ii) all requests for such access shall be directed to
the Bioceres Designated Contact. All of such information provided to Union, or
any of its Affiliates or representative shall be treated as confidential
information pursuant to the terms of the Confidentiality Agreement, the
provisions and restrictions of which are by this reference hereby incorporated
herein and expressly made applicable to and enforceable against Union.

 

(b) During the Pre-Closing Period, upon reasonable notice, Union shall provide
to Bioceres, and its authorized Representatives during normal business hours
reasonable access to all books and records of Union reasonably requested (in a
manner so as to not interfere with the normal business operations of Union);
provided that (i) such access shall occur in such a manner as Union reasonably
determines to be appropriate to protect the confidentiality of the
transactions contemplated by this Agreement and (ii) all requests for such
access shall be directed to the Union Designated Contact. All of such
information provided to Bioceres, or any of its Affiliates or representative
shall be treated as confidential information pursuant to the terms of the
Confidentiality Agreement, the provisions and restrictions of which are by
this reference hereby incorporated herein and expressly made applicable to and
enforceable against Union.

 

Section 6.4. _Efforts to Consummate; Regulatory Matters_.

 

(a) Subject to the terms and conditions herein provided, the Parties shall
cooperate with the one another and use commercially reasonable efforts to
take, or cause to be taken, all actions and to do, or cause to be done, all
things reasonably necessary, proper or advisable under applicable Laws, rules
and regulations to consummate and make effective as promptly as practicable
the transactions contemplated by this Agreement (including the satisfaction,
but not waiver, of the closing conditions set forth in _ARTICLE 7_ ).

 

(b) Each Party shall use reasonable best efforts to obtain all consents,
Permits and other authorizations of all Governmental Entities (including all
state securities law or "Blue Sky" permits and approvals) necessary to
consummate the transactions contemplated by this Agreement.

 

(c) Each Party shall furnish each other with all information concerning
itself, its Affiliates, its Representatives and shareholders and interest
holders, and such other matters as may be reasonably necessary or advisable in
connection with any schedule, statement, filing, notice or application made by
or on behalf of any Party or its Affiliates to any Governmental Entity in
connection with the transactions contemplated by this Agreement and the
Ancillary Documents. Each Party shall promptly advise the other Party upon
their or, in the case of Bioceres, any of its Subsidiaries, receiving any
communication from any Governmental Entity whose consent or approval is
required for consummation of the transactions contemplated by this Agreement
and the Ancillary Documents that causes Union to believe that there is a
reasonable likelihood that any approval of such Governmental Entity will not
be obtained or that the receipt of any such approval will be materially
delayed.

   

(d) In the event any Proceeding by any Governmental Entity or other Person is
commenced which questions the validity or legality of the transactions
contemplated hereby or seeks damages in connection therewith, the Parties
agree to cooperate and use their commercially reasonable efforts to defend
against such Proceeding and, if an injunction or other order is issued in any
such Proceeding, to use their commercially reasonable efforts to have such
injunction or other order lifted, and to cooperate reasonably regarding any
other impediment to the consummation of the transactions contemplated hereby.

 

Section 6.5. _Preparation of Proxy Statement/Registration Statement_.

 

(a) As promptly as practicable after the execution of this Agreement (provided
that Bioceres has provided to Union all of the information described in
_Section 6.5(e)_ hereof), Union and Bioceres shall use best efforts to jointly
prepare and Union shall cause to be filed with the SEC, in preliminary form,
the Registration Statement (which shall include the proxy statement/prospectus
to be filed with the SEC (such proxy statement/prospectus, together with any
amendments or supplements thereto, the " _Proxy Statement_ ")) in connection
with the registration under the Securities Act of the Exchange Shares and
Union Warrants to be issued in connection with the Exchange. Union shall use
commercially reasonable efforts to cause the Registration Statement and the
Proxy Statement to comply with the rules and regulations promulgated by the
SEC. Bioceres and their counsel shall be given a reasonable opportunity to
review and comment on the Registration Statement (which includes the Proxy
Statement) and any other document each time before any such document is filed
with the SEC, and Union shall give reasonable and good faith consideration to
any comments made by Bioceres and their counsel. Union shall provide Bioceres
and their counsel with (i) any comments or other communications, whether
written or oral, that Union or their counsel may receive from time to time
from the SEC or its staff with respect to the Registration Statement (which
includes the Proxy Statement) promptly after receipt of those comments or
other communications and (ii) a reasonable opportunity to participate in the
response of Union to those comments and to provide comments on that response
(to which reasonable and good faith consideration shall be given), including
by participating in any discussions or meetings with the SEC.

 

(b) As soon as is reasonably practicable after the filing of the Registration
Statement in preliminary form and the receipt by Union from Bioceres of all
information contemplated under _Section 6.5(a)_ , Union shall prepare and file
the Registration Statement in definitive form with the SEC under the Exchange
Act, and with all other applicable regulatory bodies, all in accordance with
and as required by any applicable rules and regulations of the SEC and the
NYSE. Union shall use its commercially reasonable efforts to have the
Registration Statement declared effective under the Securities Act as promptly
as practicable after such filing and to keep the Registration Statement
effective as long as is necessary to consummate the transactions contemplated
hereby. Union shall set a record date (the " _Record Date_ ") for determining
the holders of Union Ordinary Shares entitled to attend the Extraordinary
General Meeting. Union will cause the Proxy Statement to be mailed to each
holder of Union Ordinary Shares as of the Record Date promptly after the
Registration Statement is declared effective under the Securities Act.

   

(c) Union will advise Bioceres, promptly after Union receives notice thereof,
of the time when the Registration Statement (which includes the Proxy
Statement) has become effective or any supplement or amendment has been filed,
of the issuance of any stop order or the suspension of the qualification of
the Exchange Shares or the Union Warrants for offering or sale in any
jurisdiction, of the initiation or written threat of any Proceeding for any
such purpose, or of any request by the SEC for the amendment or supplement of
the Registration Statement (which includes the Proxy Statement) or for
additional information.

 

(d) Each of the Parties shall ensure that none of the information supplied by
or on its behalf for inclusion or incorporation by reference in (i) the
Registration Statement will, at the time the Registration Statement is filed
with the SEC, at each time at which it is amended and at the time it becomes
effective under the Securities Act, contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under
which they are made, not misleading or (ii) the Proxy Statement will, at the
date it is first mailed to holders of Union Ordinary Shares and at the time of
the Extraordinary General Meeting contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading. If at any time prior
to the Closing any information relating to Bioceres, any Group Company or
Union, or any of their respective Affiliates, directors or officers is
discovered by either Party that is required to be set forth in an amendment or
supplement to the Proxy Statement or the Registration Statement so that such
document would not include any misstatement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made,
not misleading, the Party that discovers such information shall promptly
notify the other Party and an appropriate amendment or supplement describing
such information shall be promptly filed with the SEC and, to the extent
required by Law, disseminated to the holders of Union Ordinary Shares.

 

(e) Bioceres acknowledges that a substantial portion of the Registration
Statement will include disclosure regarding Bioceres, the Group Companies and
their respective officers, directors and stockholders, and their business,
management, operations and financial condition. Accordingly, Bioceres agrees
to, and agrees to cause the Group Companies to, as promptly as reasonably
practicable, use commercially reasonable efforts to provide Union with all
such information that is required or reasonably requested by Union to be
included in the Registration Statement or any other statement, filing, notice
or application required to be made by or on behalf of Union to the SEC or the
NYSE in connection with the transactions contemplated hereby, including but
not limited to a correct and complete copy of (i) the audited combined balance
sheets of the Group Companies for the year ended June 30, 2018, six (6) months
ended June 30, 2017 and year ended December 31, 2016 and the related audited
combined statements of operations, shareholders' equity and cash flows for
such periods (including the notes related thereto) (the " _Audited Combined
Financial Statements_ ") and (ii) the unaudited combined financial statements
(including any related notes thereto) of the Group Companies at and for the
three (3) months ended September 30, 2018 and 2017 (the " _Interim Financial
Statements_ ") complying as to form in all material respects, and prepared in
accordance with IFRS, as modified by the rules and regulations of the SEC,
applied on a consistent basis throughout the periods involved (except as may
be indicated in the notes thereto). Such Audited Combined Financial Statements
and Interim Financial Statements shall fairly present in all material respects
the financial position of the Group Companies at the respective dates thereof
and the results of their operations and cash flows for the periods indicated.

   

Section 6.6. _Transaction Proposals and the Union Shareholder Approval_.

 

Union shall, as promptly as practicable after the Registration Statement is
declared effective under the Securities Act (a) give notice of and (b) convene
and hold an extraordinary general meeting (the " _Extraordinary General
Meeting_ ") in accordance with Union's Governing Documents, for the purposes
of (i) providing holders of Public Shares with the opportunity to elect to
effect a Share Redemption and (ii) seeking a vote from the holders of Union
Ordinary Shares in favor of (A) adopting and approving this Agreement, the
Ancillary Documents and any related transactions contemplated hereby or
thereby; (B) appointing seven (7) directors to the post-Closing Union Board,
five (5) of whom shall be designated by Bioceres and two (2) of whom shall be
designated by the pre-Closing Union Board; (C) amending the Union Articles to
change the name of Union to Bioceres Crop Solutions Corp. and to amend certain
other provisions that will no longer be relevant upon consummation of the
transactions contemplated herein; (D) approving the issuance of more than 20%
of the issued and outstanding Union Ordinary Shares to Bioceres for purposes
of complying with applicable provisions of Section 312.03 of the NYSE Listed
Company Manual; (E) adopting and approving any other proposals as the SEC (or
staff members thereof) may indicate are necessary in its comments to the
Registration Statement (which includes the Proxy Statement) or in
correspondence related thereto, and of any other proposals reasonably agreed
by the Parties as necessary or appropriate in connection with this Agreement
and the transactions contemplated hereby; (F) adjourning the Extraordinary
General Meeting (such proposals in (A) through (F), together, the "
_Transaction Proposals_ " and the approval in favor of such Transaction
Proposals, the " _Union Shareholder Approval_ ").

 

Section 6.7. _Third Party Consents_.

 

(a) Without limiting Bioceres' obligations set forth in this Agreement, prior
to the Closing, and as necessary, following the Closing, Bioceres shall, and
shall prior to Closing cause each of the Group Companies to, use its
commercially reasonable efforts to (i) notify any Third Parties who are
required by any Material Contract or Material Lease to be notified of the
transactions contemplated hereby; (ii) obtain all necessary consents,
approvals or waivers from Third Parties (" _Consents_ ") under any Material
Contract or Material Lease (provided that grant of such Consent is not subject
to any restrictions or other requirements that would adversely affect the
business of the Company or other Group Company) so that none of the effects
set forth in _Section 3.3(b)_ or _Section 4.2(b)_ have or will occur as a
result of the execution, delivery and performance of this Agreement and the
other agreements contemplated hereby by Bioceres or the consummation of the
transactions contemplated hereby and (iii) satisfy any legal requirement
necessary for the consummation of the transactions contemplated hereby as
promptly as possible after the date hereof. In furtherance of the foregoing,
Union shall cooperate and use all commercially reasonable efforts to assist
Bioceres in obtaining such Consents and agrees to provide such assurances as
to financial capability, resources and creditworthiness as may be reasonably
requested by any Third Party whose consent is sought hereunder.

   

(b) Without limiting Union's obligations set forth in this Agreement, prior to
the Closing, Union shall use its commercially reasonable efforts to (i) notify
any Third Parties who are required to be notified of the transactions
contemplated hereby and (ii) satisfy any legal requirement necessary for the
consummation of the transactions contemplated hereby.

 

Section 6.8. _Notice_.

 

Prior to the Closing, (a) Bioceres shall promptly notify Union in writing of
all events, circumstances, facts and occurrences arising subsequent to the
date of this Agreement which would result in a breach of any representation or
warranty of Bioceres or regarding the Group Companies or breach of any
covenant by Bioceres in this Agreement such that any of the conditions
contained in _Section 7.2(a)_ or _Section 7.2(b)_ would not be satisfied and
(b) Union shall promptly notify Bioceres in writing of all events,
circumstances, facts and occurrences arising subsequent to the date of this
Agreement which would result in a breach of any representation or warranty or
covenant of Union in this Agreement such that any of the conditions contained
in _Section 7.3(a)_ or _Section 7.3(b)_ would not be satisfied.

 

Section 6.9. _Public Announcements_.

 

Union and Bioceres shall consult with one another and seek one another's
written approval before issuing any Reviewable Document, and shall not, and
shall cause their respective Affiliates not to, issue any such Reviewable
Document prior to such consultation and approval; provided that either Party
may make any such announcement which it in good faith believes, based on
advice of counsel, is necessary or advisable in connection with any
requirement of law or regulation or rule of any applicable national securities
exchange, it being understood and agreed that either Party shall provide the
other Party with copies of any such announcement in advance of such issuance;
_provided_ , _further_ , that either Party may make internal announcements to
their respective employees that are not inconsistent in any material respects
with the Parties' prior public disclosures regarding the transactions
contemplated hereby. Any language included in a Reviewable Document that
reflects the comments of the reviewing party, as well as any text as to which
the reviewing party has not commented upon after being given a reasonable
opportunity to comment, shall be deemed to have been approved by the reviewing
party and may henceforth be used by the other party in other Reviewable
Documents and in other documents distributed by the other party in connection
with the transactions contemplated by this Agreement without further review or
consent of the reviewing party.

 

Section 6.10. _Exclusive Dealing_.

 

(a) During the Pre-Closing Period, Bioceres and Parent, as applicable, shall
not take, nor shall either permit any of their respective Representatives to
take, any action to solicit, encourage, initiate or engage in discussions or
negotiations with, or provide any information to or enter into any agreement
with any Person (other than with Union and/or its Affiliates) concerning any
purchase of any of the Company's or Bioceres Semillas' equity securities (to
the extent owned by Parent) or any merger, sale of substantial assets or
similar transaction involving any Group Company.

   

(b) During the Pre-Closing Period, Union shall not take, nor shall it permit
any of its respective Representatives to take, any action to solicit,
encourage, initiate or engage in discussions or negotiations with, or provide
any information to or enter into any agreement with any Person (other than
with Bioceres, Parent and/or their respective Affiliates) concerning any
Business Combination or the acquisition of any operating business, merger, or
acquisition of substantial assets or similar transaction involving Union.

 

Section 6.11. _Documents and Information_.

 

From and after the Closing Date, Union and Bioceres shall (and Bioceres shall
cause the Group Companies to) retain all books and records relating to the
Group Companies and their respective businesses, in each case, with respect to
the period before the Closing, for a period of six (6) years after the Closing
Date (or such longer period as may be required under applicable Law). The
Parties shall cooperate in the defense of any action or inquiry relating to
periods prior to the Closing Date and each shall provide access to properties
and individuals as reasonably requested and furnish or cause to be furnished
records, information and testimony, and attend such conferences, discovery
proceedings, hearings, trials or appeals as may reasonably be requested by a
Party in connection therewith.

 

Section 6.12. _Contact with Customers, Suppliers and Other Business
Relations_.

 

During the Pre-Closing Period, Union hereby agrees that (other than with
respect to the Bioceres Designated Contact) it is not authorized to and shall
not (and shall not permit any of its Representatives or Affiliates to) contact
any partner, member, equityholder (other than Bioceres), officer, director,
employee, customer, supplier, distributor, joint-venture partner, lessor,
lender or other material business relation of any Group Company regarding any
Group Company, its business or the transactions contemplated by this
Agreement, in each case, without the prior written consent of Bioceres, which
shall not be unreasonably withheld.

 

Section 6.13. _[RESERVED]_.

 

Section 6.14. _No Ordinary Shares Transactions; Listing_.

 

Neither Bioceres or Parent nor any of their respective Affiliates, directly or
indirectly, shall engage in any transactions involving the securities of the
Company or of Bioceres Semillas, applicable, prior to the time of the making
of a public announcement of the transactions contemplated by this Agreement.
Bioceres and Parent shall use reasonable best efforts to require each of their
respective Representatives, associates, clients and customers to comply with
the foregoing sentence. From the date of this Agreement through the Closing,
Union shall take all reasonable efforts which are necessary or reasonably
desirable for Union to remain listed as a public company on, and for the Union
Ordinary Shares to be tradable on the NYSE.

   

Section 6.15. _No Claim Against Trust Account_.

 

Notwithstanding anything else in this Agreement, Bioceres acknowledges that it
has read the final prospectus of Union, dated February 28, 2018, prepared,
filed and made available to the public in accordance with applicable
securities law, rules and regulations and understands that Union has
established the Trust Account for the benefit of holders of Public Shares and
that prior to the Closing, Union may disburse monies from the Trust Account
only in accordance with the express terms of the Trust Agreement. Bioceres
further acknowledges that, if the transactions contemplated by this Agreement
(or, upon termination of this Agreement, if the transactions contemplated by
another Business Combination) are not consummated by December 2, 2019, Union
will be obligated to return to its shareholders the amounts being held in the
Trust Account, unless such date is otherwise extended pursuant to the terms of
the Union Articles. Accordingly, Bioceres and each of its members, for each of
itself, himself, herself and the Subsidiaries, affiliated entities,
shareholders and Representatives of Bioceres and all other associates and
Affiliates, hereby waive all rights, title, interest or claim of any kind
against Union to collect from the Trust Account any monies that may be owed to
them by Union for any reason whatsoever, including a breach of this Agreement
by Union or any negotiations, agreements or understandings with Union (whether
in the past, present or future), and will not seek recourse against the Trust
Account at any time for any reason whatsoever, in each case except as
expressly contemplated by this Agreement (including the remedies provided in
_Section 10.13_ ). This paragraph will survive the termination of this
Agreement for any reason.

 

Section 6.16. _Union Borrowings_.

 

Through the Closing, Union shall be allowed to borrow funds from its
directors, officers, shareholders and/or their respective affiliates to meet
its reasonable capital requirements, with any such loans to be made only as
reasonably required by the operation of Union in due course on a non-interest
bearing basis and repayable in cash at Closing; _provided_ , _however_ , that
Union's directors, officers, shareholders and their respective Affiliates may
loan funds to Union for deposit in the Trust Account to fund the extension of
the date by which Union must complete its initial business combination as long
as such loans are repaid in cash upon or prior to Closing. The proceeds of
such loans shall not be used for the payment of salaries, bonuses or other
compensation to any of Union's directors, officers or shareholders.

 

Section 6.17. _Post-Closing Integration and Transition_.

 

The Parties agree to cooperate with one another in the preparation of a post-
Closing integration and transition plan.

 

Section 6.18. _Amending Governing Documents_.

 

Immediately following the Closing and subject to approval by the holders of
Union Ordinary Shares at the Extraordinary General Meeting, Union shall amend
the Union Governing Documents to change the name of Union to Bioceres Crop
Solutions Corp. (among other things that Union deems necessary to reflect the
consummation of the transactions contemplated by this Agreement). Immediately
following the Closing and subject to the requisite approval, Bioceres'
Governing Documents shall be amended as Union deems necessary to reflect the
consummation of the transactions contemplated by this Agreement.

 

Section 6.19. _Post-Closing Union Board_.

 

The Parties shall use commercially reasonable efforts to ensure that at the
Closing the Union Board shall be comprised of seven (7) members, five (5) of
whom shall be designated by Bioceres and two (2) of whom shall be designated
by the pre-Closing Union Board. One director designated by the pre-Closing
Union Board will serve in the second class of directors, whose term will
expire at the second annual meeting and one director designated by the pre-
Closing Union Board will serve in the third class of directors, whose term
will expire at the third annual meeting. For the avoidance of doubt, any such
directors designated by Union shall receive consideration for their duties as
members of the Union Board commensurate with that which is received by the
non-officer members of the Union Board that are not designated by Union.

    

Section 6.20. _[RESERVED]_.

 

Section 6.21. _D andO Insurance and Indemnification_.

 

(a) After the Closing, the Parties agree that all rights to indemnification,
advancement of expenses and exculpation by Union now existing in favor of each
Person who is now, or has been at any time prior to the date hereof, or who
becomes prior to the Closing Date, an officer or director of Union shall
survive the Closing Date and shall continue in full force and effect in
accordance with their respective terms.

 

(b) After the Closing, Union shall (i) maintain in effect for a period of six
(6) years after the Closing Date, if available, the current policies of
directors' and officers' liability insurance maintained by Union immediately
prior to the Closing Date ( _provided,_ that Union may substitute therefor
policies of at least the same coverage and amounts and containing terms and
conditions that are not less advantageous to the directors and officers of
Union when compared to the insurance maintained by Union as of the date
hereof), or (ii) obtain as of the Closing Date "tail" insurance policies with
a claims period of six (6) years from the Closing Date with at least the same
coverage and amounts, and containing terms and conditions that are not less
advantageous to the directors and officers of Union, in each case with respect
to claims arising out of or relating to events that occurred on or prior to
the Closing Date (including in connection with the transactions contemplated
hereby).

 

Section 6.22. _Pre-Closing Reorganization_.

 

(a) Within five (5) days of the approval of the transactions contemplated
herein by the then-current holders of the Union Ordinary Shares, (i) Bioceres
shall be converted into a Delaware limited liability company and (ii) all of
the assets and liabilities of Bioceres shall be transferred to the Company and
(iii) all of the Bioceres Semillas Shares shall be transferred by the Parent
to Bioceres (in exchange for limited liability company interests in Bioceres)
such that Bioceres will be the owner of the Bioceres Semillas Shares. The
foregoing clauses (i) through (iii) are referred to herein as the " _Pre-
Closing Reorganization_ ". For the avoidance of doubt, the steps that are
necessary to effect the Pre-Closing Reorganization are set forth on _Schedule
6.22(a)_.

 

(b) Notwithstanding the foregoing, Bioceres shall cause all documentation
necessary to properly effect the Pre-Closing Reorganization as contemplated by
the parties hereto to have been received, approved and authorized, as
applicable, including but not limited to (i) the Pre-Closing Reorganization
Consents, (ii) all documentation relating to the transfer of any equity
ownership among the relevant Group Companies and its Affiliates and (iii) all
documentation necessary to assign any Group Company Intellectual Property or
other Intellectual Property rights owned, licensed or sublicensed by Bioceres
or Parent, as applicable, which, for the avoidance of doubt shall include any
Marks, to the Company in order for the management and operations of the
business of the Group Companies to continue to be managed and operated as they
were immediately prior to the Pre-Closing Reorganization. For the avoidance of
doubt, all steps involved in the Pre-Closing Reorganization shall be effected
in a manner such that the business of the Group Companies individually and
collectively continues to be managed and operated in the same manner as it was
managed and operated prior to the Pre-Closing Reorganization.

   

(c) On the Closing Date, Union shall file a registration before the Public
Registry of Commerce of the City of Buenos Aires as a shareholder of Bioceres
Semillas.

 

Section 6.23. _Parent Joinder_.

 

Simultaneously with the Closing, Parent shall sign a joinder to this Agreement
(the " _Parent Joinder_ ") in the form attached hereto as _Exhibit E_ solely
for the purposes set forth therein.

 

Section 6.24. _Rizobacter Call Option_.

 

(a) Simultaneously with the Closing, the option set forth in the Rizobacter
call option agreement attached as _Exhibit F_ hereto (the " _Rizobacter Call
Option_ "), shall be exercised in accordance with its terms, whereby the
shares of Rizobacter Argentina S.A. (" _Rizobacter_ ") shall be purchased by
RASA Holding LLC (and not Parent) using (a) cash in the Trust Account, (b)
Union Ordinary Shares redeemed prior to or concurrently with the Closing, (c)
Exchange Shares or (d) any combination of items (a) through (c).

 

(b) The parties hereto agree that following the Closing, for so long as the
Founders maintain any equity interest in Union, the Founders shall have
information rights with respect to any and all matters (whether in person or
in writing) that come before the boards of directors of RASA Holding LLC and
Rizobacter.

 

Section 6.25. _Intellectual Property_.

 

(a) All Intellectual Property license and/or sublicense agreements which are
necessary or convenient for the performance of each of the Group Companies'
businesses as currently conducted or as proposed to be conducted shall be in
written form and shall be in full force and effect prior to the
commercialization of the products of each Group Company, including but not
limited to a perpetual, worldwide license from Parent to the Company,
including the right of the Company to grant sublicenses to any other Group
Company or to Third Parties in any country in the world, over any Intellectual
Property owned by or licensed to Parent related to HAHB-4, HB4 Modified,
HAHB-10, COXC5-1 and rGRF-3 technologies, as applied to, or in any way
applicable to, wheat, soy and corn, and over any technology owned by or
licensed to Parent that is related in any way to agriculture, including but
not limited to crop productivity solutions such as seeds, seed traits, seed
treatments, biologicals, high-value adjuvants and fertilizers.

   

(b) Prior to the Closing, Bioceres shall (i) file the assignments to the
applicable Group Company with the Network Information Center of Argentina or
its equivalent in another jurisdiction the internet domain names listed in
_Schedule 6.25(b)(i)_ and (ii) file the assignments to the applicable Group
Company before the Argentine Patent and Trademark Office-- _Instituto Nacional
de la Propiedad Industrial_ (INPI) all Marks listed in _Schedule 6.25(b)(ii)_
and/or before any other pertinent trademark office.

 

(c) Prior to the Closing, Bioceres shall obtain from Parent a written
undertaking that it will enter into a license agreement on the terms set forth
in the IP Outline attached as Exhibit D to that certain LLC Agreement of
Verdeca LLC, dated February 24, 2012, between ArcadiaBiosciences, Inc. and
Bioceres, Inc. as Parent is not a party to such Letter Agreement.

 

(d) Notwithstanding the forgoing, prior to the Closing, (i) Parent shall grant
to the applicable Group Company and (ii) Bioceres and Parent shall use best
efforts to obtain from any Third Party all assignments, licenses, sublicenses,
consents and/or any other authorizations or documents necessary or convenient
to fully comply with the provisions of this _Section 6.25_.

 

(e) Prior to the Closing, Bioceres shall, or shall cause Parent or the
applicable Group Company to, file all documents (whether physical, digital or
otherwise) with, and/or perform any required procedures before, the applicable
Governmental Entity in any country in the world in charge of the registration
of Intellectual Property (such as the Argentine Patent and Trademark Office--
_Instituto Nacional de la Propiedad Industrial_ (INPI)) that may be necessary
or required by applicable Law to (i) give effect to the provisions of this
_Section 6.25_ or any other provision of this Agreement and (ii) to ensure
Union receives the benefits it has bargained for hereunder.

 

Section 6.26. _Pre-Closing Matters_.

 

Prior to the Closing, Bioceres shall and shall cause Parent to (a) take the
remedial actions set forth on _Schedule 6.26(a)_ and (b) (i) deliver written
notice to and (ii) use commercially reasonable efforts to obtain an
acknowledgement of such notice from the Third Parties set forth on _Schedule
6.26(b)_ in connection with the agreements set forth therein.

 

Section 6.27. _Intellectual Property and Technology Rights_.

 

Bioceres, Parent and Union agree that, following the Closing, Union will have
a perpetual right to (i) obtain an exclusive license to use any Intellectual
Property developed (whether in development as of the date of this Agreement or
hereafter) by Bioceres or Parent (or any of their respective direct or
indirect Subsidiaries, including but not limited to the Excluded Subsidiaries)
or that comes into Bioceres or Parent's (or any of their respective direct or
indirect Subsidiaries', including but not limited to the Excluded
Subsidiaries') possession and to (ii) obtain an exclusive right to
commercialize any Intellectual Property or new technology that is developed
(whether in development as of the date of this Agreement or hereafter) by
Bioceres or Parent (or any of their respective direct or indirect
Subsidiaries, including but not limited to the Excluded Subsidiaries) that is
related in any way to agriculture, including but not limited to crop
productivity solutions such as seeds, seed traits, seed treatments,
biologicals, high-value adjuvants and fertilizers.

   

ARTICLE 7 
CONDITIONS TO CONSUMMATION OF 
THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT

 

Section 7.1. _Conditions to the Obligations of Union and Bioceres_.

 

The obligations of the Parties to consummate the transactions contemplated by
this Agreement are subject to the satisfaction (or, if permitted by applicable
Law, waiver by the Parties) of the following conditions:

 

(a) no statute, rule, regulation, executive order, decree, temporary
restraining order, preliminary or permanent injunction or other order issued
by any court or other Governmental Entity of competent jurisdiction or other
legal restraint or prohibition preventing the consummation of the transactions
contemplated by this Agreement shall be in effect and no Proceeding shall have
been commenced by any Governmental Entity for the purpose of obtaining any
such order, decree, injunction, restraint or prohibition; _provided_ ,
_however_ , that no Party shall be entitled to invoke this condition unless
the Party shall have used commercially reasonable efforts to prevent the entry
of any such injunction or other order or the commencement of any such
Proceeding and to appeal as promptly as possible any injunction or other order
that may be entered;

 

(b) the filings of the Parties required, if any, pursuant to any anti-
competition Laws shall have been made and the applicable waiting period and
any extensions thereof shall have expired or been terminated;

 

(c) the Union Shareholder Approval shall have been obtained;

 

(d) each party hereto shall have executed and delivered, or caused to be
executed and delivered, to the other parties hereto copies of each Ancillary
Document to which such party or any of its respective Affiliates is a party;

 

(e) the Registration Statement shall have been declared effective; and

 

(f) Union shall have at least five million and one U.S. Dollars (US$5,000,001)
of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of
the Exchange Act).

 

Section 7.2. _Other Conditions to the Obligations of Union_.

 

The obligations of Union to consummate the transactions contemplated by this
Agreement are subject to the satisfaction or, if permitted by applicable Law,
waiver by Union of the following further conditions:

 

(a) the representations and warranties regarding the Group Companies set forth
in _ARTICLE 3_ hereof and of Bioceres and Parent set forth in _ARTICLE 4_
hereof shall be true and correct in all material respects as of the Closing
Date as though made on and as of the Closing Date (except, in each case, to
the extent such representations and warranties are made on and as of a
specified date, in which case the same shall be so true and correct as of the
specified date);

   

(b) Bioceres and Parent, as applicable, shall have performed and complied in
all material respects with all covenants required to be performed or complied
with by Bioceres and/or Parent under this Agreement at or prior to the
Closing;

 

(c) since the date of this Agreement, no Bioceres Material Adverse Effect
shall have occurred and be continuing;

 

(d) the Indebtedness of the Group Companies shall not be more than one hundred
and one million U.S. Dollars (US$101,000,000);

 

(e) all Consents under the Contracts listed in _Section 3.3(b)_ and _Section
4.2(b)_ of the Disclosure Schedule shall have been obtained;

 

(f) the Pre-Closing Reorganization shall have been effected and the Pre-
Closing Reorganization Consents shall have been obtained;

 

(g) the Rizobacter Call Option shall have been exercised;

 

(h) the Parent Joinder shall have been executed and delivered by Parent;

 

(i) the sole member of Bioceres shall have approved and declared advisable
this Agreement and the transactions contemplated hereby; and

 

(j) prior to or at the Closing, Bioceres shall have delivered the following
closing documents:

 

(i) certificates (if any) evidencing the Company Shares, duly executed by
officers of the Company;

 

(ii) certificates (if any) evidencing the Bioceres Semillas Shares, duly
executed by officers of Bioceres Semillas;

 

(iii) a certificate of an authorized officer of Bioceres, dated as of the
Closing Date, certifying (A) that the conditions specified in _Section 7.2(a)_
and _Section 7.2(b)_ have been satisfied by Bioceres and (B) the resolutions
of the sole member of Bioceres authorizing the execution and delivery of this
Agreement, the Ancillary Documents and the consummation of the transactions
contemplated hereby;

 

(iv) a properly executed certificate, dated as of the Closing Date, in a form
reasonably acceptable to Union conforming to the requirements of Treasury
Regulations Section 1.1445-2(c)(3), and a properly executed notice as
described in Treasury Regulations Section 1.897-2(h). Union shall be
authorized to deliver such notice and a copy of such statement to the IRS on
behalf of the Company upon the Closing; and

 

(v) the Escrow Agreement, duly executed by an authorized officer of Bioceres.

   

Section 7.3. _Other Conditions to the Obligations of Bioceres_.

 

The obligations of Bioceres to consummate the transactions contemplated by
this Agreement are subject to the satisfaction or, if permitted by applicable
Law, waiver by Bioceres of the following further conditions:

 

(a) the representations and warranties of Union set forth in _ARTICLE 5_
hereof shall be true and correct in all material respects as of the Closing
Date as though made on and as of the Closing Date (except, in each case, to
the extent such representations and warranties are made on and as of a
specified date, in which case the same shall be so true and correct as of the
specified date);

 

(b) Union shall have performed and complied in all material respects with all
covenants required to be performed or complied with by Union under this
Agreement on or prior to the Closing;

 

(c) since the date of this Agreement, no Union Material Adverse Effect shall
have occurred and be continuing;

 

(d) the NYSE shall have approved Union, post Business Combination, for listing
on the NYSE, subject to round lot holder requirements and Union Ordinary
Shares shall be listed on the NYSE; and

 

(e) prior to or at the Closing, Union shall have delivered the following
closing documents:

 

(i) the Escrow Shares, in book entry form, to the Escrow Agent;

 

(ii) the Closing Exchange Shares, in book entry form, to Bioceres;

 

(iii) certificates representing the Union Warrants to Bioceres;

 

(iv) a certificate of an authorized officer of Union, dated as of the Closing
Date, certifying (A) that the conditions specified in _Section 7.3(a)_ and
_Section 7.3(b)_ have been satisfied and (B) the resolutions of the Union
Board authorizing the execution and delivery of this Agreement, the Ancillary
Documents and the consummation of the transactions contemplated hereby;

 

(v) the Escrow Agreement, duly executed by an authorized officer of Union.

 

Section 7.4. _Frustration of Closing Conditions_.

 

No Party may rely on the failure of any condition set forth in this _ARTICLE
7_ to be satisfied if such failure was caused by such Party's failure to use
the efforts to cause the Closing to occur required by _Section 6.4_.

   

ARTICLE 8 
TERMINATION; AMENDMENT; WAIVER; EXPENSES

 

Section 8.1. _Termination_.

 

This Agreement may be terminated and the transactions contemplated by this
Agreement may be abandoned at any time prior to the Closing:

 

(a) by mutual written consent of Union and Bioceres;

 

(b) by either Union or Bioceres, if any Governmental Entity shall have issued
an order, decree or ruling or taken any other action permanently enjoining,
restraining or otherwise prohibiting the transactions contemplated by this
Agreement and such order, decree or ruling or other action shall have become
final and non-appealable;

 

(c) by either Union or Bioceres, if any of the conditions to Closing set forth
in _ARTICLE 7_ shall not have been satisfied or waived on or prior to March
31, 2019 (the " _Outside Date_ "); _provided_ , that the right to terminate
this Agreement pursuant to this _Section 8.1(c)_ shall not be available to
Union or Bioceres if the failure of the Closing to occur on or before the
Outside Date is the result of a breach by Union or Bioceres of its
representations, warranties, obligations or covenants under this Agreement;

 

(d) by either Union or Bioceres if the Union Shareholder Approval is not
obtained at the Extraordinary General Meeting duly convened therefor (unless
such Extraordinary General Meeting has been adjourned, in which case at the
final adjournment thereof) at which a vote on the Transaction Proposals was
taken;

 

(e) by Union, if there is a breach by Bioceres of (i) any of the
representations or warranties regarding the Group Companies set forth in
_ARTICLE 3_ , (ii) any of the representations and warranties of Bioceres and
Parent set forth in _ARTICLE 4_ , (iii) any covenant or (iv) any other
agreement contained in this Agreement, which would result in the failure of a
condition to Closing set forth in _Section 7.2(a)_ or _Section 7.2(b)_ to be
satisfied; _provided_ , that prior to any termination of this Agreement under
this _Section 8.1(e)_ , Bioceres and Parent, as applicable, shall be entitled
to cure any such breach during a thirty (30) day period following receipt of
written notice by Union to Bioceres or Parent, as applicable, of such breach
(it being understood that Union may not terminate this Agreement pursuant to
this _Section 8.1(e)_ if such breach by Bioceres or Parent, as applicable, is
cured during such thirty (30) day period so that such condition to Closing
would then be satisfied); or

 

(f) by Bioceres, if there is a breach by Union of (i) any of the
representations and warranties of Union set forth in _ARTICLE 5_ , (ii) any
covenant or (iii) any other agreement contained in this Agreement, which would
result in the failure of a condition to Closing set forth in _Section 7.3(a)_
or _Section 7.3(b)_ to be satisfied; _provided_ , that prior to any
termination of this Agreement under this _Section 8.1(f)_ , Union shall be
entitled to cure any such breach during a thirty (30) day period following
receipt of written notice by Bioceres to Union of such breach (it being
understood that Bioceres may not terminate this Agreement pursuant to this
_Section 8.1(f)_ if such breach by Union is cured during such thirty (30) day
period so that such condition to Closing would then be satisfied).

   

Section 8.2. _Notice of Termination_.

 

Any Party desiring to terminate this Agreement pursuant to _Section 8.1_ shall
give written notice of such termination to the other Party, together with a
brief description of the basis on which the Party is terminating this
Agreement.

 

Section 8.3. _Effect of Termination_.

 

In the event of the termination of this Agreement pursuant to _Section 8.1_ ,
this entire Agreement shall forthwith become void (and there shall be no
Liability or obligation on the part of any Party, its Affiliates, or their
respective officers, directors or equityholders) with the exception of the
Confidentiality Agreement, the provisions of _Section 6.3_ , _Section 6.15_ ,
this _Section 8.3_ , _Section 8.6_ and _ARTICLE 10_ , which shall survive such
termination; _provided_ , _however_ , that nothing in this Agreement shall
relieve Union, Bioceres or Parent from Liability for any breach by such party
of the terms and provisions of this Agreement prior to such termination or
fraud.

 

Section 8.4. _Amendment_.

 

This Agreement may be amended or modified only by a written agreement executed
and delivered by duly authorized officers of the Parties. This Agreement may
not be modified or amended except as provided in the immediately preceding
sentence and any purported amendment by any Party or Parties effected in a
manner which does not comply with this _Section 8.4_ shall be void.

 

Section 8.5. _Extension; Waiver_.

 

Subject to _Section 8.1(c)_ , at any time prior to the Closing, Bioceres may
(a) extend the time for the performance of any of the obligations or other
acts of Union contained herein, (b) waive any inaccuracies in the
representations and warranties of Union contained herein or in any document,
certificate or writing delivered by Union pursuant hereto or (c) waive
compliance by Union with any of the agreements or conditions contained herein.
Subject to _Section 8.1(c)_ , at any time prior to the Closing, Union may (i)
extend the time for the performance of any of the obligations or other acts of
Bioceres contained herein, (ii) waive any inaccuracies in the representations
and warranties regarding the Group Companies or of Bioceres or Parent
contained herein or in any document, certificate or writing delivered by
Bioceres or Parent pursuant hereto or (iii) waive compliance by Bioceres or
Parent with any of the agreements or conditions contained herein. Any
agreement on the part of any Party to any such extension or waiver shall be
valid only if set forth in a written instrument duly authorized and executed
on behalf of such Party. No course of dealing or other failure of any Party to
assert any of its rights hereunder shall constitute a waiver of such rights.

 

Section 8.6. _Fees and Expenses_.

 

Except as otherwise set forth in this Agreement, whether or not the
transactions contemplated by this Agreement are consummated, all fees and
expenses incurred in connection with or related to the authorization,
preparation, negotiation, execution or performance of this Agreement or any
Ancillary Document and all other matters related to the consummation of this
Agreement, including the fees and expenses of counsel, financial advisors and
accountants, shall be paid by the party incurring such fees or expenses;
_provided_ , _however_ , if the Closing occurs, all Transaction Expenses shall
be paid by Union.

   

ARTICLE 9 
INDEMNIFICATION

 

Section 9.1. _Survival of Representations, Warranties and Covenants_.

 

All of the representations and warranties, covenants and agreements contained
herein shall survive the Closing and remain in full force and effect for the
Survival Period; _provided_ , _however_ , that (a) any Indemnification Claim
made in writing prior to the termination of the Survival Period shall be
preserved despite the subsequent termination of the Survival Period and shall
survive until final resolution thereof and (c) all covenants and agreements
that contemplate performance following the Closing shall survive in accordance
with their respective terms as provided in this Agreement. For the avoidance
of doubt, all pre-Closing covenants will expire on the Closing Date.

 

Section 9.2. _Indemnification_.

 

Subject to the other provisions of this _ARTICLE 9_ , from and after the
Closing, Bioceres and Parent shall jointly and severally indemnify and defend
Union and its Affiliates (other than Bioceres and Parent) and their respective
Representatives, successors and assigns, as the case may be (the " _Union
Indemnified Parties_ ") and hold it and each of them harmless from and
against, and reimburse and pay it and each of them as actually incurred with
respect to any and all actual losses, liabilities, obligations, damages,
deficiencies, actions, suits, proceedings, demands, assessments, judgments,
penalties, diminutions in value, lost earnings, costs and expenses, including
reasonable attorneys' fees and costs of investigation, suffered or paid by
them (collectively, " _Losses_ ") as a result of, arising out of or associated
with (whether or not involving a Third Party Claim):

 

(i) any breach or inaccuracy of any representation or warranty regarding the
Group Companies or of Bioceres and Parent that Bioceres and Parent, as
applicable, has made in ARTICLES 3 or 4 of this Agreement.

 

(ii) any non-fulfillment, breach, violation or default by Bioceres or Parent
of any of their respective covenants, agreements or obligations contained in
this Agreement;

 

(iii) Indebtedness of the Group Companies being more than one hundred and one
million U.S. Dollars (US$101,000,000);

 

(iv) the Rizobacter Injunction, or any other Proceeding resulting from,
arising out of, associated with or in connection with (A) the Rizobacter
Injunction or (B) the facts or circumstances surrounding the litigation among
historical shareholders of Rizobacter arising from a disputed transfer of
Rizobacter shares (as more fully described in the Parent's Registration
Statement on Form F-1 filed with the SEC on January 8, 2018), whether or not
existing as of the date of this Agreement or in the future, subject to the
Rizobacter Injunction Cap; and

   

(v) the items set forth in _Section 3.13(a)_ , _Section 3.23(a)_ , and
_Section 3.23(e)_ of the Disclosure Schedule.

 

Section 9.3. _Indemnification Claim Procedures_.

 

If any Proceeding is commenced or threatened or Losses are incurred that may
give rise to a claim for indemnification (an " _Indemnification Claim_ ") by
any Person entitled to indemnification under this Agreement (each, an "
_Indemnified Party_ "), then such Indemnified Party will promptly give notice
to the Indemnitor. The notice shall describe in reasonable detail the facts
known to the Indemnified Party giving rise to such Indemnification Claim and
the amount or good faith estimate of the amount arising therefrom. The failure
of the Indemnified Party to provide prompt notice of any Indemnification Claim
to the Indemnitor will not relieve the Indemnitor of any Liability that it may
have to the Indemnified Party except to the extent the defense of any such
Proceeding is materially prejudiced by the Indemnified Party's failure to give
such notice. An Indemnitor may elect at any time to assume and thereafter
conduct the defense of any Proceeding subject to any such Indemnification
Claim with counsel of the Indemnitor's choice and to settle or compromise any
such Proceeding, and each Indemnified Party shall cooperate in all respects
with the conduct of such defense by the Indemnitor and/or the settlement of
such Proceeding by the Indemnitor; _provided_ , _however_ , that the
Indemnitor will not approve of the entry of any judgment or enter into any
settlement or compromise with respect to the Indemnification Claim without the
Indemnified Party's prior written approval (which shall not be unreasonably
withheld or delayed), unless (a) there is no finding or admission of any
violation of Laws or any violation of the rights of any Person and no effect
on any other claims that may be made against the Indemnified Party, (b) the
sole relief provided is monetary damages that are paid in full by the
Indemnitor, and (c) there is an unconditional release of the Indemnified Party
from all Liability or obligation with respect to the claims asserted in such
Proceeding. If the Indemnified Party gives an Indemnitor notice of an
Indemnification Claim and the Indemnitor does not, within sixty (60) days
after such notice is given, give notice to the Indemnified Party of its
election to assume the defense of the Proceeding or Proceedings subject to
such Indemnification Claim, then the Indemnified Party may conduct the defense
of such Proceeding; _provided_ , _however_ , that the Indemnified Party will
not approve of the entry of any judgment or enter into any settlement or
compromise with respect to the Indemnification Claim without the Indemnitor's
prior written approval (which shall not be unreasonably withheld or delayed).
A claim for any matter not involving a Third Party may be asserted by written
notice to the party from whom indemnification is sought; _provided_ ,
_however_ , that any assertion of an Indemnification Claim shall be subject to
the limitations as to time set forth in this Agreement.

 

Section 9.4. _Basket_.

 

Notwithstanding any provision hereof to the contrary, the Union Indemnified
Parties shall only be entitled to recover for Losses pursuant to this _ARTICLE
9_ to the extent the aggregate amount of all such Losses incurred by the Union
Indemnified Parties for which the Union Indemnified Parties are entitled to
indemnification hereunder exceeds in the aggregate two million seven hundred
thousand U.S. Dollars ($2,700,000) (the " _Basket_ ") in which event the Union
Indemnified Parties shall be entitled to indemnification for the amount of
such Losses from the first dollar. Notwithstanding the foregoing, the Basket
shall not apply to Losses with respect to claims for indemnification by the
Union Indemnified Parties arising directly or indirectly from or in connection
with (a) any breach or inaccuracy of any Bioceres Fundamental Representation,
(b) any breach or non-fulfillment of any covenant, (c) _Section 9.2(iii)_ ,
_(iv)_ and _(v)_ , or (d) fraud, in which case, Bioceres and Parent will be
liable for all such Losses from the first dollar.

   

Section 9.5. _Other Limitations on Indemnification_.

 

(a) Any indemnification obligations of Bioceres and Parent hereunder shall
first be applied against the Escrow Shares and then against any other Escrow
Property. Any Escrow Shares or other Union Ordinary Share received by Union as
an indemnification payment shall be promptly cancelled by Union.

 

(b) The aggregate Liability of Bioceres and Parent to the Union Indemnified
Parties (i) for Losses pursuant to _Section 9.2(i)_ shall not exceed twenty
million U.S. Dollars ($20,000,000) (the " _General Liability Cap_ ") and (ii)
for Losses pursuant to _Section 9.2(iv)_ shall not exceed twenty-three million
U.S. Dollars ($23,000,000), provided that the Rizobacter Call Option is
exercised, or seventeen million three-hundred thousand U.S. Dollars
($17,300,000) in the event the Rizobacter Call Option is not exercised (in
each case, the " _Rizobacter Injunction Cap_ "); _provided_ , _however_ , that
the General Liability Cap shall not apply to Losses of the Union Indemnified
Parties arising directly or indirectly from or in connection with (A) any
breach or inaccuracy of any Bioceres Fundamental Representation, (B) any
breach or non-fulfillment of any covenant contained in this Agreement and (C)
_Sections 9.2(iii)_ and _(v)_ , or (d) fraud, _provided_ , _further_ ,
however, that the aggregate Liability of Bioceres and Parent to the Union
Indemnified Parties for Losses pursuant to subclauses (A) and (B) of the
foregoing proviso shall not exceed the value of the Exchange Shares at
Closing. For the avoidance of doubt, Losses pursuant to _Section 9.2(iv)_
shall not be applied towards the General Liability Cap, which is reserved
solely for Losses pursuant to _Section 9.2(i)_.

 

(c) Notwithstanding anything to the contrary contained herein, upon any
Indemnified Party becoming aware of any Indemnification Claim, such
Indemnified Party shall utilize all reasonable efforts, consistent with normal
practices and policies and good commercial practice, to mitigate such Losses.
For purposes of this _ARTICLE 9_ , all Losses shall be computed net of (i) any
insurance proceeds actually received, (ii) any amounts recovered by the
Indemnified Party or any of its respective Affiliates from any Person with
respect to such Losses (whether under any agreement for indemnification,
contribution or otherwise) and (iii) the amount of any actual reduction in
Taxes payable, in each case, by the Indemnified Party (as applicable, or any
Affiliate thereof) that is attributable to the Losses to which such claim
relates, and with respect to clause (iii) in the taxable period in which such
Losses are incurred, treating any item of loss, deduction or credit as a
result of such Losses as the last item used in such period, and taking into
account any Tax detriment suffered by the Indemnified Party as a result of
such Losses and the receipt of the related indemnity payment (in the case of
clauses (i), (ii) and (iii), net of the cost and expense of obtaining any such
benefits, proceeds, payments or reimbursements). The Indemnified Party shall
use commercially reasonable efforts to pursue, and to cause their respective
Affiliates to pursue, all insurance claims, other third party payments and Tax
benefits to which it or they may be entitled in connection with any Losses
incurred. If any Indemnified Party actually receives any insurance or other
Third Party payment in connection with any claim for Losses for which it has
already received a payment under this _ARTICLE 9_ , it shall pay to the
Indemnitor within thirty (30) days after such payment is received, an amount
equal to the excess of (x) the amount previously received by such Indemnified
Party with respect to such claim plus the amount of such insurance or other
Third Party payment, less the costs of collection and, if insurance proceeds
are received, any increase in premiums directly caused by the receipt of such
insurance proceeds, over (y) the amount of Losses to which the Indemnitor has
become entitled under this Agreement in connection with such claim.

    

(d) Notwithstanding anything in this Agreement to the contrary, for the
purpose of calculating the amount of any Losses incurred as a result of any
breach or inaccuracy of the representations and warranties contained in this
Agreement, any qualification with respect to materiality or Bioceres Material
Adverse Effect or other similar qualification shall be deemed made or given
without such qualification and without giving effect to such words; provided
that the foregoing disapplication of qualifiers shall not apply to qualifiers
that define the scope of any scheduling or listing requirements of any
representation or warranty made by Bioceres in this Agreement. For the
avoidance of doubt, the materiality scrape in the foregoing sentence shall not
apply for purposes of determining whether there has a been a breach of any
representation or warranty under this Agreement.

 

(e) Notwithstanding anything else to the contrary set forth herein, the right
to indemnification, payment of Losses or any other remedy based on
representations, warranties or covenants will not be affected by any
investigation conducted with respect to or any knowledge acquired (or capable
of being acquired) at any time with respect to the accuracy or inaccuracy of
or compliance with, any such representation, warranty or covenant.

 

(f) IN NO EVENT WILL BIOCERES BE LIABLE FOR PUNITIVE DAMAGES EXCEPT TO THE
EXTENT PAID TO A THIRD PARTY.

 

Section 9.6. _Adjustment to Consideration_.

 

Amounts paid for indemnification under this _ARTICLE 9_ shall be deemed to be
an adjustment to the consideration paid by Union to Bioceres for all income
tax purposes, except as otherwise required by applicable Law.

 

Section 9.7. _Exclusive Remedy_.

 

From and after the Closing, indemnification pursuant to the provisions of this
_ARTICLE 9_ shall be the sole and exclusive recourse and remedy of the Parties
with respect to any claim arising from this Agreement or the transactions
contemplated hereby, whether by contract, tort or otherwise, _provided_ ,
_however_ , the provisions of this _ARTICLE 9_ will not (a) limit a Party's
Liability for fraud, (b) restrict the right of any Party to seek specific
performance or other equitable remedies in connection with any breach of any
of the covenants contained in this Agreement, or (c) restrict the right of any
Party to pursue any remedies for claims specifically relating to or arising
under any agreement or instrument delivered pursuant to this Agreement that
may be available under or pursuant to such agreements and not relating to or
arising under this Agreement.

    

ARTICLE 10 
MISCELLANEOUS

 

Section 10.1. _Entire Agreement; Assignment_.

 

This Agreement, the Ancillary Documents and the Confidentiality Agreement (a)
constitute the entire agreement among the Parties with respect to the subject
matter hereof and supersede all other prior agreements and understandings,
both written and oral, among the Parties with respect to the subject matter
hereof, including the Term Sheet, and (b) shall not be assigned by any Party
(whether by operation of law or otherwise), without the prior written consent
of Union and Bioceres.

 

Section 10.2. _Notices_.

 

All notices, requests, claims, demands and other communications hereunder
shall be in writing and shall be given (and shall be deemed to have been duly
given upon receipt) by delivery in person, by cable, telegram, facsimile,
scanned pages, E-mail or telex, or by registered or certified mail (postage
prepaid, return receipt requested) to the other Parties as follows:

 

To Union (following the Closing):

 

Union Acquisition Corp. 
400 Madison Avenue, Suite 11A 
New York, NY 10017 
Attention: Kyle Bransfield 
Email: kbransfield@apcap.com

 

with a copy (which shall not constitute notice to Union) to:

 

Arnold and Porter Kaye Scholer LLP 
250 West 55th Street 
New York, NY 10019-9710 
Attention: Stephen Koval, Esq. 
E-mail: stephen.koval@arnoldporter.com

 

Linklaters LLP 
1345 Avenue of the Americas 
New York, NY 10105 
Attention: Matthew Poulter 
E-mail: matthew.poulter@linklaters.com

 

To the Pre-Closing Union Representative

 

Joseph J. Schena 
162 College Park Drive 
Fairfield, CT 06824 
Email: J.schena@sbcglobal.net

    

with a copy (which shall not constitute notice to Union) to:

 

Arnold and Porter Kaye Scholer LLP 
250 West 55th Street 
New York, NY 10019-9710 
Attention: Stephen Koval, Esq. 
E-mail: stephen.koval@arnoldporter.com

 

To Bioceres (prior to the Closing):

 

1209 Orange St., 
Wilmington, DE 19801 
Attention: Gloria Montaron Estrada 
E-mail: gloria.montaron@bioceres.com.ar

 

with a copy to.

 

Ocampo 210bis, Predio CCT, 
Rosario, 2000, 
Santa Fe, Argentina 
Attention: Gloria Montaron Estrada 
E-mail: gloria.montaron@bioceres.com.ar

 

with a copy (which shall not constitute notice to Bioceres) to:

 

Linklaters LLP 
1345 Avenue of the Americas 
New York, NY 10105 
Attention: Matthew Poulter 
E-mail: matthew.poulter@linklaters.com

 

To Parent:

 

1209 Orange St., 
Wilmington, DE 19801 
Attention: Gloria Montaron Estrada 
E-mail: gloria.montaron@bioceres.com.ar

 

with a copy to.

 

Ocampo 210bis, Predio CCT, 
Rosario, 2000, 
Santa Fe, Argentina 
Attention: Gloria Montaron Estrada 
E-mail: gloria.montaron@bioceres.com.ar

    

with a copy (which shall not constitute notice to Parent) to:

 

Linklaters LLP 
1345 Avenue of the Americas 
New York, NY 10105 
Attention: Matthew Poulter 
E-mail: matthew.poulter@linklaters.com

 

or to such other address as the Party to whom notice is given may have
previously furnished to the others in writing in the manner set forth above.

  

Section 10.3. _Governing Law_.

 

This Agreement and any claim, controversy or dispute arising under or related
in any way to this Agreement, the relationship of the Parties, the transaction
leading to this Agreement or contemplated hereby and/or the interpretation
and/or enforcement of the respective rights and duties of the Parties
hereunder or related in any way to the foregoing, shall be governed by and
construed in accordance with the internal, substantive laws of the State of
New York applicable to agreements entered into and to be performed solely
within such state, without giving effect to any choice of law or conflict of
law provision or rule (whether of the State of New York or any other
jurisdiction) that would cause the application of the law of any jurisdiction
other than the State of New York.

 

Section 10.4. _Construction; Interpretation_.

 

The headings contained in this Agreement are inserted for convenience only and
shall not affect in any way the meaning or interpretation of this Agreement.
No Party, nor its respective counsel, shall be deemed the drafter of this
Agreement for purposes of construing the provisions hereof, and all provisions
of this Agreement shall be construed according to their fair meaning and not
strictly for or against any Party. Unless otherwise indicated to the contrary
herein by the context or use thereof: (i) the words, "herein," "hereto,"
"hereof" and words of similar import refer to this Agreement as a whole,
including the Schedules, Exhibits and Annexes, and not to any particular
section, subsection, paragraph, subparagraph or clause contained in this
Agreement; (ii) masculine gender shall also include the feminine and neutral
genders, and vice versa; (iii) words importing the singular shall also include
the plural, and vice versa; (iv) references to a Person are also to its
successors and permitted assigns; (v) the word "extent" in the phrase of "to
the extent" shall mean the degree to which a subject or other thing extends,
and such phrase shall not mean simply "if"; (vi) any reference to any month or
any day period shall mean the calendar month or the calendar day period unless
expressly specified otherwise; and (vii) whenever the words "include,"
"includes" or "including" are used in this Agreement, they are deemed to be
followed by the words "without limitation".

 

Section 10.5. _Exhibits and Schedules_.

 

(a) All exhibits and Schedules, or documents expressly incorporated into this
Agreement (including the terms of the Exclusivity Agreement), are hereby
incorporated into this Agreement and are hereby made a part hereof as if set
out in full in this Agreement. Any item disclosed in any Schedule referenced
by a particular section in this Agreement shall be deemed to have been
disclosed with respect to every other section in this Agreement if the
relevance of such disclosure to such other sections is reasonably apparent on
its face. The specification of any dollar amount in the representations or
warranties contained in this Agreement (or in any certificate delivered
pursuant to _Section 7.2(j)_ or _Section 7.3(e)_ , as the case may be) or the
inclusion of any specific item in any Schedule is not intended to imply that
such amounts, or higher or lower amounts or the items so included or other
items, are or are not material, and no party shall use the fact of the setting
of such amounts or the inclusion of any such item in any dispute or
controversy as to whether any obligation, items or matter not described herein
or included in a Schedule is or is not material for purposes of this
Agreement.

    

Section 10.6. _Parties in Interest_.

 

This Agreement shall be binding upon and inure solely to the benefit of each
Party and its successors and permitted assigns and, except as provided herein,
nothing in this Agreement, express or implied, is intended to or shall confer
upon any other Person any rights, benefits or remedies of any nature
whatsoever under or by reason of this.

 

Section 10.7. _No Recourse Against Non-Party Affiliates_.

 

All claims, obligations, liabilities, or causes of action (whether in contract
or in tort, in law or in equity, or granted by statute) that may be based
upon, in respect of, arise under, out or by reason of, be connected with, or
relate in any manner to this Agreement or any Ancillary Document, or the
negotiation, execution, or performance of this Agreement or any Ancillary
Document (including any representation or warranty made in connection with, or
as an inducement to, this Agreement or any Ancillary Document), may be made
only against (and are those solely of) the entities that are expressly
identified as parties in the preamble to this Agreement. No Person who is not
a contracting party to this Agreement, including without limitation any
director, officer, employee, incorporator, member, partner, manager,
unitholder, shareholder, stockholder, Affiliate, agent, attorney, or
representative of, and any financial advisor or lender to, any contracting
party to this Agreement, or any director, officer, employee, incorporator,
member, partner, manager, unitholder, stockholder, Affiliate, agent, attorney,
or representative of, and any financial advisor or lender to, any of the
foregoing (" _Non-Party Affiliates_ "), shall have any Liability (whether in
contract or in tort, in law or in equity, or granted by statute) for any
claims, causes of action, obligations, or liabilities arising under, out of,
in connection with, or related in any manner to this Agreement or any
Ancillary Document or based on, in respect of, or by reason of this Agreement
or any Ancillary Document or the negotiation, execution, performance, or
breach thereof; and, to the maximum extent permitted by law, each party to
this Agreement hereby waives and releases all such liabilities, claims, causes
of action, and obligations against any such Non-Party Affiliates. Without
limiting the foregoing, to the maximum extent permitted by law, (a) each party
to this Agreement hereby waives and releases any and all rights, claims,
demands, or causes of action that may otherwise be available at law or in
equity, or granted by statute, to avoid or disregard the entity form of any
party to this Agreement or otherwise impose Liability of a party to this
Agreement on any Non-Party Affiliate, whether granted by statute or based on
theories of equity, agency, control, instrumentality, alter ego, domination,
sham, single business enterprise, piercing the veil, unfairness,
undercapitalization, or otherwise; and (b) each party to this Agreement
disclaims any reliance upon any Non-Party Affiliates with respect to the
performance of this Agreement or any Ancillary Document or any representation
or warranty made in, in connection with, or as an inducement to this Agreement
or Ancillary Document.

    

Section 10.8. _Severability_.

 

Whenever possible, each provision of this Agreement will be interpreted in
such a manner as to be effective and valid under applicable Law, but if any
term or other provision of this Agreement is held to be invalid, illegal or
unenforceable under applicable Law, all other provisions of this Agreement
shall remain in full force and effect so long as the economic or legal
substance of the transactions contemplated hereby is not affected in any
manner materially adverse to any party hereto. Upon such determination that
any term or other provision of this Agreement is invalid, illegal or
unenforceable under applicable Law, the Parties hereto shall negotiate in good
faith to modify this Agreement so as to effect the original intent of the
Parties as closely as possible in an acceptable manner in order that the
transactions contemplated hereby are consummated as originally contemplated to
the greatest extent possible. Notwithstanding the foregoing, to the extent
that any representation, warranty, covenant or agreement of Bioceres or of
Parent contained in this Agreement or the Schedules addresses a particular
issue with specificity, and no breach by Bioceres or Parent, as applicable,
exists under such specific provision, neither Bioceres nor Parent, as
applicable, shall be deemed to be in breach of any other provision of this
Agreement (with respect to such issue) that addresses such issue with less
specificity than such specific provision and if such specific provision is
qualified or limited by the Knowledge of Bioceres, or in any other manner, no
other provision shall supersede or limit such qualification in any manner.

 

Section 10.9. _Counterparts_.

 

This Agreement may be executed in one or more counterparts, each of which
shall be deemed to be an original, but all of which shall constitute one and
the same agreement. Delivery of an executed counterpart of a signature page to
this Agreement by scanned pages or any other electronic means shall be
effective as delivery of a manually executed counterpart to this Agreement.

 

Section 10.10. _WAIVER OF JURY TRIAL_.

 

EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO
TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (A) ARISING
UNDER THIS AGREEMENT OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL
TO THE DEALINGS OF THE PARTIES IN RESPECT OF THIS AGREEMENT OR ANY OF THE
TRANSACTIONS RELATED HERETO, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER
ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY
HEREBY FURTHER AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR
CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE
PARTIES MAY FILE A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE
OF THE CONSENT OF THE PARTIES TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

    

Section 10.11. _Jurisdiction and Venue_.

 

Each of the Parties (a) submits to the exclusive jurisdiction of any state or
federal court sitting in the State of New York, in any Proceeding arising out
of or relating to this Agreement, (b) agrees that all claims in respect of
such Proceeding may be heard and determined in any such court and (c) agrees
not to bring any Proceeding arising out of or relating to this Agreement in
any other court. Each of the Parties waives any defense of inconvenient forum
to the maintenance of any Proceeding so brought and waives any bond, surety or
other security that might be required of any other Party with respect thereto.
Each Party agrees that service of summons and complaint or any other process
that might be served in any Proceeding may be made on Union by sending or
delivering a copy of the process to the Party to be served at the address of
the Party and in the manner provided for the giving of notices in _Section
10.2_. Nothing in this _Section 10.11_ , however, shall affect the right of
any Party to serve legal process in any other manner permitted by law. Each
Party agrees that a final, non-appealable judgment in any Proceeding so
brought shall be conclusive and may be enforced by suit on the judgment or in
any other manner provided by law.

 

Section 10.12. _Liability of Pre-Closing Union Representative_.

 

(a) Union hereby irrevocably appoints the Pre-Closing Union Representative as
their exclusive representative, agent, proxy and attorney-in-fact (coupled
with an interest) for all purposes under this Agreement including the full
power and authority on the behalf of the Initial Holders: to (i) consummate
the transactions contemplated by this Agreement and the Ancillary Documents
(including, for the avoidance of doubt, the matters described in _Section 2.6_
) and (ii) negotiate claims and disputes arising under, or relating to, this
Agreement and the Ancillary Documents (including, for the avoidance of doubt,
the claims for indemnification under _ARTICLE 9_ ). The Pre-Closing Union
Representative shall have no duties or obligations hereunder, including any
fiduciary duties, except those set forth herein, and such duties and
obligations shall be determined solely by the express provisions of this
Agreement or any Ancillary Document. Should the Pre-Closing Union
Representative resign or be unable to serve, a new Pre-Closing Union
Representative shall be selected by majority vote of the Initial Holders (each
voting in proportion to their respective economic interest in the Union
Ordinary Shares at the time of such vote.)

 

(b) The Pre-Closing Union Representative and its Non-Recourse Parties shall be
indemnified, held harmless and reimbursed by Union, against all costs,
expenses (including reasonable attorneys\' fees), judgments, fines and amounts
paid or incurred by the Pre-Closing Union Representative and its Non-Recourse
Parties in connection with any claim, action, suit or proceeding to which the
Pre-Closing Union Representative or such other Person is made a party by
reason of the fact that it is or was acting as the Pre-Closing Union
Representative pursuant to the terms of this Agreement, except in case of
fraud, willful misconduct or gross negligence of the Pre-Closing Union
Representative.

 

Section 10.13. _Specific Performance_.

 

Each Party hereby acknowledges and agrees that irreparable damage would occur
if any of the provisions of this Agreement are not performed in accordance
with their specific terms, and that in the event of breach of this Agreement
by a Party, the non-breaching Party would not be adequately compensated in all
cases by monetary damages alone. Accordingly, after such time as the Parties
have agreed on the forms of each of the Ancillary Documents, in addition to
any other right or remedy to which the non-breaching Party may be entitled, it
shall be entitled to enforce any provision of this Agreement by a decree of
specific performance and to temporary, preliminary and permanent injunctive
relief to prevent breaches or threatened breaches of any of the provisions of
this Agreement, without posting any bond or other undertaking.

    

Section 10.14. _Conflicts; Privilege_.

 

(a) The parties hereto acknowledge and agree, on their own behalf and on
behalf of their respective directors, members, shareholders, stockholders,
partners, officers, employees and Affiliates, as applicable, that:

 

(i) Arnold and Porter Kaye Scholer LLP, Mitrani Caballero and Ruiz Moreno and
Graubard Miller (the " _Pre-Closing Union Group Law Firms_ ") have acted as
counsel to Union, the holders of Union Ordinary Shares and the Union
Representative (individually and collectively, the " _Union Group_ "), in
connection with the negotiation, preparation, execution and delivery of this
Agreement and the applicable Ancillary Documents and the consummation of the
transactions contemplated hereby and thereby. Parent and Bioceres agree, and
shall cause the Group Companies to agree, that, following consummation of the
transactions contemplated hereby, such representation and any prior
representation of Union by the Pre-Closing Union Group Law Firms, or any
successors thereto, shall not preclude the Pre-Closing Union Group Law Firms
from serving as counsel to the Union Group or any director, member,
shareholder, stockholder, partner, officer or employee of the Union Group, in
connection with any litigation, claim or obligation arising out of or relating
to this Agreement or the transactions contemplated hereby. Neither Parent nor
Bioceres shall, and each shall cause the Group Companies not to, seek to or
have the Pre-Closing Union Group Law Firms disqualified from any such
representation based upon the prior representation of Union by the Pre-Closing
Union Group Law Firms. The parties hereto hereby consent thereto and waive any
potential conflict of interest arising from such prior representation, and
each of such parties shall cause any of their respective Affiliates to consent
to waive any potential conflict of interest arising from such representation.
Each of the parties acknowledges that such consent and waiver is voluntary,
that it has been carefully considered, and that the parties have consulted
with counsel or have been advised they should do so in connection herewith.

    

(ii) Linklaters LLP and Marval O'Farral and Mairal (" _Bioceres Group Law Firms_
") have acted as counsel to Parent, Bioceres and the Group Companies
(individually and collectively, the " _Bioceres Group_ "), in connection with
the negotiation, preparation, execution and delivery of this Agreement and the
applicable Ancillary Documents and the consummation of the transactions
contemplated hereby and thereby. Union agrees, and shall cause the Group
Companies to agree, that, following consummation of the transactions
contemplated hereby, such representation and any prior representation of the
Group Companies by the Bioceres Group Law Firms shall not preclude the
Bioceres Group Law Firms from serving as counsel to the Bioceres Group or any
director, member, shareholder, partner, officer or employee of the Bioceres
Group, in connection with any litigation, claim or obligation arising out of
or relating to this Agreement or the transactions contemplated hereby. Union
shall not, and shall cause the Group Companies not to, seek or have the
Bioceres Group Law Firms disqualified from any such representation based upon
the prior representation of the Group Companies by the Bioceres Group Law
Firms. Each of the parties hereto hereby consents thereto and waives any
potential conflict of interest arising from such prior representation, and
each of such parties shall cause any of its Affiliates to consent to waive any
potential conflict of interest arising from such representation. Each of the
parties acknowledges that such consent and waiver is voluntary, that it has
been carefully considered, and that the parties have consulted with counsel or
have been advised they should do so in connection herewith.

 

(iii) The covenants, consents and waivers contained in this _Section 10.14_
shall not be deemed exclusive of any other rights to which the Pre-Closing
Union Group Law Firms or the Pre-Closing Bioceres Group Law Firms are entitled
whether pursuant to law, contract or otherwise.

 

(b) All communications between the Pre-Closing Union Group, on the one hand,
and Pre-Closing Union Group Law Firms, on the other hand, relating to the
negotiation, preparation, execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby (the " _Union Privileged
Communications_ ") and all communications between the Bioceres Group, on the
one hand, and Bioceres Group Law Firms, on the other hand, relating to the
negotiation, preparation, execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby (the " _Bioceres
Privileged Communications_ ") shall be deemed to be attorney-client privileged
and the expectation of client confidence relating thereto shall belong solely
to the Pre-Closing Union Group and the Bioceres Group, as applicable, and
shall not pass to or be claimed by Parent, Bioceres or any Group Company (in
the case of Union Privilege Communication) or the pre-Closing Union (in the
case of Bioceres Privileged Communication). Accordingly, Parent, Bioceres and
the Group Companies shall not have access to any Union Privileged
Communications or to the files of the Pre-Closing Union Group Law Firms and
Union shall not have access to the Bioceres Privileged Communications or to
the files of the Bioceres Group Law Firms relating to the engagement of the
Pre-Closing Union Group Law Firms by the Union Group and the Bioceres Group
Law Firms by the Bioceres Group, as applicable, from and after Closing.

    

(c) Without limiting the generality of the foregoing, from and after the
Closing, (i) (A) the Pre-Closing Union Group (and not Parent, Bioceres or any
Group Company) shall be the sole holders of the attorney-client privilege with
respect to the engagement of the Pre-Closing Union Group Law Firms, and none
of Parent, Bioceres or any Group Company shall be a holder thereof and (B) the
Bioceres Group (and not Union or the Group Companies) shall be the sole
holders of the attorney-client privilege with respect to the engagement of the
Bioceres Group Law Firms, and none of Union or any Group Company shall be a
holder thereof, (ii) (A) to the extent that files of the Pre-Closing Union
Group Law Firms in respect of their engagement by the Pre-Closing Union Group
constitute property of the client, only the Pre-Closing Union Group (and not
Parent, Bioceres nor any Group Company) shall hold such property rights and
(B) to the extent that files of Bioceres Group Law Firm in respect of their
engagement by the Bioceres Group constitute property of the client, only the
Bioceres Group (and not Union nor any Group Company) shall hold such property
rights and (iii) (A) the Pre-Closing Union Group Law Firms shall have no duty
whatsoever to reveal or disclose any such attorney-client communications or
files to Parent, Bioceres or any Group Company by reason of any attorney-
client relationship between the Pre-Closing Union Group Law Firms and Union or
otherwise and (B) the Bioceres Group Law Firms shall have no duty whatsoever
to reveal or disclose any such attorney-client communications or files to
Union or any Group Company by reason of any attorney-client relationship
between the Bioceres Group Law Firms and the Group Companies or otherwise.

 

(d) Notwithstanding the foregoing, in the event that a dispute arises between
Union or its Affiliates (including any Group Company), on the one hand, and a
third party other than any of the Bioceres Group, on the other hand, Union and
its Affiliates (including the Group Companies) may assert the attorney-client
privilege to prevent disclosure of confidential communications to such third
party; _provided, however_ , that neither Union nor any of its Affiliates
(including any Group Company) may waive such privilege without the prior
written consent of Bioceres, which consent shall not be unreasonably withheld,
conditioned or delayed. In the event that Union or any of its Affiliates
(including any Group Company) is legally required by order of a Governmental
Entity or otherwise legally required to access or obtain a copy of all or a
portion of the Bioceres Privileged Communications, to the extent (x) permitted
by applicable Law, and (y) advisable in the opinion of Union's counsel, then
Union shall immediately (and, in any event, within five (5) Business Days)
notify Bioceres in writing so that Bioceres can seek a protective order.

 

(e) This _Section 10.14_ is intended for the benefit of, and shall be
enforceable by, the Union Group and the Bioceres Group. This _Section 10.14_
shall be irrevocable, and no term of this _Section 10.14_ may be amended,
waived or modified, without the prior written consent of the Pre-Closing Union
Group Law Firms or Bioceres Group Law Firms, as applicable. _[SIGNATURE PAGE FOLLOWS]_

    

IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be duly
executed on its behalf as of the day and year first above written.

 

     Union  | 
---|--- 
     | 
   Union Acquisition Corp.  | 
     | 
   By:  |   | /s/ Kyle P. Bransfield  | __ 
      |   | Name: Kyle P. Bransfield  | 
     |   | Title: Chief Executive Officer  | 
     |   |   | 
     |   |   | 
   Pre-Closing Union Representative  | 
     | 
   Joseph J. Schena  | 
     | 
   By:  |   | /s/ Joseph J. Schena  | __ 
      | 
     | 
   Bioceres  | 
     | 
   Bioceres, Inc.  | 
     | 
   By:  |   | /s/ Federico Trucco  | __ 
      |   | Name: Federico Trucco  | 
     |   | Title: President and Chief Executive Officer  |   

Exhibit A

 

ESCROW AGREEMENT

 

This ESCROW AGREEMENT (this " _Agreement_ ") is made and entered into as of
__________________, by and among: (i) UNION ACQUISITION CORP., an exempted
company incorporated under the laws of the Cayman Islands, which will be known
after the consummation of the transactions contemplated by the Share Exchange
Agreement (as defined herein) as "Bioceres Crop Solutions Corp." (including
any successor entity thereto, " _Union_ "), solely in respect of its
obligations under _Section 13_ of this Agreement (ii) Joseph J. Schena, in the
capacity as the Union Representative under the Share Exchange Agreement (as
defined herein) (including any successor Union Representative appointed
pursuant to and in accordance therewith, the " _Union Representative_ _"_ );
(iii) BIOCERES S.A., a _sociedad an onima _formed under the laws of the
Republic of Argentina (" _Parent_ "); (iv) BIOCERES LLC, a Delaware limited
liability company (" _Bioceres_ "); and (v) Continental Stock Transfer and Trust
Company, as escrow agent (the " _Escrow Agent_ "). Capitalized terms used
herein but not otherwise defined herein shall have the meaning given to such
terms in the Share Exchange Agreement.

 

WHEREAS, on November 8, 2018, Union, the Union Representative and Bioceres
entered into that certain Share Exchange Agreement (as amended from time to
time in accordance with the terms thereof, the " _Share Exchange Agreement_
"), pursuant to which, subject to the terms and conditions thereof, Union
will (i) acquire from Parent all of Parent's equity interest in Bioceres
Semillas S.A., representing 87.2739% of the issued and outstanding capital
stock of Bioceres Semillas S.A. and (ii) acquire from Bioceres all of
Bioceres' issued and outstanding equity interests of New Bioceres, Inc.,
representing 100% of New Bioceres, Inc. in exchange for (A) newly issued
Union Ordinary Shares, subject to the withholding of the Escrow Shares (as
defined below) being deposited into the Escrow Account (as defined below) in
accordance with the terms and conditions of the Share Exchange Agreement and
this Agreement and (B) the Union Warrants;

 

WHEREAS, pursuant to the Share Exchange Agreement, Union and its Affiliates
(other than Bioceres and Parent) and their respective Representatives,
successors and assigns, as the case may be (the " _Union Indemnified Parties_
") are entitled to be indemnified in certain respects, jointly and severally,
by Bioceres and Parent;

 

WHEREAS, in accordance with the Share Exchange Agreement and this Agreement,
at the Closing, Union shall issue to the Escrow Agent five percent (5%) of
the Exchange Shares (together with any equity securities paid as dividends or
distributions with respect to such shares or into which such shares are
exchanged or converted, the " _Escrow Shares_ ") to be held, along with any
other Escrow Property (as defined below), by the Escrow Agent in a segregated
escrow account (the " _Escrow Account_ ", and as reduced by any disbursements
of such Escrow Shares from the Escrow Account by the Escrow Agent in
accordance with the terms of this Agreement and the Share Exchange Agreement,
the " _Escrow Property_ ") and disbursed therefrom in accordance with the
terms of this Agreement and _Section 2.4_ of the Share Exchange Agreement; 

 

WHEREAS, pursuant to the Share Exchange Agreement, the Union Representative
has been exclusively designated to act on behalf of Union to take all
necessary actions and make all decisions pursuant to this Agreement; and  

WHEREAS, the Escrow Agent is willing to administer the escrow under the terms
and conditions of this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing premises and of the mutual
covenants and agreements contained herein, the parties hereto hereby agree as
follows:

 

Section 1. _Appointment_. Bioceres and the Union Representative hereby appoint
the Escrow Agent as their escrow agent for the purposes set forth herein, and
the Escrow Agent hereby agrees to perform the duties of their escrow agent
under this Agreement. The escrow services to be rendered by the Escrow Agent
under this Agreement will not begin until the Escrow Agent has received the
documentation necessary to establish the Escrow Account on its books and has
received the Escrow Shares in accordance with this Agreement.

 

Section 2. _Delivery of Escrow Shares_. Pursuant to _Section 2.1(c)_ of the
Share Exchange Agreement, on the Closing Date, Union shall, in cooperation
with the Escrow Agent and Union's transfer agent, transfer the Escrow Shares
to the Escrow Agent in book entry form.

 

Section 3. _Maintenance of the Escrow Shares and other Escrow Property_.
During the term of this Agreement, the Escrow Agent shall hold the Escrow
Property in the Escrow Account and shall not sell, transfer, dispose of, lend
or otherwise subject to a Lien any of the Escrow Property except until and to
the extent that they are disbursed in accordance with _Section 4_. Except as
Bioceres and the Union Representative may otherwise agree in joint written
instructions executed and delivered to the Escrow Agent, no part of the Escrow
Property may be withdrawn except as expressly provided in this Agreement.
While the Escrow Shares are held in the Escrow Account, Bioceres shall have
the right to vote the Escrow Shares.

 

Section 4. _Delivery of the Escrow Property_. The Escrow Agent shall hold the
Escrow Property and shall deliver the Escrow Property to either Union or
Bioceres, as applicable, in accordance with the following procedures:

 

(a) At any time and from time to time after the date hereof but no later than
the Escrow Release Date, the Union Representative may assert a claim for
indemnification on behalf of a Union Indemnified Party pursuant to the Share
Exchange Agreement (an " _Indemnification Claim_ ") by providing prompt
written notice (as the same may be amended or modified as set forth herein, "
_Claim Notice_ ") of such claim to Bioceres and the Escrow Agent, which Claim
Notice shall describe in reasonable detail the facts known to the Union
Indemnified Party giving rise to such Indemnification Claim and the amount or
good faith estimate of the amount arising therefrom (the " _Claim Amount_ ").
The Union Representative may, at any time supplement an outstanding Claim
Notice, including by way of establishing, increasing or reducing the Claim
Amount with respect thereto, by delivering such supplement to the Escrow
Agent, with a contemporaneous copy to Bioceres.  

(b) Unless Bioceres (on behalf of itself and Parent, as applicable) provides
to the Union Representative and the Escrow Agent a written notice objecting to
such Indemnification Claim (an " _Objection Notice_ "), which Objection Notice
shall provide a description, in reasonable detail, of the facts upon which
such objection is based, by 11:59 p.m. New York City time on the thirtieth
(30th) day after the date of delivery of the Claim Notice (the date of the
delivery of the Claim Notice through such time, the " _Objection Period_ "),
Bioceres and/or Parent, as applicable, will be deemed to have accepted
responsibility for the Losses set forth in such Claim Notice and will have no
further right to contest the validity of such Claim Notice, and the Escrow
Agent shall promptly (in any event within five (5) Business Days) after the
expiration of the Objection Period disburse to Union Escrow Property from the
Escrow Account in an amount equal to the Claim Amount. If Bioceres provides an
Objection Notice during the Objection Period that disputes only a portion of
the Claim Amount, the Escrow Agent shall promptly (in any event within five
(5) Business Days) after the expiration of the Objection Period disburse to
Union Escrow Property from the Escrow Account in an amount equal to the
undisputed portion of the Claim Amount. Notwithstanding the foregoing, if
during the Objection Period, Bioceres provides affirmative written
instructions to the Escrow Agent to release Escrow Property from the Escrow
Account in an amount equal to the Claim Amount or undisputed portion of the
Claim Amount, as applicable, the Escrow Agent shall promptly (in any event
within five (5) Business Days) after the Escrow Agent's receipt of such
instructions from Bioceres, disburse to Union such Escrow Property from the
Escrow Account as instructed.

 

(c) If Bioceres timely disputes an Indemnification Claim by providing an
Objection Notice to the Union Representative and the Escrow Agent during the
Objection Period, the Escrow Agent shall not distribute to Bioceres any
portion of the Escrow Property with respect to the disputed portion of the
Claim Amount, until receipt of (i) joint written instructions executed and
delivered by Bioceres and the Union Representative stating that the dispute
has been resolved and that Union Indemnified Party has the right to the Claim
Amount (or some portion thereof) (" _Joint Instructions_ ") or (ii) a copy of
an arbitration award or a court order from a court of competent jurisdiction
establishing the Union Indemnified Party's right to the Claim Amount (or some
portion thereof) pursuant to the Share Exchange Agreement (a " _Binding Award_
"). Upon receipt of such Joint Instructions or Binding Award, the Escrow Agent
shall, without further action on the part of Bioceres or the Union
Representative, promptly (in any event within five (5) Business Days) disburse
to Union the Escrow Property from the Escrow Account in the amount set forth
in the Joint Instructions or the Binding Award, as applicable.

 

(d) Payments from the Escrow Account with respect to any Indemnification
Claims shall first be paid with the Escrow Shares and then with any remaining
property in the Escrow Account. For any Escrow Shares to be disbursed with
respect to Indemnification Claims, the Escrow Shares shall be valued as of the
date that an Indemnification Claim is finally determined in accordance with
the Share Exchange Agreement and this Agreement (the " _Resolution Date_ ").
For the avoidance of doubt, the Resolution Date shall be (i) if no Objection
Notice is delivered by Bioceres during the Objection Period, the thirty-first
(31) day after the date that the Claim Notice is delivered; (ii) if prior to
the date described in clause (i) above, Bioceres provides affirmative written
instructions to the Escrow Agent to release the Escrow Property for the amount
set forth in the Claim Notice, the date that the Escrow Agent receives such
written instructions; (iii) if Bioceres provides an Objection Notice during
the Objection Period that disputes only a portion of the Claim Amount with
respect to the undisputed portion of such Claim Amount, the date that the
Escrow Agent receives such Objection Notice and (iv) with respect to any
disputed Claim Amount, either the date that the Escrow Agent receives Joint
Instructions or a Binding Award.  

(e) With respect to any Indemnification Claims made in accordance with the
Share Exchange Agreement and this Agreement on or prior to the Escrow Release
Date that remain unresolved at the time of the Escrow Release Date (" _Pending
Claims_ "), all or a portion of the Escrow Property reasonably necessary to
satisfy such Pending Claims (as determined based on (i) the Claim Amount
included in the Claim Notice (as it may be adjusted) provided by the Union
Representative and (ii) the value of the Escrow Shares as of the Escrow
Release Date), shall remain in the Escrow Account until such Pending Claim has
been finally resolved pursuant to the provisions of the Share Exchange
Agreement and this Agreement. After the Escrow Release Date, any Escrow
Property remaining in the Escrow Account that is not subject to Pending
Claims, if any, and not subject to resolved but unpaid claims in favor of an
Indemnified Party, shall be disbursed by the Escrow Agent to Bioceres.
Promptly after the final resolution of all Pending Claims and the payment of
all indemnification obligations in connection therewith, the Escrow Agent
shall disburse any Escrow Property remaining in the Escrow Account to
Bioceres.

 

(f) Notwithstanding the foregoing, (i) the Escrow Property shall be
distributed and released pursuant to Joint Instructions to pay a specified
amount to Union to cover the costs and expenses of any defense and any payment
in respect of any settlement of any Proceeding that is subject to an
Indemnification Claim that is assumed by the Union Representative (on behalf
of Union) pursuant to _Section 9.3_ of the Share Exchange Agreement and (ii)
all interest, earnings or income, if any, earned with respect to the Escrow
Property while held by the Escrow Agent shall be distributed to Bioceres by
the Escrow Agent within ten (10) days of the end of each calendar quarter.

 

(g) Any amount of Escrow Property required to be transferred to any Person
pursuant to this _Section 4_ shall be transferred by the Escrow Agent pursuant
to such delivery instructions as provided by the Union Representative or
Bioceres. The Escrow Agent shall rely exclusively on instructions provided by
Union Representative and Bioceres as to the amount and recipient of any
distribution of Escrow Property pursuant to this _Section 4_ , or the relevant
order of any court of competent jurisdiction or other award granted pursuant
to other binding legal process (including any binding arbitration). The Escrow
Agent has no duty or responsibility to calculate any distribution or to
confirm the accuracy of any distribution amount so instructed.

 

Section 5. _Tax Matters_. Union, the Union Representative and Bioceres agree
and acknowledge that, for all U.S. and foreign tax purposes, except as
required by applicable Law, Bioceres shall be treated as the owner of the
Escrow Property while held in the Escrow Account and until released to
Bioceres, and all interest, earnings or income, if any, earned with respect to
the Escrow Property while held by the Escrow Agent shall be treated as earned
by Bioceres and shall be distributed in accordance with Section 4(f) hereof.
The Escrow Agent shall have the right to deduct and withhold taxes from any
payments to be made hereunder if such withholding is required by law and to
request and receive any necessary tax forms from the applicable recipient of
the Escrow Property.  

Section 6. _Duties_. The Escrow Agent's duties are entirely ministerial and
not discretionary, and the Escrow Agent will be under no duty or obligation to
do or to omit the doing of any action with respect to the Escrow Property,
except to give notice, provide monthly reports, make disbursements, keep an
accurate record of all transactions with respect to the Escrow Property, hold
the Escrow Property in accordance with the terms of this Agreement and to
comply with any other duties expressly set forth in this Agreement. The Escrow
Agent shall not have any interest in the Escrow Property but shall serve as
escrow holder only and have only possession thereof. Nothing contained herein
shall be construed to create any obligation or liability whatsoever on the
part of the Escrow Agent to anyone other than the parties to this Agreement.
There are no third party beneficiaries to this Agreement.

 

Section 7. _Determination of the Value of the Escrow Shares_. In the event
that the Escrow Agent has any question as to the value of the Escrow Shares,
Bioceres and the Union Representative shall cooperate to promptly provide the
Escrow Agent with their good faith determination of the value of the Escrow
Shares pursuant to Joint Instructions or a Binding Award (and in the event of
any dispute as to the value of the Escrow Shares, the Escrow Agent shall not
disburse the applicable Escrow Property until such dispute has been resolved).

 

Section 8. _Monthly Reports Upon Request_. The Escrow Agent shall provide
monthly account statements to the Union Representative and Bioceres with
respect to the Escrow Account. The Union Representative and Bioceres have one
hundred twenty (120) days to object in writing to such reports. If no written
notice detailing a party's objections has been received by the Escrow Agent
within this period, an acceptance of such reports shall be deemed to have
occurred.

 

Section 9. _Authorized Parties; Reliance_. The parties hereby acknowledge that
the Union Representative has the sole and exclusive authorization to act on
behalf of Union under this Agreement. The Union Representative and Bioceres
agree to provide, on _Exhibit A_ (as it may be amended from time to time) to
this Agreement, the names and specimen signatures of those persons who are
authorized to issue notices and instructions to the Escrow Agent and execute
required documents under this Agreement. The Escrow Agent may rely and shall
be protected in acting or refraining from acting upon any written notice,
instruction or request furnished to it hereunder and believed by it to be
genuine and to have been signed or presented by the proper party or parties.
The Escrow Agent is entitled to rely on, and shall be fully protected in
relying on, the instructions and notices from any one of the authorized
signers, as identified on the attached _Exhibit A_ (as it may be amended from
time to time) to this Agreement, from each of the Union Representative and
Bioceres, either acting alone, until such time as their authority is revoked
in writing, or until successors have been appointed and identified by notice
in the manner described in _Section 15_ below.

 

Section 10. _Good Faith_. The Escrow Agent shall not be liable for any action
taken by it in good faith and reasonably believed by it to be authorized or
within the rights or powers conferred upon it by this Agreement and may
consult with counsel of its own choice and shall have full and complete
authorization and protection for any action taken or suffered by it hereunder
in good faith and in accordance with the opinion of such counsel.

 

Section 11. _Right to Resign_. The Escrow Agent may resign and be discharged
from its duties or obligations hereunder by giving such notice in writing of
such resignation specifying a date when such resignation shall take effect,
which shall be a date not less than sixty (60) days after the date of the
notice of such resignation. Similarly, the Escrow Agent may be removed and
replaced following the giving of thirty (30) days' notice to the Escrow Agent
by all of the other parties hereto. In either event, the Union Representative
and Bioceres shall agree upon a successor escrow agent. If the Union
Representative and Bioceres are unable to agree upon a successor or shall have
failed to appoint a successor prior to the expiration of sixty (60) days
following the date of resignation or thirty (30) days following the date of
removal, the then-acting escrow agent may petition any court of competent
jurisdiction for the appointment of a successor escrow agent or otherwise
appropriate relief, and any such resulting appointment shall be binding upon
all of the parties hereto. Any successor escrow agent shall execute and
deliver to the predecessor escrow agent, the Union Representative and Bioceres
an instrument accepting such appointment and the transfer of the Escrow
Property and agreeing to the terms of this Agreement.  

Section 12. _Compensation_. The Escrow Agent shall be entitled to receive the
fees as set forth on _Exhibit B_ for the services to be rendered hereunder,
and to be paid or reimbursed for all reasonable documented out-of-pocket
expenses, disbursements and advances, including reasonable documented out-of-
pocket attorneys' fees, incurred or paid in connection with carrying out its
duties hereunder, such amounts to be paid by Union.

 

Section 13. _Indemnification_. Each of Bioceres and Union hereby agrees to
jointly and severally indemnify the Escrow Agent for, and to hold it harmless
against any loss, liability or expense incurred without gross negligence or
willful misconduct on the part of the Escrow Agent, arising out of or in
connection with its entering into this Agreement and carrying out its duties
hereunder. Notwithstanding the foregoing, as between Bioceres and Union, each
of Bioceres and Union, between themselves, shall be responsible for one-half
(1/2) of such indemnification obligations, and each of Bioceres and the Union
Representative shall have the right to seek contribution from Bioceres or
Union, as applicable, to the extent that it pays for more than one-half (1/2)
of such indemnification obligations.

 

Section 14. _Disputes_. If a controversy arises between the parties hereto as
to whether or not or to whom the Escrow Agent shall transfer all or any
portion of the Escrow Property or as to any other matter arising out of or
relating to this Agreement or the Escrow Property, the Escrow Agent shall not
be required to determine the same, shall not make any transfer of and shall
retain the Escrow Property in dispute without liability to anyone until the
rights of the parties to the dispute shall have finally been determined by
mutual written agreement of Bioceres and the Union Representative, or by a
final non-appealable judgment or order of any state or federal court located
in New York County, New York (or in any court in which appeal from such courts
may be taken) but the Escrow Agent shall be under no duty whatsoever to
institute or defend any such proceedings. The Escrow Agent shall be entitled
to assume that no such controversy has arisen unless it has received notice of
such controversy or conflicting written notices from the parties to this
Agreement. Any disputes arising out of, related to, or in connection with,
this Agreement between Bioceres and the Union Representative, including a
dispute arising from a party's failure or refusal to sign a joint written
notice hereunder, shall be determined in accordance with the provisions of
_Section 10.3_ of the Share Exchange Agreement.  

Section 15. _Notices_. Except to the extent expressly set forth herein, all
notices and communications hereunder shall be in writing and shall be deemed
to be given if (a) delivered personally, (b) sent by facsimile or email (with
affirmative confirmation of receipt), (c) sent by recognized overnight courier
that issues a receipt or other confirmation of delivery or (d) sent by
registered or certified mail, return receipt requested, postage prepaid to the
parties as follows:

      

_If to Union, to:_

Union Acquisition Corp. 
400 Madison Avenue, Suite 11A 
New York, NY 10017 
Attention: Kyle Bransfield 
Telephone No.: (212) 981-0633 
Email: kbransfield@apcap.com  |  

_with a copy (which will not constitute notice) to:_

 

Arnold and Porter Kaye Scholer LLP 
250 West 55th Street 
New York, NY 10019-9710 
Attention: Stephen Koval, Esq. 
Telephone No.: (212) 836-8019 
Email:   stephen.koval@arnoldporter.com

 

_with a copy (which will not constitute notice) to:_

 

Linklaters LLP 
1345 Avenue of the Americas 
New York, NY 10105 
Attention: Matthew Poulter 
Telephone No.: (212) 903-9306 
Email: matthew.poulter@linklaters.com 

---|--- 
     

_If to the Union Representative, to:_

   

Joseph J. Schena 
162 College Park Drive 
Fairfield, CT 06824 
Telephone No.: (212) 380-2653 
Email:  j.schena@sbcglobal.net

  |   

_with a copy (which will not constitute notice) to:_

   

Arnold and Porter Kaye Scholer LLP 
250 West 55th Street 
New York, NY 10019-9710 
Attention: Stephen Koval, Esq. 
Telephone No.: (212) 836- 8019 
Email:   stephen.koval@arnoldporter.com 

     

_If to Bioceres, to:_

   

Bioceres LLC 
1209 Orange St., 
Wilmington, DE 19801 
Attention: Gloria Montaron Estrada

 

With copy to:

 

Ocampo 210bis, Predio CCT, 
Rosario, 2000, 
Santa Fe, Argentina 
Attention: Gloria Montaron Estrada 
E-mail:  gloria.montaron@bioceres.com.ar 
Telephone No.: +54 341 4861122

  |   

_with a copy (which will not constitute notice) to:_

   

Linklaters LLP 
1345 Avenue of the Americas 
New York, NY 10105 
Attention: Matthew Poulter 
Telephone No.: (212) 903-9306 
Email: matthew.poulter@linklaters.com

  
     

_If to the Escrow Agent, to:_

   

Continental Stock Transfer and Trust 
Company 
1 State Street, 30th Floor 
New York, NY 10004 
Attention: Account Administration 
Facsimile No: (212) 509-5150 
Telephone No: (212) 845-4000

  |     

or at such other address as any of the above may have furnished to the other
parties in a notice duly given as provided herein. Any such notice or
communication given in the manner specified in this _Section 15_ shall be
deemed to have been given (i) on the date personally delivered or transmitted
by facsimile or email (with affirmative confirmation of receipt), (ii) one (1)
Business Day after the date sent by recognized overnight courier that issues a
receipt or other confirmation of delivery or (iii) three (3) Business Days
after being sent by registered or certified mail, return receipt requested,
postage prepaid.

 

Section 16. _Term_. This Agreement shall terminate upon the final, proper and
complete distribution of the Escrow Property in accordance with the terms
hereof; _provided_ , that Bioceres and Union's obligations under _Section 13_
hereof shall survive any termination of this Agreement.

 

Section 17. _Entire Agreement_. The terms and provisions of this Agreement
(including the Exhibits hereto, which are hereby incorporated by reference
herein) constitute the entire agreement between the Escrow Agent and the other
parties hereto with respect to the subject matter hereof. Notwithstanding the
foregoing, as between Bioceres and the Union Representative, the terms of the
Share Exchange Agreement shall control and govern over the terms of this
Agreement in the event of any conflict or inconsistency between this Agreement
and the Share Exchange Agreement. The actions of the Escrow Agent shall be
governed solely by this Agreement.

 

Section 18. _Amendment; Waiver_. This Agreement may be amended or modified
only by a written instrument duly signed by the parties hereto, and any
provision hereof may be waived only by a written instrument duly signed by the
party against whom enforcement of such waiver is sought.

 

Section 19. _Severability_. In the event that any provision of this Agreement
or the application thereof, becomes or is declared by a court of competent
jurisdiction to be illegal, void or unenforceable, the remainder of this
Agreement will continue in full force and effect and the application of such
provision to other Persons or circumstances will be interpreted so as
reasonably to effect the intent of the parties hereto. The parties further
agree to replace such void or unenforceable provision of this Agreement with a
valid and enforceable provision that will achieve, to the extent possible, the
economic, business and other purposes of such void or unenforceable provision.  

Section 20. _Further Assurances_. From time to time on and after the date
hereof, the Bioceres and the Union Representative shall deliver or cause to be
delivered to the Escrow Agent such further documents and instruments and shall
do and cause to be done such further acts as the Escrow Agent shall reasonably
request (it being understood that the Escrow Agent shall have no obligation to
make any such request) to carry out more effectively the provisions and
purposes of this Agreement, to evidence compliance herewith or to assure
itself that it is protected in acting hereunder.

 

Section 21. _Accounting_. In the event of the resignation or removal of the
Escrow Agent, upon the termination of this Agreement or upon demand at any
time of either Bioceres or the Union Representative under reasonable
circumstances, the Escrow Agent shall render to Bioceres, the Union
Representative and the successor escrow agent (if any) an accounting (free of
charge) in writing of the property constituting the Escrow Property.

 

Section 22. _Interpretation_. The parties acknowledge and agree that: (a) this
Agreement is the result of negotiations between the parties and will not be
deemed or construed as having been drafted by any one party, (b) each party
and its counsel have reviewed and negotiated the terms and provisions of this
Agreement (including any Exhibits attached hereto) and have contributed to its
revision and (c) the rule of construction to the effect that any ambiguities
are resolved against the drafting party will not be employed in the
interpretation of this Agreement. The headings contained in this Agreement are
for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. In this Agreement, unless the context
otherwise requires: (i) words of the masculine, feminine or neuter gender will
include the masculine, neuter or feminine gender, and words in the singular
number or in the plural number will each include, as applicable, the singular
number or the plural number; (ii) reference to any Person includes such
Person's successors and assigns but, if applicable, only if such successors
and assigns are permitted by this Agreement, and reference to a Person in a
particular capacity excludes such Person in any other capacity; (iii)
reference to any law means such law as amended, modified codified or
reenacted, in whole or in part, and in effect from time to time, including
rules and regulations promulgated thereunder; (iv) any agreement or instrument
defined or referred to herein or in any agreement or instrument that is
referred to herein means such agreement or instrument as from time to time
amended, modified or supplemented, including by waiver or consent and
references to all attachments thereto and instruments incorporated therein;
(v) the term "or" means "and/or"; (vi) the words "herein, "hereof" and
"hereunder" and other words of similar import refer to this Agreement as a
whole and not to any particular Article, Section or other subdivision; (vii)
the words "include," "includes" and "including" when used herein shall be
deemed in each case to be followed by the words "without limitation"; (viii)
any reference herein to "dollars" or "$" shall mean United States dollars; and
(ix) reference to any Section or Exhibit means such Section hereof or Exhibit
hereto.

 

Section 23. _Successors and Assigns_. This Agreement and the rights and
obligations hereunder may not be assigned without the prior written consent of
each of the parties hereto; _provided_ , _however_ , that if the Union
Representative is replaced in accordance with the terms of the Share Exchange
Agreement, the replacement Union Representative shall automatically become a
party to this Agreement as if it were the original Union Representative
hereunder upon providing (a) written notice to the Escrow Agent and Bioceres
of such replacement and accepting its rights and obligations under this
Agreement and (ii) the Escrow Agent with the documentation referenced in
_Section 28_ hereof from such replacement Union Representative and any
replacement authorized individuals to act on behalf of the Union
Representative for purposes of _Exhibit A_. This Agreement will be binding
upon, inure to the benefit of and be enforceable by the parties and their
respective successors and permitted assigns.  

Section 24. _Failure or Indulgence Not Waiver; Remedies Cumulative_. No
failure or delay on the part of any party hereto in the exercise of any right
hereunder will impair such right or be construed to be a waiver of, or
acquiescence in, any breach of any representation, warranty, covenant or
agreement herein, nor will any single or partial exercise of any such right
preclude any other (or further) exercise thereof or of any other right. All
rights and remedies existing under this Agreement are cumulative to, and not
exclusive to or exclusive of, any rights or remedies otherwise available to a
party hereunder.

 

Section 25. _Governing Law; Venue_. The terms and provisions of this Agreement
shall be construed and enforced in accordance with the laws of the State of
New York without reference to its conflict of law provisions. Subject to
_Section 14_ , each of the parties hereto irrevocably consents to the
exclusive jurisdiction and venue of any state or federal court located in New
York County, New York (or in any court in which appeal from such courts may be
taken) in connection with any matter based upon or arising out of this
Agreement or the matters contemplated herein, agrees that process may be
served upon them in any manner authorized by the laws of the State of New York
for such Persons and waives and covenants not to assert or plead any objection
which they might otherwise have to such jurisdiction, venue and such process.

 

Section 26. _Waiver of Jury Trial_. EACH PARTY HEREBY WAIVES THEIR RESPECTIVE
RIGHTS TO A TRIAL BY JURY IN ANY LITIGATION, CLAIM, CAUSE OF ACTION OR OTHER
LEGAL PROCEEDING BASED UPON OR ARISING OUT OF OR RELATED TO THIS AGREEMENT, IN
ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY OF THE
PARTIES HERETO AGAINST ANY OTHER PARTY OR PARTIES, WHETHER WITH RESPECT TO
CONTRACT CLAIMS, TORT CLAIMS, OR OTHERWISE. THE PARTIES HERETO EACH AGREE THAT
ANY SUCH LITIGATION, CLAIM, CAUSE OF ACTION OR OTHER LEGAL PROCEEDING SHALL BE
TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE FOREGOING, THE
PARTIES HERETO FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS
WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM OR OTHER
PROCEEDING WHICH SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR
ENFORCEABILITY OF THIS AGREEMENT OR ANY PROVISION HEREOF. THIS WAIVER SHALL
APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO
THIS AGREEMENT.  

Section 27. _Counterparts_. This Agreement may be executed simultaneously in
two or more counterparts (including by facsimile or other electronic
transmission), each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

 

Section 28. _U.S. Patriot Act_. Bioceres and the Union Representative agree to
provide the Escrow Agent with the information reasonably requested by the
Escrow Agent to verify and record Bioceres's and the Union Representative's
respective identities pursuant to the Escrow Agent's procedures for compliance
with the U.S. Patriot Act and any other applicable laws.

 

Section 29. _Representations of the Parties_. Each of the parties hereto
hereby represents and warrants that as of the date hereof: (a) it has the
power and authority to execute and deliver this Agreement and to perform its
obligations hereunder, and all such actions have been duly and validly
authorized by all necessary proceedings; and (b) this Agreement has been duly
authorized, executed and delivered by it, and constitutes a legal, valid and
binding agreement of it.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE  

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed and delivered as of the day and year first written above.

 

     Union Acquisition Corp. 
--- 
     | 
   By:  | 
     | Name: 
     | Title: 
     | 
     | 
   Joseph J. Schena 
     | 
   Joseph J. Schena, solely in the capacity under the Share Exchange
Agreement as the Union Representative 
     | 
     | 
   Bioceres LLC 
     | 
   By:  | 
     | Name: 
     | Title: 
     | 
     | 
   Bioceres S.A. 
     | 
   By:  | 
     | Name: 
     | Title: 
     | 
     | 
   Continental Stock Transfer and Trust Company 
     | 
   By:   | 
     | Name: 
     | Title: 

  

 _[Signature Page to Escrow Agreement]_   

EXHIBIT A 
_AUTHORIZED SIGNERS_

 

Bioceres: 
Individuals authorized by Bioceres:

     Name  |   | Telephone Number  |   | Specimen Signature 
---|---|---|---|--- 
     |   |   |   | 
   1.  |   |   |   |   | 
   2.  |   |   |   |   | 
   3.  |   |   |   |   | 
  
     Union Representative: 
--- 
  
     Name  |   | Telephone Number  |   | Specimen Signature 
---|---|---|---|--- 
     |   |   |   | 
   1.  |   |   |   |   |   

EXHIBIT B 
FEE INFORMATION

 

$3,500 for review and set up.

 

$200/month for so long as Escrow Agent is serving as Escrow Agent under this  

Exhibit B

 

RIGHT OF FIRST REFUSAL AGREEMENT

 

THIS RIGHT OF FIRST REFUSAL AGREEMENT (this "Agreement") is made as of
________________ by and among Bioceres S.A., a _sociedad an onima _organized
under the laws of the Republic of Argentina (together with its permitted
successors and assigns, the "Parent"), and the investors listed on Schedule 1
hereto (the "Union Investors", and together with Parent, collectively, the
"Parties" and individually, a "Party"). Any capitalized term used but not
defined in this Agreement will have the meaning ascribed to such term in that
certain Share Exchange Agreement (as amended from time to time in accordance
with the terms thereof, the "Share Exchange Agreement"), by and among Union
Acquisition Corp. ("Union"), Joseph J. Schena, in his capacity under the Share
Exchange Agreement as the Pre-Closing Union Representative (including any
successor Pre-Closing Union Representative appointed in accordance therewith,
the "Pre-Closing Union Representative") and Bioceres, Inc., a Delaware
Corporation ("Bioceres").

 

WHEREAS, on November 8, 2018, Union, the Pre-Closing Union Representative and
Bioceres entered into the Share Exchange Agreement pursuant to which, subject
to the terms and conditions thereof, Union will (i) acquire from Parent all of
Parent's equity interest in Bioceres Semillas S.A., a _sociedad an onima
_organized under the laws of the Republic of Argentina, representing 87.2739%
of the issued and outstanding capital stock of Bioceres Semillas S.A. and (ii)
acquire from Bioceres all of the issued and outstanding equity interests of
New Bioceres, Inc., a Delaware corporation, in exchange for (A) twenty-seven
million, one hundred sixteen thousand, one hundred seventy-four (27,116,174)
newly issued Union Ordinary Shares, a portion of which will be set aside in
escrow and held in an escrow account in accordance with the terms and
conditions of the Share Exchange Agreement and the Escrow Agreement and (B)
the Union Warrants;

 

WHEREAS, pursuant to the Share Exchange Agreement, and in view of the valuable
consideration to be received by the Parties thereunder, the Parties hereto
desire to enter into this Agreement, pursuant to which Parent shall be granted
a right of first refusal to purchase from any Union Investor any and all Union
Ordinary Shares held by such Union Investor (including shares issuable upon
the exercise of any option, warrant or other right to acquire Union Ordinary
Shares), prior to such Union Investor's sale, transfer or other disposition of
such shares (a "Transfer") to an unaffiliated third party (a "Third Party
Buyer").

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set
forth herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties hereto agree as
follows:

 

     1  |   

 Right of First Refusal of Parent. 

---|--- 
     | 
     |   (a)  |   

If any Union Investor (the "Selling Investor") receives from or wishes to
present to a Third Party Buyer, a bona fide offer for the Transfer of any or
all of such Selling Investor's Union Ordinary Shares, prior to accepting such
offer, such Selling Investor shall first offer to sell such Union Ordinary
Shares to Parent in accordance with the terms of this Agreement (the "Parent
Right of First Refusal").   
 

       | (b)  |   

 In the event a bona fide offer is received by or presented to a Selling
Investor, such Selling Investor shall deliver a written notice of such bona
fide offer (a "Transfer Notice") to Parent, describing in reasonable detail
the Union Ordinary Shares proposed to be sold, the name of the Third Party
Buyer, the price offered per each Union Ordinary Share, the payment terms and
all other material terms of the proposed Transfer. Upon receipt of a Transfer
Notice, Parent shall have the right and option for thirty (30) days from the
date of the Transfer Notice, to deliver a written notice to the Selling
Investor (a "Response Notice") stating whether or not Parent wishes to
purchase all or any part of the Union Ordinary Shares proposed to be
transferred by the Selling Investor at the Purchase Price (as defined below)
and on the other terms of the proposed Transfer set forth in the Transfer
Notice. 

---|---|--- 
      |   | 
     | (c)  |  

If Parent states in any Response Notice that it wishes to purchase all or any
part of the Union Ordinary Share proposed to be transferred by the Selling
Investor, the exercise price granted to Parent for such Union Ordinary Shares
(the "Purchase Price") shall be equal to the highest weighted average trading
price for any five (5) consecutive trading days selected from the twenty (20)
trading days immediately prior to the date of the applicable Response Notice. 

     |   | 
     | (d)  |  

Absent the delivery of a Response Notice to the Selling Investor within the
thirty (30) day period following receipt of the Transfer Notice, Parent shall
be deemed to have waived the Parent Right of First Refusal. 

     |   | 
     | (e)  |   

If Parent elects to purchase all or any part of the offered Union Ordinary
Shares, the closing of the purchase and sale of such Union Ordinary Shares
shall be held at the place and on the date established in the Response Notice,
which in no event shall be less than ten (10) or more than forty-five (45)
days from the date of such Response Notice. In any case where any aspect of
the terms of such offer depends on the unique attributes of the Third Party
Buyer or otherwise cannot be precisely and reasonably duplicated by someone
other than the Third Party Buyer, purchases by Parent shall be made on terms
that constitute the reasonable economic equivalent of the terms of such bona
fide offer, as determined by the board of directors of Union in good faith. 

     |   | 
     | (f)  |   

In the event that Parent does not elect to purchase all Union Ordinary Shares
offered in a Transfer Notice, the Selling Investor may, subject to the other
provisions of this Agreement, sell the portion of the offered Union Ordinary
Shares not purchased by Parent to the Third Party Buyer specified in such
Transfer Notice at a price no less than the price specified in such Transfer
Notice and on other terms no more favorable to the Third Party Buyer than
specified in such Transfer Notice. In the event that any of the offered Union
Ordinary Shares are not transferred to the applicable Third Party Buyer
specified in the Transfer Notice within forty-five (45) days immediately
following the last day on which Parent could have elected to purchase the
offered Union Ordinary Shares, any subsequent Transfer of such shares shall
once again be offered to Parent in accordance with Section 1 of this
Agreement. 

   
   \t 2     
 

     2  |   

Miscellaneous. 

---|--- 
     | 
   2.1  |   

_Governing Law_. 

     | 
     |   

This Agreement and any claim, controversy or dispute arising under or related
in any way to this Agreement, the relationship of the Parties, the transaction
leading to this Agreement or contemplated hereby and/or the interpretation
and/or enforcement of the respective rights and duties of the Parties
hereunder or related in any way to the foregoing, shall be governed by and
construed in accordance with the internal, substantive laws of the State of
New York applicable to agreements entered into and to be performed solely
within such state, without giving effect to any choice of law or conflict of
law provision or rule (whether of the State of New York or any other
jurisdiction) that would cause the application of the law of any jurisdiction
other than the State of New York. 

     | 
   2.2  |   

_Counterparts; Facsimile._ 

     | 
     |   

This Agreement may also be executed and delivered by facsimile signature or by
email in portable document format in two (2) or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute
one and the same instrument. 

 

[ _Signatures Follow on Next Page_ ]

    \t 3    

IN WITNESS WHEREOF, the Parties hereto have executed this Right of First
Refusal Agreement as of the date first specified above.

 

     __Union Investor:__ 
--- 
     | 
   By:  | 
   Name:  | 
   Title:  | 
      | 
   __Parent:__ 
     | 
   Bioceres S.A. 
     | 
   By:  | 
   Name:  | 
   Title:  | 
  

  

[Signature Page to Right of First Refusal Agreement]   

Schedule 1

     1.  | Juan Sartori 
---|--- 
     | 
   2.  | Kyle P. Bransfield 
     | 
   3.  | Gerald W. Haddock 
     | 
   4.  | Daniel W. Fink 
     | 
   5.  | Joseph J. Schena 
     | 
   6.  | Union Group International Holdings Limited 
     | 
   7\.   | Union Acquisition Associates, LLC 
     | 
   8.  | Jim Manley 
 

[Schedule 1 to Right of First Refusal Agreement]  

Exhibit C

 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF
CONTINENTAL STOCK TRANSFER and TRUST COMPANY (" _WARRANT AGENT_ "), TO THE
COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND
ANY CERTIFICATE ISSUED IS REGISTERED IN SUCH NAME AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF WARRANT AGENT (AND ANY PAYMENT IS MADE TO SUCH
ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF WARRANT AGENT) ANY
TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF HAS AN INTEREST
HEREIN. TRANSFERS OF THIS GLOBAL WARRANT SHALL BE LIMITED TO TRANSFERS IN
WHOLE, BUT NOT IN PART, TO NOMINEES OF WARRANT AGENT OR TO A SUCCESSOR THEREOF
OR SUCH SUCCESSOR'S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL WARRANT
SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET
FORTH IN THE WARRANT AGREEMENT REFERRED TO ON THE REVERSE HEREOF. ANY TRANSFER
OF THE WARRANTS REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE CONDITIONS
SPECIFIED IN THE WARRANT AGREEMENT (THE " _WARRANT AGREEMENT_ ") DATED AS OF [
], BETWEEN UNION ACQUISITION CORP. (INCLUDING ITS SUCCESSORS, THE " _COMPANY_
") AND WARRANT AGENT, SOLELY IN ITS CAPACITY AS WARRANT AGENT. BY ACCEPTING
DELIVERY OF THE WARRANTS REPRESENTED BY THIS CERTIFICATE, ANY TRANSFEREE SHALL
BE DEEMED TO HAVE AGREED TO BE BOUND BY THE WARRANT AGREEMENT AS IF THE
TRANSFEREE HAD EXECUTED AND DELIVERED THE WARRANT AGREEMENT.

 

       

NUMBER 
_____________

  | (SEE REVERSE SIDE FOR LEGEND) 
THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO 
THE EXPIRATION DATE (DEFINED BELOW)  | 2,500,000 WARRANTS 
---|---|--- 

 

UNION ACQUISITION CORP.

       |   

**CUSIP [ ] ** 

---|--- 
   
  

WARRANT

 

THIS CERTIFIES THAT, for value received Cede and Co. is the registered holder of
a warrant or warrants (the " _Warrant_ ") of the Company, expiring at 5:00
p.m., New York City time, on ____________ , 202__1, to purchase one fully paid
and non-assessable ordinary share, par value $0.0001 per share (" _Shares_ "),
of the Company for each whole Warrant evidenced by this Warrant Certificate.
The Warrant entitles the holder thereof to purchase from the Company,
commencing on []2, such number of Shares of the Company at the Warrant Price
(as defined below), upon surrender of this Warrant Certificate and payment of
the Warrant Price at the office or agency of Warrant Agent, but only subject
to the conditions set forth herein and in the Warrant Agreement. This Warrant
is issued under and in accordance with the Warrant Agreement, and is subject
to the terms and provisions contained in the Warrant Agreement, to all of
which terms and provisions the holder of this Warrant consents by acceptance
hereof. The Warrant Agreement is hereby incorporated herein by reference and
made a part hereof. Capitalized terms used but not defined herein shall have
the meanings ascribed thereto in the Warrant Agreement. In no event will the
Company be required to net cash settle any warrant exercise. The Warrant
Agreement provides that upon the occurrence of certain events the Warrant
Price and the number of Shares purchasable hereunder, set forth on the face
hereof, may, subject to certain conditions, be adjusted. The term " _Warrant
Price_ " as used in this Warrant Certificate refers to the price per Share at
which Shares may be purchased at the time the Warrant is exercised. The
initial Warrant Price per Share for any Warrant is equal to $[]3 per share.

 

No fraction of a Share will be issued upon any exercise of a Warrant. If the
holder of a Warrant would be entitled to receive a fraction of a Share upon
any exercise of a Warrant, the Company shall, upon such exercise, round up to
the nearest whole number the number of Shares to be issued to such holder.

 

Upon any exercise of the Warrant for less than the total number of full Shares
provided for herein, there shall be issued to the registered holder hereof or
the registered holder's assignee a new Warrant Certificate covering the number
of Shares for which the Warrant has not been exercised.

 

Warrant Certificates, when surrendered at the office or agency of the Warrant
Agent by the registered holder in person or by attorney duly authorized in
writing, may be exchanged in the manner and subject to the limitations
provided in the Warrant Agreement, but without payment of any service charge,
for another Warrant Certificate or Warrant Certificates of like tenor and
evidencing in the aggregate a like number of Warrants.

 

____________________

 

1 Date to be (5) five years from the Closing of the Business Combination. 
2The three tranches of warrants delivered at Closing will vest at the
following times: (i) if and when the price of the Company's ordinary shares
trade above $15.00 for any 20 trading days within any 30 trading day period ("
_Tranche 1_ "), (ii) upon issuance (" _Tranche 2_ "), and (iii) upon issuance
(" _Tranche 3_ "). 
3At Closing, Bioceres Crop Solutions Corp. will deliver Tranche 1 at a strike
price of $11.50, Tranche 2 at a strike price $15.00, and Tranche 3 at a strike
price $18.00.   
  

Upon due presentment for registration of transfer of the Warrant Certificate
at the office or agency of the Warrant Agent, a new Warrant Certificate or
Warrant Certificates of like tenor and evidencing in the aggregate a like
number of Warrants shall be issued to the transferee in exchange for this
Warrant Certificate, subject to the limitations provided in the Warrant
Agreement, without charge except for any applicable tax or other governmental
charge.

 

The Company and the Warrant Agent may deem and treat the registered holder as
the absolute owner of this Warrant Certificate (notwithstanding any notation
of ownership or other writing hereon made by anyone), for the purpose of any
exercise hereof, of any distribution to the registered holder, and for all
other purposes, and neither the Company nor the Warrant Agent shall be
affected by any notice to the contrary.

 

This Warrant does not entitle the registered holder to any of the rights of a
shareholder of the Company.

  
      By   |   |   |   | 
---|---|---|---|--- 
     | President  |   | Secretary  |  

FORM OF EXERCISE NOTICE 
To Be Executed by the Registered Holder in Order to Exercise Warrants

 

The undersigned Registered Holder irrevocably elects to exercise
______________ Warrants represented by this Warrant Certificate, and to
purchase the Shares issuable upon the exercise of such Warrants, and requests
that Certificates for such shares shall be issued in the name of

     (PLEASE TYPE OR PRINT NAME AND ADDRESS) 
--- 
   
   
   
        | (SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER) 
---|--- 
    

and be delivered to 

  | 
     | (PLEASE PRINT OR TYPE NAME AND ADDRESS) 
     | 
      and, if such number of Warrants shall not be all the Warrants
evidenced by this Warrant Certificate, that a new Warrant Certificate for the
balance of such Warrants be registered in the name of, and delivered to, the
Registered Holder at the address stated below: 
--- 
  
     Dated:   |   |   | 
---|---|---|--- 
     |   |   | (SIGNATURE) 
     |   |   | 
     |   |   | (ADDRESS) 
     |   |   | 
     |   |   | 
     |   |   | (TAX IDENTIFICATION NUMBER) 
  

ASSIGNMENT 
To Be Executed by the Registered Holder in Order to Assign Warrants

 

For Value Received, _______________________ hereby sell, assign, and transfer
unto

     (PLEASE TYPE OR PRINT NAME AND ADDRESS) 
--- 
   
   
   
        | (SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER) 
---|--- 
   and be delivered to   | 
     | (PLEASE PRINT OR TYPE NAME AND ADDRESS) 
  

______________________ of the Warrants represented by this Warrant
Certificate, and hereby irrevocably constitute and appoint
_________________________________ Attorney to transfer this Warrant
Certificate on the books of the Company, with full power of substitution in
the premises.

     Dated:   |   |   | 
---|---|---|--- 
     |   |   | (SIGNATURE) 
  

The signature to the assignment of the Subscription Form must correspond to
the name written upon the face of this Warrant Certificate in every
particular, without alteration or enlargement or any change whatsoever, and
must be guaranteed by a commercial bank or trust company or a member firm of
the NYSE American, Nasdaq, New York Stock Exchange, Pacific Stock Exchange, or
Chicago Stock Exchange.  

Exhibit D

 

 _LOCK-UP AGREEMENT_

 

THIS LOCK-UP AGREEMENT (this " _Agreement_ ") is made and entered into as of
November 8, 2018, effective as of the Closing of the transactions contemplated
by the Share Exchange Agreement (as defined herein), by and among (i) Union
Acquisition Corp., an exempted company incorporated under the laws of the
Cayman Islands, which will be known after the consummation of the transactions
contemplated by the Share Exchange Agreement (as defined below) as "Bioceres
Crop Solutions Corp." (including any successor entity thereto, " _Union_ _"_
), (ii) Joseph J. Schena, in his capacity under the Share Exchange Agreement
as the Pre-Closing Union Representative (including any successor Pre-Closing
Union Representative appointed in accordance therewith, the " _Pre-Closing
Union Representative_ "), and (iii) the undersigned holder (" _Holder_ " and
together with Union and the Pre-Closing Union Representative, collectively the
" _Parties_ " and individually a " _Party_ "). Any capitalized term used but
not defined in this Agreement will have the meaning ascribed to such term in
that certain the Share Exchange Agreement (as amended from time to time in
accordance with the terms thereof, the " _Share Exchange Agreement_ "), by and
among Union, the Pre-Closing Union Representative, and Holder.

 

WHEREAS, as of the date hereof, Union, the Pre-Closing Union Representative
and Holder entered into Share Exchange Agreement pursuant to which, subject to
the terms and conditions thereof, Union will acquire from Holder, among other
equity interests from Bioceres S.A., all of the issued and outstanding equity
interests of New Messi, Inc., a Delaware corporation (the " _Company_ ") in
exchange for, among other securities, twenty-seven million, one hundred
sixteen thousand, one hundred seventy-four (27,116,174) newly issued Union
Ordinary Shares, a portion of which will be set aside in escrow and held in an
escrow account in accordance with the terms and conditions of the Share
Exchange Agreement and the Escrow Agreement;

 

WHEREAS, pursuant to the Share Exchange Agreement, and in view of the valuable
consideration to be received by Holder thereunder, the parties hereto desire
to enter into this Agreement, pursuant to which the Exchange Shares to be
issued to Holder (including any shares held in escrow as Escrow Shares) (such
Exchange Shares, together with any securities paid as dividends or
distributions with respect to such securities or into which such securities
are exchanged or converted, the _"_ _Restricted Securities_ _"_ ) shall become
subject to limitations on disposition as set forth herein.

   

NOW, THEREFORE, in consideration of the premises set forth above, which are
incorporated into this Agreement as if fully set forth below, and intending to
be legally bound hereby, the parties hereby agree as follows:

 

1\. _Lock-Up Provisions_.

 

(a) Holder hereby agrees not to, until the earlier of (A) the earlier of (x)
one (1) year after the Closing of the transactions contemplated by the Share
Exchange Agreement and (y) the date on which the closing price of Union's
Ordinary Shares equals or exceeds $12.00 per share (as adjusted for stock
splits, stock dividends, reorganizations, and recapitalizations) for any 20
trading days within any 30-trading day period commencing one hundred and fifty
(150) days after the Closing of the transactions contemplated by the Share
Exchange Agreement and (B) the date that the combined company consummates a
subsequent liquidation, merger stock exchange or other similar transaction
which results in all shareholders having the right to exchange their ordinary
shares for cash, securities or other properties (collectively, the " _Lock-Up
Period_ ") (i) lend, offer, pledge, hypothecate, encumber, donate, assign,
sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, or
otherwise transfer or dispose of, directly or indirectly, any Restricted
Securities, (ii) enter into any swap or other arrangement that transfers to
another, in whole or in part, any of the economic consequences of ownership of
the Restricted Securities, or (iii) publicly disclose the intention to do any
of the foregoing, whether any such transaction described in clauses (i), (ii)
or (iii) above is to be settled by delivery of Restricted Securities or other
securities, in cash or otherwise (any of the foregoing described in clauses
(i), (ii) or (iii), a " _Prohibited Transfer_ "). The foregoing sentence shall
not apply to the transfer of any or all of the Restricted Securities owned by
Holder (other than Escrow Shares if and until such Escrow Shares are disbursed
to Holder from the Escrow Account in accordance with the terms and conditions
of the Share Exchange Agreement and the Escrow Agreement) (A) if Holder is an
individual, by gift, will or intestate succession upon the death of Holder,
(B) to any Permitted Transferee or (C) if Holder is an individual, pursuant to
a court order or settlement agreement related to the distribution of assets in
connection with the dissolution of marriage or civil union; _provided_ ,
however, that in any of cases (A), (B) or (C) it shall be a condition to such
transfer that (x) the transferee executes and delivers to Union and the Pre-
Closing Union Representative an agreement stating that the transferee is
receiving and holding the Restricted Securities subject to the provisions of
this Agreement applicable to Holder, and there shall be no further transfer of
such Restricted Securities except in accordance with this Agreement and (y)
such transfer shall not reduce Holder's ownership of Union Ordinary Shares to
an amount that is below fifty one percent (51%) of the then outstanding Union
Ordinary Shares. As used in this Agreement, the term " _Permitted Transferee_
" shall mean: (I) if Holder is an individual, the members of Holder's
immediate family (for purposes of this Agreement, "immediate family" shall
mean with respect to any natural person, any of the following: such person's
spouse, the siblings of such person and his or her spouse, and the direct
descendants and ascendants (including adopted and step children and parents)
of such person and his or her spouses and siblings), (II) if Holder is an
individual, any trust for the direct or indirect benefit of Holder or the
immediate family of Holder, (III) if Holder is a trust, to the trustor or
beneficiary of such trust or to the estate of a beneficiary of such trust,
(IV) if Holder is an entity, as a distribution to limited partners,
shareholders, members of, or owners of similar equity interests in Holder upon
the liquidation and dissolution of Holder, (V) to any Affiliate of Holder,
(VI) any Person selling shares of Bioceres Semillas S.A. pursuant to Section 4
of the Shareholders Agreement of Bioceres Semillas S.A., dated June 1, 2010,
as consideration thereof, in accordance with Section 2.8 of the Share Exchange
Agreement and (VII) any Person selling shares of Rizobacter S.A. pursuant to
the exercise of the Rizobacter Call Option (as defined in the Share Exchange
Agreement) as consideration thereunder, in accordance with Section 6.25 of the
Share Exchange Agreement. Holder further agrees to execute such agreements as
may be reasonably requested by Union or the Pre-Closing Union Representative
that are consistent with the foregoing or that are necessary to give further
effect thereto.

   

(b) Holder further acknowledges and agrees that it shall not be permitted to
engage in any Prohibited Transfer with respect to any Escrow Shares until such
Escrow Shares are disbursed to Holder from the Escrow Account in accordance
with the terms and conditions of the Share Exchange Agreement and the Escrow
Agreement.

 

(c) Notwithstanding the foregoing, Holder may during the Lock-Up Period pledge
its Restricted Securities (other than its Escrow Shares) to an unaffiliated
third party lender as a guarantee to secure borrowings by Union or any of its
Subsidiaries; _provided_ , that, it shall be a condition to any such pledge
and related guarantee that the applicable lender executes and delivers to
Union and the Pre-Closing Union Representative an agreement stating that the
lender is being guaranteed Restricted Securities that are subject to the
provisions of this Agreement applicable to Holder, and that in the event it
becomes a holder of such Restricted Securities pursuant to the terms of any
applicable pledge, loan or similar agreement, its shall be prohibited from
transferring such Restricted Securities except in accordance with this
Agreement.

 

(d) If any Prohibited Transfer is made or attempted contrary to the provisions
of this Agreement, such purported Prohibited Transfer shall be null and void
ab initio, and Union shall refuse to recognize any such purported transferee
of the Restricted Securities as one of its equity holders for any purpose. In
order to enforce this _Section 1_ , Union may impose stop-transfer
instructions with respect to the Restricted Securities of Holder (and
permitted transferees and assigns thereof) until the end of the Lock-Up
Period.

 

(e) During the Lock-Up Period (and with respect to any Escrow Shares, during
the period when such Escrow Shares are held in the Escrow Account), each
certificate (if any) evidencing any Restricted Securities shall be stamped or
otherwise imprinted with a legend in substantially the following form, in
addition to any other applicable legends:

 

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON
TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [], BY AND AMONG THE
ISSUER OF SUCH SECURITIES (THE "ISSUER") AND THE ISSUER'S SECURITY HOLDER
NAMED THEREIN, AS AMENDED. A COPY OF SUCH LOCK-UP AGREEMENT WILL BE FURNISHED
WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST."

 

(f) For the avoidance of any doubt, Holder shall retain all of its rights as a
holder of Union Ordinary Shares during the Lock-Up Period, including the right
to vote any Restricted Securities.

 

2\. _Miscellaneous._

 

(a) _Termination of Share Exchange Agreement_. Notwithstanding anything to the
contrary contained herein, in the event that the Share Exchange Agreement is
terminated in accordance with its terms prior to the Closing, this Agreement
and all rights and obligations of the parties hereunder shall automatically
terminate and be of no further force or effect.

   

(b) _Binding Effect; Assignment_. This Agreement and all of the provisions
hereof shall be binding upon and inure to the benefit of the parties hereto
and their respective permitted successors and assigns. This Agreement and all
obligations of Holder are personal to Holder and may not be transferred or
delegated by Holder at any time. Union may assign any or all of its rights
under this Agreement, in whole or in part, to any successor entity (whether by
merger, consolidation, equity sale, asset sale or otherwise) upon obtaining
the consent or approval of Holder. If the Pre-Closing Union Representative is
replaced in accordance with the terms of the Share Exchange Agreement, the
replacement Pre-Closing Union Representative shall automatically become a
party to this Agreement as if it were the original Pre-Closing Union
Representative hereunder.

 

(c) _Third Parties_. Nothing contained in this Agreement or in any instrument
or document executed by any party in connection with the transactions
contemplated hereby shall create any rights in, or be deemed to have been
executed for the benefit of, any person or entity that is not a party hereto
or thereto or a successor or permitted assign of such a party.

 

(d) _Governing Law_. This Agreement and any claim, controversy or dispute
arising under or related in any way to this Agreement, the relationship of the
Parties, the transaction leading to this Agreement or contemplated hereby
and/or the interpretation and/or enforcement of the respective rights and
duties of the Parties hereunder or related in any way to the foregoing, shall
be governed by and construed in accordance with the internal, substantive laws
of the State of New York applicable to agreements entered into and to be
performed solely within such state, without giving effect to any choice of law
or conflict of law provision or rule (whether of the State of New York or any
other jurisdiction) that would cause the application of the law of any
jurisdiction other than the State of New York.

 

(e) _Jurisdiction and Venue_. Each of the Parties (a) submits to the exclusive
jurisdiction of any state or federal court sitting in the State of New York,
in any Proceeding arising out of or relating to this Agreement, (b) agrees
that all claims in respect of such Proceeding may be heard and determined in
any such court and (c) agrees not to bring any Proceeding arising out of or
relating to this Agreement in any other court. Each of the Parties waives any
defense of inconvenient forum to the maintenance of any Proceeding so brought
and waives any bond, surety or other security that might be required of any
other Party with respect thereto. Each Party agrees that service of summons
and complaint or any other process that might be served in any Proceeding may
be made on Union by sending or delivering a copy of the process to the Party
to be served at the address of the Party and in the manner provided for the
giving of notices in _Section 10.2_. Nothing in this _Section 2(e)_ , however,
shall affect the right of any Party to serve legal process in any other manner
permitted by law. Each Party agrees that a final, non-appealable judgment in
any Proceeding so brought shall be conclusive and may be enforced by suit on
the judgment or in any other manner provided by law.

 

(f) _WAIVER OF JURY TRIAL_. EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR
CAUSE OF ACTION (A) ARISING UNDER THIS AGREEMENT OR (B) IN ANY WAY CONNECTED
WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF
THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE,
WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT,
EQUITY, OR OTHERWISE. EACH PARTY HEREBY FURTHER AGREES AND CONSENTS THAT ANY
SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL
WITHOUT A JURY AND THAT THE PARTIES MAY FILE A COPY OF THIS AGREEMENT WITH ANY
COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE WAIVER OF THEIR
RIGHT TO TRIAL BY JURY.

    

(g) _Interpretation_. The titles and subtitles used in this Agreement are for
convenience only and are not to be considered in construing or interpreting
this Agreement. In this Agreement, unless the context otherwise requires: (i)
any pronoun used in this Agreement shall include the corresponding masculine,
feminine or neuter forms, and the singular form of nouns, pronouns and verbs
shall include the plural and vice versa; (ii) "including" (and with
correlative meaning "include") means including without limiting the generality
of any description preceding or succeeding such term and shall be deemed in
each case to be followed by the words "without limitation"; (iii) the words
"herein," "hereto," and "hereby" and other words of similar import in this
Agreement shall be deemed in each case to refer to this Agreement as a whole
and not to any particular section or other subdivision of this Agreement; and
(iv) the term "or" means "and/or". The parties have participated jointly in
the negotiation and drafting of this Agreement. Consequently, in the event an
ambiguity or question of intent or interpretation arises, this Agreement shall
be construed as if drafted jointly by the parties hereto, and no presumption
or burden of proof shall arise favoring or disfavoring any party by virtue of
the authorship of any provision of this Agreement.

 

(h) _Notices_. All notices, requests, claims, demands and other communications
hereunder shall be in writing and shall be given (and shall be deemed to have
been duly given upon receipt) by delivery in person, E-mail, or by registered
or certified mail (postage prepaid, return receipt requested) to the other
Parties as follows:

     _If to Union after the Closing, to:_   | _With copies to (which
shall not constitute notice):_ 
---|--- 
   
   Union Acquisition Corp.  | Arnold and Porter Kaye Scholer LLP 
   400 Madison Avenue, Suite 11A  | 250 West 55th Street 
   New York, NY 10017  | New York, NY 10019-9710 
   Attention: Kyle Bransfield  | Attention: Stephen Koval, Esq. 
   Email: kbransfield@apcap.com  | Email: steve.koval@arnoldporter.com 
   
     | Linklaters LLP 
     | 1345 Avenue of the Americas 
     | New York, NY 10105 
     | Attention: Matthew Poulter 
     | E-mail: matthew.poulter@linklaters.com 
   
   _If to the Pre-Closing Union_   | _With copies to (which shall not
constitute notice):_ 
   _Representative, to:_   | 
   
   Joseph J. Schena  | Arnold and Porter Kaye Scholer LLP 
   162 College Park Drive  | 250 West 55th Street 
   Fairfield, CT 06824  | New York, NY 10019-9710 
   Email: j.schena@sbcglobal.net  | Attention: Stephen Koval, Esq. 
     | Email: steve.koval@arnoldporter.com 
   
   _If to Holder, to_ : the address set forth below on the signature page to
this Agreement. 
     

(i) _Amendments and Waivers_. Any term of this Agreement may be amended and
the observance of any term of this Agreement may be waived (either generally
or in a particular instance, and either retroactively or prospectively) only
with the written consent of the Pre-Closing Union Representative and Holder.
No failure or delay by a party in exercising any right hereunder shall operate
as a waiver thereof. No waivers of or exceptions to any term, condition, or
provision of this Agreement, in any one or more instances, shall be deemed to
be or construed as a further or continuing waiver of any such term, condition,
or provision.

 

(j) _Severability_. Whenever possible, each provision of this Agreement will
be interpreted in such a manner as to be effective and valid under applicable
Law, but if any term or other provision of this Agreement is held to be
invalid, illegal or unenforceable under applicable Law, all other provisions
of this Agreement shall remain in full force and effect so long as the
economic or legal substance of the transactions contemplated hereby is not
affected in any manner materially adverse to any party hereto. Upon such
determination that any term or other provision of this Agreement is invalid,
illegal or unenforceable under applicable Law, the Parties hereto shall
negotiate in good faith to modify this Agreement so as to effect the original
intent of the Parties as closely as possible in an acceptable manner in order
that the transactions contemplated hereby are consummated as originally
contemplated to the greatest extent possible.

 

(k) _Specific Performance_. Holder acknowledges that its obligations under
this Agreement are unique, recognizes and affirms that in the event of a
breach of this Agreement by Holder, money damages will be inadequate and Union
(and the Pre-Closing Union Representative on behalf of Union) will have no
adequate remedy at law, and agrees that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed by
Holder in accordance with their specific terms or were otherwise breached.
Accordingly, each of Union and the Pre-Closing Union Representative shall be
entitled to enforce any provision of this Agreement by a decree of specific
performance and to temporary, preliminary and permanent injunctive relief to
prevent breaches or threatened breaches of any of the provisions of this
Agreement, without posting any bond or other undertaking.

   

(l) _Entire Agreement_. This Agreement constitutes the full and entire
understanding and agreement among the parties with respect to the subject
matter hereof, and any other written or oral agreement relating to the subject
matter hereof existing between the parties is expressly canceled; _provided_ ,
that, for the avoidance of doubt, the foregoing shall not affect the rights
and obligations of the parties under the Share Exchange Agreement or any
Ancillary Document. Notwithstanding the foregoing, nothing in this Agreement
shall limit any of the rights or remedies of Union and the Pre-Closing Union
Representative or any of the obligations of Holder under any other agreement
between Holder and Union or the Pre-Closing Union Representative or any
certificate or instrument executed by Holder in favor of Union or the Pre-
Closing Union Representative, and nothing in any other agreement, certificate
or instrument shall limit any of the rights or remedies of Union or the Pre-
Closing Union Representative or any of the obligations of Holder under this
Agreement.

 

(m) _Further Assurances_. From time to time, at another party's request and
without further consideration (but at the requesting party's reasonable cost
and expense), each party shall execute and deliver such additional documents
and take all such further action as may be reasonably necessary to consummate
the transactions contemplated by this Agreement.

 

(n) _Counterparts; Facsimile_. This Agreement may also be executed and
delivered by facsimile signature or by email in portable document format in
two or more counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument.

 

 _[Remainder of Page Intentionally Left Blank; Signature Pages Follow]_

    

IN WITNESS WHEREOF, the parties have executed this Lock-Up Agreement as of the
date first written above.

 

     ______Union:__ 
--- 
     | 
   Union Acquisition Corp. 
     | 
   By:   | /s/ Kyle P. Bransfield 
   Name: Kyle P. Bransfield 
   Title: Chief Executive Officer 
     | 
   ______Pre-Closing Union Representative:__ 
     | 
   Joseph J. Schena, 
   in his capacity under the Share Exchange 
   Agreement as the Pre-Closing Union 
   Representative 
     | 
   By:  | /s/ Joseph J. Schena 

  



 



 



 



 



 

[Signature Page to Lock-Up Agreement]   

IN WITNESS WHEREOF, the parties have executed this Lock-Up Agreement as of the
date first written above.

     ______Holder:__   | ____ 
---|--- 
    BIOCERES, INC.  | 
   By:   | /s/ Federico Trucco  
| 
   Name: Federico Trucco  | 
   Title: President and Chief Executive  | 
   Officer  | 
   ___Number of Union Ordinary Shares:_ 27,116,174  | __ 
    ___Address for Notice:_   | __ 
    Ocampo 210bis, Predio CCT,  | 
   Rosario, 2000,  | 
   Santa Fe, Argentina  | 
   Attention: Gloria Montaron Estrada  | 
   Email: gloria.montaron@bioceres.com.ar  | 
   Telephone No.: +54 341 4861122  | 
  



 



 



 



 



 

[Signature Page to Lock-Up Agreement]  

Exhibit E

 

JOINDER AGREEMENT

 

By execution of this Joinder Agreement, the undersigned hereby agrees to
become a party to that certain Share Exchange Agreement (the " _Agreement_ "),
dated as of November 8, 2018, by and among Union Acquisition Corp., Joseph J.
Schena, solely in his capacity as representative of the holders of Union
Ordinary Shares immediately prior to the Closing and their successors (and any
successor representative appointed in accordance therewith) and Bioceres, Inc.
The undersigned shall have all the rights, and shall observe all the
obligations, applicable to it under the Agreement. Capitalized terms used and
not otherwise defined herein have the meanings ascribed to them in the
Agreement.

 

Date: __________________

 

     BIOCERES S.A. 
--- 
     | 
     | 
   By:   | 
     | Name: Federico Trucco 
     | Title: Chief Executive Officer 

  
     Address for Notices: 
--- 
   
   Bioceres S.A. 
   Ocampo 210 bis 
   Predio CCT, Rosario Santa Fe, Argentina 
 

Attention: Gloria Montaron Estrada 
 Email: gloria.montaron@bioceres.com.ar 
 Telephone No.: +54 341 486 1122   

Exhibit F

 

Buenos Aires city, October 22, 2018

  

Attn. 
Maria Marta Mac Mullen 
Pedro Enrique Mac Mullen 
International Property Services Corp.

  

Re: _Proposed Addendum No. 1/2018_

  

Dear sirs/madams,

  

This is in connection with Offer No. 4/5-C/2016 dated October 19, 2016 (the "
_Call Option Offer_ "), with respect to the granting of a call option on
certain of your equity interests in Rizobacter Argentina S.A., an Argentine
company domiciled at Dr. Arturo Frondizi 1150 (Parque Industrial Pergamino,
Pergamino, Provincia de Buenos Aires (hereinafter, " _RASA_ ") to submit to
your consideration (the " _Sellers_ " and/or " _MMM_ " and/or " _PMM_ " and/or
" _IPS_ ", as applicable and jointly with Bioceres S.A. and its subsidiary
Rasa Holding LLC-- the " _Buyer_ " and/or " _Bioceres_ ", the " _Parties_ "
and/or the " _Party_ ", as appropriate) the following offer to amend the Call
Option Offer (the " _Proposed Addendum_ ").

  

In this sense, and considering the negotiations held in the current month
between the Parties tending to modify the terms and conditions of the Call
Option Offer, we submit to you this Proposed Addendum which, if accepted by
you, shall be governed in accordance with the terms attached hereto as
_Appendix 1_.

  

This Proposed Addendum shall be valid for three (3) business days and shall be
deemed accepted if all Sellers send written notice to Buyer informing Buyer of
their acceptance of the Proposed Addendum.

  

Yours sincerely,

  

 _/s/ Federico Trucco 
_ BIOCERES S.A. 
Printed Name: Federico Trucco 
Capacity of: Legal Representative

  

 _/s/ Federico Trucco 
_ RASA HOLDING LLC 
Printed Name: Federico Trucco 
Capacity of: Chairperson

     

 _APPENDIX 1 
_ _PROPOSED ADDENDUM TERMS AND CONDITIONS_

  

WHEREAS:

         A.   |     

(i) International Property Services Corp., a corporation duly organized and
lawfully in existence at this date pursuant to the laws of the Republic of
Panama, with domicile at Almirante Brown 3185 Piso 4 Ofic. 6, Ciudad de Mar
del Plata, Provincia de Buenos Aires (" _IPS_ ") is the holder of 5,404,000
shares accounting for 13.51% of the capital stock and votes of Rizobacter
Argentina S.A. (" _RASA_ " or the " _Company_ "); (ii) MMM is the holder of
3,256,000 shares accounting for 8.24% of the capital stock and votes of RASA;
and (iii) PMM is the holder of 3,256,000 shares accounting for 8.24% of the
capital stock and votes of RASA; 

 
---|--- 
     B.   |     

Pursuant to the Call Option Offer, a copy of which is attached hereto as
_Appendix A_ , the Sellers granted Bioceres S.A. a Call Option on the Shares
Subject to Option I (as defined below); and 

 
     C.   |     

The Sellers have negotiated with Bioceres S.A. and its Affiliates in order to
modify the terms of the Call Option. 

   

NOW THEREFORE, if this Proposed Addendum is accepted, the Parties shall submit
to the following terms and conditions.

  

FIRST: _DEFINITIONS_

  

I.A. Unless otherwise stipulated, words used here in capital letters shall
have the meaning assigned to them below.

  

 _UAC Shares_ : Shares of UAC, valued at the redemption value resulting at the
Closing of the _Proyecto Harvest_ and/or the NYSE listing value under the
symbol "LTN" on the day of Closing of _Proyecto Harvest_ , as applicable.

  

 _Shares Subject to Option I:_ Means globally: (i) 1,404,000 non-endorsable
registered common shares of $1 par value each and entitled to five (5) votes
per share representing 3.51% of the capital stock and votes of RASA owned by
IPS (the " _IPS Shares Subject to Option I_ "); (ii) 1,296,000 non-endorsable
registered common shares of $1 par value each and entitled to five (5) votes
per share representing 3.24% of the capital stock and votes of RASA owned by
MMM (the " _MMM Shares Subject to Option I_ "); and 1,296,000 non-endorsable
registered common shares of $1 par value each and entitled to five (5) votes
per share representing 3.24% of the capital stock and votes of RASA owned by
PMM (the " _PMM Shares Subject to Option I_ ").

     

 _Shares Subject to Option II_ : Means globally: (i) 5,404,000 non-endorsable
registered common shares of $1 par value each and entitled to five (5) votes
per share representing 13.51% of the capital stock and votes of RASA owned by
IPS (the " _IPS Shares Subject to Option II_ "); (ii) 3,256,000 non-endorsable
registered common shares of $1 par value each and entitled to five (5) votes
per share representing 8.24% of the capital stock and votes of RASA owned by
MMM (the " _MMM Shares Subject to Option II_ "); and 3,256,000 non-endorsable
registered common shares of $1 par value each and entitled to five (5) votes
per share representing 8.24% of the capital stock and votes of RASA owned by
PMM (the " _PMM Shares Subject to Option II_ ").

  

 _Affiliate_ : With respect to a Party, any corporation or other legal entity
that controls it, that is currently or in the future controlled, directly or
indirectly, by that Party or that is subject to common control with that
Party. In this sense, "controlled" companies are those in which another person
or company, either directly or through another company that is also
controlled: (a) holds an interest by any title that grants the votes necessary
to form the social will, or (b) exercises a dominant influence due to the
special links between them.

  

 _Bioceres LLC_ : A company incorporated under the laws of the State of
Delaware, United States of America, continuation of Bioceres Inc.

  

 _Closing of_ _ _Proyecto Harvest__ : The date on which the acts and
transactions of _Proyecto Harvest_ will be completed.

  

 _Shareholders ' Agreement_: Has the meaning ascribed to it in Clause 5.2(iv).

  

 _Business Day_ : Any day other than Saturday, Sunday in the Argentine
Republic or in the United States of America and in which the banks of both
jurisdictions are authorized to operate.

  

 _Closing Date_ : The date of effective transfer of the Shares Subject to
Option II to the Buyer (and/or any of its Affiliates).

  

 _Notice of Exercise of the Call Option_ : The written communication to be
sent by the Buyer and/or any of its Affiliates to the Sellers, to the
domiciles herein registered for such purposes, relative to its will to
exercise the Call Option I or II, as the case may be, prior to the expiration
of the Term of Exercise of Call Option I or II, as the case may be.

  

 _Call Option I_ : The right to purchase the Shares Subject to Option I
granted in the Call Option Offer by MMM, PMM and IPS in favor of the Buyer and
its Affiliates.

  

 _Call Option II_ : The right to purchase the Shares Subject to Option II
granted in this Agreement by MMM, PMM and IPS in favor of the Buyer and its
Affiliates.

     

 _Term of Exercise of Call Option I_ : From the acceptance of this Proposed
Addendum until [March 31, 2019], if the Closing of _Proyecto Harvest_ does not
occur.

  

 _Term of Exercise of Call Option II_ : From the acceptance of this Proposed
Addendum to the day of Closing of _Proyecto Harvest_.

  

 _Purchase Price II_ : Has the scope established in Clause 4.

  

 _ _Proyecto Harvest__ : A transaction or series of transactions that will
consist primarily of the possible reverse acquisition of UAC by Bioceres LLC
(a subsidiary of Bioceres S.A.) contributing certain assets to UAC (100% of
its interest in New Bioceres Inc.) in return for a majority interest in UAC.

  

 _UAC_ : Union Acquisition Corporation, a company incorporated in the Cayman
Islands, whose shares are listed on the New York Stock Exchange (NYSE "LTN")
and which, after the Closing of the _Proyecto Harvest_ will be controlled by
Bioceres LLC.

  

 _USD_ : U.S. Dollars.

  

I.B. _Interpretation_.

  

(a) The titles used in this Proposed Addendum are purely indicative and in no
way affect the extent and scope of the respective provisions or the rights and
obligations assumed by the Parties under them.

  

(b) If the context so requires, words in the singular include the plural and
vice versa, and words in the masculine or neuter gender in Spanish include the
masculine, feminine, and neuter.

  

(c) References to Sections, Articles and Appendixes included in this Proposed
Addendum shall be construed (unless otherwise indicated) as references to
Sections, Articles and Appendixes of this Proposed Addendum.

  

I.C. _Referral_.

  

Unless otherwise stated, words used herein in capital letters shall have the
meaning assigned to them in the Call Option Offer.

  

 _SECOND_ : _GRANTING OF CALL OPTIONS_. _CALL OPTION I and CALL OPTION II_

  

2.1 Upon acceptance of this Proposed Addendum, the Sellers grant to the Buyer
(and/or any of its Affiliates) the Call Option I on the Shares Subject to
Option I and the Call Option II on the Shares Subject to Option II, under the
terms set forth herein.

     

2.2 The Call Options I and II may be exercised indistinctly by the Buyer
and/or any of its Affiliates, and must only notify such circumstance to the
Sellers in the event of submission of the Notice of Exercise of Call Option I
or II, as appropriate.

  

2.3 The Call Options I or II shall only be exercised by the Buyer (and/or its
Affiliates) one time and on all of the Shares Subject to Option I or II, as
applicable.

  

2.4 Call Options I and II are mutually exclusive. The Buyer may only exercise
Call Option I during the Term of Exercise of Call Option I if as of March 31,
2019 the Closing of the _Proyecto Harvest_ has not occurred. In this case, the
provisions set forth in Clause Two of the Call Option Offer shall apply to
Call Option I, including in the Purchase Price of Option I an interest of 4.5%
per annum as of the acceptance of this Proposed Addendum on the price pending
collection, as set forth in Section 4.2 (i). Otherwise, if before March 31,
2019 the Closing of the _Proyecto Harvest_ has occurred, Call Option I shall
lapse in its entirety and, therefore, Buyer and/or its Affiliates shall only
be entitled to exercise Call Option II under the terms and conditions hereof.
For the sake of clarity, it is established that in all cases the closing of
the transactions contemplated under Call Option II shall be conditioned upon
the Closing of _Proyecto Harvest_.

  

2.5 Call Options I and II will become a put option in favor of the Sellers to
sell to the Buyer and/or its Affiliates the Shares Subject to Option I and II,
as applicable, upon the expiration of the Terms of Exercise of Options I and
II, respectively (the "Put Options I and II"). All the financial terms
established herein will be applied to Put Options I and II. For greater
clarity, once the Put Option I or II has been exercised, as the case may be
and as agreed in this Proposed Addendum, the Buyer shall be obliged to acquire
the Shares Subject to the various Call Options I or II, as the case may be,
owned by IPS, PMM and MMM in accordance with the terms agreed upon under this
Proposal.

  

 _THIRD_ : _CALL OPTION II_

  

3.1 The Buyer (and/or any of its Affiliates) may exercise Call Option II on
the Shares Subject to Option II by giving the Sellers Notice of Exercise of
the Call Option.

  

3.2 Given by the Buyer (and/or any of its Affiliates) the Notice of Exercise
of the Call Option within a period not greater than ten (10) Business Days
from the date of receipt of the last of the notices: (i) the Parties shall
complete the purchase and sale of the Shares Subject to Option II; (ii) the
Sellers shall transfer the Shares Subject to Option II to the Buyer (and/or
its Affiliates); and (iii) the Buyer (and/or its Affiliates) shall pay or
cause to be paid to the Sellers the Purchase Price II and shall perform the
other acts provided in Clause Fifth (the " _Closing_ ").

     

3.3 The terms of the purchase and sale of the Shares Subject to Option II
shall follow the agreement herein and substantially reflect the terms and
conditions of the Appendix I to the Call Option Offer.

  

 _FOURTH_ : _PURCHASE PRICE OF THE SHARES SUBJECT TO OPTION II_

  

4.1 The price of the Shares Subject to Option II (the " _Purchase Price II_ ")
will be USD 49,980,000 (forty-nine million nine hundred and eighty thousand
U.S. Dollars), of which USD 22,020,000 (twenty-two million twenty thousand
U.S. Dollars) correspond to IPS; (ii) USD 13,980,000 (thirteen million nine
hundred and eighty thousand US Dollars) correspond to PMM; and (iii) USD
13,980,000 (thirteen million nine hundred and eighty thousand US Dollars)
correspond to PMM.

  

4.2 Buyer (and/or any of its Affiliates) shall pay Purchase Price II on the
Closing Date by payment to Sellers of: (i) the sum of USD 14,985,000 (fourteen
million nine hundred and eighty-five thousand U.S. Dollars) to Sellers'
proprietary accounts as indicated by Sellers in writing to Buyer (and/or any
of its Affiliates) payable in full and/or by way of advances, at Buyer's
discretion, prior to the Closing Date; and (ii) payment in UAC Shares
equivalent to USD 34,995,000 (thirty-four million nine hundred and ninety-five
thousand U.S. dollars); all in accordance with the proportions corresponding
to the Sellers indicated in _Appendix 4.2_ hereof. Likewise, the Parties agree
that in the event that the Closing of _Proyecto Harvest_ does not occur as of
March 31, 2019, any type of advances that may have been received in such
respect shall be discounted from the Purchase Price of Option I.

  

4.3. Without prejudice to the proportions of payment of Purchase Price II set
forth in 4.2 (i) and (ii), the Buyer (and/or any of its Affiliates) shall have
the power, at its discretion, to alter such proportions by cancelling Purchase
Price II by delivery to the Sellers of greater or lesser quantity of cash
and/or UAC Shares. Notwithstanding the foregoing, in all cases, the Buyer
(and/or any of its Affiliates) shall make payments in cash or in kind, as the
case may be, on a _pro rata_ basis among the Sellers in accordance with their
shareholdings and communicate such circumstance in the Notice of Exercise of
the Call Option.

  

4.4 If Buyer (and/or any of its Affiliates) elects to pay Sellers the Purchase
Price II by payment in kind of an amount greater than the equivalent of USD
34,995,000 (thirty-four million nine hundred and ninety-five thousand U.S.
Dollars, ) in UAC Shares, then the Sellers will have an irrevocable put option
whereby the Sellers will have the right to sell and the Buyer (and/or any of
its Affiliates) will be obligated to purchase from the Sellers the quantity of
UAC Shares delivered in excess of the Purchase Price II set forth in Clause
4.2(ii), all on the terms of _Appendix 4.4_ hereof. Shares Subject to the
Irrevocable Put Option under the terms of Appendix 4.4 shall be exempt from
any transfer limitation and from the exercise of the Option as well as from
the pledge agreed in Appendix 4.6.

     

4.5 If, on the contrary, Buyer (and/or any of its Affiliates) chooses to pay
Sellers the Purchase Price II in cash in an amount greater than USD 14,985,000
(fourteen million nine hundred and eighty-five thousand U.S. Dollars), then
Sellers will grant Buyer (and/or its Affiliates) an irrevocable put option
under which Buyer (and/or any of its Affiliates) will have the right to sell
and Sellers will be obligated to purchase from Buyer (and/or any of its
Affiliates) UAC Shares for the sum of U.S. Dollars paid in excess of Purchase
Price II set forth in Clause 4.2 (i), as set forth in _Appendix 4.5_ hereof.

  

4.6 The particular provisions described in _Appendix 4.6_ hereof in relation
to the payment of Purchase Price II under Purchase Option II shall apply to
PMM and MMM.

  

 _FIFTH: CLOSING DATE OF CALL OPTION II_

  

5.1 The Closing will take place at Av. Leandro N. Alem 882, piso 13, Ciudad de
Buenos Aires, on the date indicated by the Buyer (and/or any of its
Affiliates) in the Notice of Exercise of the Call Option.

  

5.2 On Closing Date:

         (i)   |     

The Sellers will perform all acts conducive to transferring the Subject Shares
to Option II to the Buyer (and/or any of its Affiliates) substantially in
accordance with the terms and conditions of _Appendix I_ of the Call Option
Offer; 

---|--- 
     (ii)   |     

The Buyer (and/or any of its Affiliates) shall pay or cause to be paid in
favor of the Sellers the Purchase Price II in UAC Shares, pursuant to their
registration in the UAC Record Book, and/or in cash in the proportions
indicated in the Notice of Exercise of Call Option; 

     (iii)   |     

Subject to the proportions of payment of Purchase Price II in UAC Shares
and/or cash, the Parties will subscribe irrevocable put options on terms
substantially similar to those set forth in the _Appendixes 4.4_ and _4.5_ ,
as applicable; 

     (iv)   |     

The Sellers shall enter into a Shareholder Agreement with the Buyer and/or its
Affiliates in substantially the same terms as _Appendix 5.2(iv)_ regulating
their rights and obligations as shareholders of UAC and establishing
limitations on the transfer of UAC Shares; 

      
         (v)   |     

MMM and PMM shall grant to the Buyer and/or its Affiliates, as applicable, a
first priority pledge on 75% of the UAC Shares they receive as part of the
payment of Purchase Price II. This guarantee and its form of release shall be
governed by the terms set out in _Appendix 5.2(v)_ and record shall be kept
that the UAC Shares paid in excess as agreed in clause 4.4 hereof are not
included and are not within the stipulated percentage. 

---|--- 
     (vi)   |     

The Parties shall perform all acts desirable or conducive to completing the
transactions which are the purpose of Purchase Option II and this Proposed
Addendum. 

   

 _SIXTH_ : _MISCELLANEOUS PROVISIONS_

  

6.1 _Notices_

  

All notifications between the Parties shall be in writing and in a faithful
manner, addressed to the following addresses:

  

 _To IPS_ : 
Almirante Brown 3185 Piso 4 Ofic. 6, 
Ciudad de Mar del Plata 
Provincia de Buenos Aires 
Argentina

  

CC (which shall not constitute a notification) to: 
Andrea Capriotti 
Pinto 1200, Ciudad de Pergamino 
Provincia de Buenos Aires

  

 _To Mar ia Marta Mac Mullen_: 
25 de mayo 2974 UF 19 Barrio El Carmen, 
Ciudad de Pergamino, 
Provincia de Buenos Aires

  

 _To Pedro Enrique Mac Mullen_ : 
Henrich 399, Barrio Las Marias, 
Ciudad de Pergamino, 
Provincia de Buenos Aires

  

CC (which shall not constitute a notification) to:

     

Andrea Capriotti 
Carlos Gorordo 
Av. de Mayo 380 - Planta Alta, 
Ciudad de Pergamino, 
Provincia de Buenos Aires

  

 _To the Buyer_ : 
Ocampo 210 bis 
Predio CCT, Rosario, Sta. Fe, ARG. 
Tel.: +54 341 4861100 
Attn.: Gloria Montaron Estrada

  

CC (which shall not constitute a notification) to:

  

Marval, O'Farrell and Mairal 
Leandro N. Alem 882 
Ciudad de Buenos Aires 
Tel.: 54 11 4310 0100 
Fax: 54 11 4310 0200 
Attn.: Diego S. Krischcautzky

  

6.2 _Confidentiality_

  

All information exchanged by the Parties in connection with this Proposed
Addendum is confidential and shall remain so except where it comes to the
public's knowledge by a third party not bound by an obligation of
confidentiality or by the Party that provided the confidential information
and/or where such information is required by administrative or judicial
authority with proper authority to do so and/or in the event of a dispute
between the Parties arising out of the interpretation, validity, performance
and breach hereof.

  

6.3 _Assignment_

  

Neither Party shall be entitled to assign the rights and/or obligations
arising hereunder without the prior express consent of the other, with the
exception of the Buyer, which shall be entitled to assign its rights and
obligations to an Affiliate.

     

6.4 _Ratification_

  

Except as modified herein, the Parties ratify all remaining terms and
conditions of the Call Option Offer.

  

6.5 _Governing Law and Dispute Settlement_

         (a)   |     

This Proposed Addendum shall be governed by and construed in accordance with
the laws of the Argentine Republic. 

---|--- 
     (b)   |     

In the event of any disagreement, controversy or conflict arising with respect
to the validity, interpretation, performance or resolution hereof, the Parties
expressly agree to conduct an initial mediation process during a period of 30
days, submitting themselves to the Mediation and the Rules of Procedure and
Code of Ethics of _Centro Empresarial de Mediaci on y Arbitraje (Asociacion
Civil)_, based in the city of Buenos Aires, Argentina. The Parties may extend
said term. In the event that they have not reached an agreement, the dispute
or the unresolved partial aspects thereof shall be submitted to arbitration in
accordance with the rules of the aforementioned center. For the execution of
the award and all other cases outside the arbitration jurisdiction, the
Parties submit to the ordinary jurisdiction of the Courts of the City of
Buenos Aires. The corresponding award shall be final and non-appealable for
the Parties who expressly establish that this arbitration clause shall be
considered as an autonomous agreement independent of the other stipulations
contained in this proposal; that the total or partial nullity thereof shall
not imply the nullity of the arbitration clause, and that the arbitrator(s)
shall have the power to decide on their own competence and on the existence or
validity of the arbitration clause. 

      

Appendix A 
Copy of the Call Option Offer

     

Appendix 4.2 
Allocation of Purchase Price II

         Individual    | Holdings    | Total USD    | USD Cash
   | USD in shares 
---|---|---|---|--- 
     Pedro Mac Mullen    | 8.24%   | 13,980,000   | 4,860,000   |
9,120,000 
     Maria Marta Mac Mullen    | 8.24%   | 13,980,000   |
4,860,000   | 9,120,000 
     IPS    | 13.51%   | 22,020,000   | 5,265,000   | 16,755,000 
     Totals    | 29.99%   | 49,980,000   | 14,985,000   |
34,995,000 
      

Appendix 4.4 
Irrevocable Put Option Model (IPS /MM)

     

Appendix 4.5 
Irrevocable Put Option Model (BIOX)

     

Appendix 4.6 
Particular Provisions Applicable to PMM and MMMM

  

PMM and MMM state that on 10% of the MMM Shares Subject to Option II and the
PMM Shares Subject to Option II there is an interim measure ordered in the
case entitled " _Harnan Miguel, Marcos y Martina c/Mac Mullen Jorge y otros s/
Medidas cautelares "_, Case N 76.745 filed at the Civil and Commercial Court
No. 2 of San Nicolas, Buenos Aires Province (the "Interim Measure"), under
which an embargo was placed on 44% of RASA's share capital. The Interim
Measure also placed an embargo on 30% of the dividends accruing from the
liened RASA shares. Likewise, the MMM Shares Subject to Option II and the PMM
Shares Subject to Option II could be affected by a nullity lawsuit in which
the ownership of 80% of RASA's share capital is argued in the proceedings "
_Harnan, Miguel, Marcos y Martina c/ Mac Mullen Jorge Enrique y otros s/ Acci
on de nulidad_", Case No. 76806, filed before the Civil and Commercial Court
No. 5 of San Nicolas, Buenos Aires Province (the "Nullity Lawsuit").

  

Accordingly, in the event of an unfavorable outcome (the procedural principles
set out in the following paragraph apply) of the Interim Measure and/or the
Nullity Lawsuit, PMM and MMM undertake to return to the Buyer and/or its
Affiliates 75% of the UAC Shares received in payment in the event of the
exercise of Call Option II, excluding shares received in excess of such
calculation and which are subject to the irrevocable put option set forth in
clause 4.4. As security for the fulfilment of their obligation, they undertake
to pledge on the Closing Date such UAC Shares in substantially the same manner
as the terms set out in Appendix 5.2 (v) in favor of the Buyer and/or its
Affiliates.

  

The pledge on the UAC Shares will expire once the judicial proceedings listed
above obtain a favorable result that completely rejects the claim of the
plaintiff (in accordance with the modes of termination of the proceedings
regulated in the Code of Civil and Commercial Procedure of the Province of
Buenos Aires, including the transaction validated by final judgment) and are
completed and, as long as there is no pending resolution or compliance with
any claim, action or procedure directly or indirectly related to such legal
proceedings, or which in any way could affect the peaceful ownership of and/or
the exercise of the rights derived from the MMM Shares Subject to Option II
and the PMM Shares Subject to Option II. It shall be understood that the
conditions for the cancellation of the pledge have been met when: (i) the
aforementioned conditions are met, (ii) the one-year limitation period for the
autonomous action for review of the _res judicata_ has elapsed (article 2564
Civil and Commercial Code), from the date on which the final judgement or
decision on the merits which terminates the last of the legal proceedings
referred to above becomes final (in accordance with the modes of termination
of the proceedings regulated in the Civil and Commercial Procedural Code of
the Province of Buenos Aires), and (iii) the termination of such proceedings
has been notified in a reliable manner to the Buyer and/or its Affiliates.

     

PMM and MMM undertake to sustain and/or continue with the defense presented to
date in the judicial proceedings mentioned above and not to perform any act
that may affect the acquisition of MMM Shares Subject to Option II and PMM
Shares Subject to Option II by the Buyer and/or its Affiliates.

     

Appendix 5.2(iv) 
Shareholders' Agreement Model

     

Appendix 5.2(v) 
Pledge of Shares Contract Offer Model

        '

